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Abstract 
 
The mammalian mitochondria contain their own genome that encodes thirteen 
polypeptide components of the oxidative phosphorylation (OxPhos) system, and the 
mitochondrial (mt-) rRNAs and tRNAs required for their translation. The maturation 
of the mitochondrial ribosome requires both mt-rRNAs to undergo post-
transcriptional chemical modifications, folding of the rRNA and assembly of the 
protein components assisted by numerous biogenesis factors. The post-transcriptional 
modifications of the mt-rRNAs include base methylations, 2’-O-ribose methylations 
and pseudouridylation. However, the exact function of these modifications is 
unknown. Many mitoribosome biogenesis factors still remain to be identified and 
characterised. This work aims to broaden our understanding of two proteins involved 
in mitoribosome biogenesis through the study of the function of an rRNA 
methyltransferase and a novel biogenesis factor.  
Firstly, we characterised MRM1 (mitochondrial rRNA methyltransferase 1), a highly 
conserved 2’-O-ribose methyltransferase. We confirmed that MRM1 modifies a 
guanine in the peptidyl (P) transferase region of the 16S mt-rRNA that specifically 
interacts with the 3’ end of the tRNA at the ribosomal P-site. In bacteria, the 
modification is dispensable for ribosomal biogenesis and cell viability under standard 
conditions. However, in yeast mitochondria, Mrm1p is vital for ribosomal assembly 
and function. We generated knockout cells lines using programmable nuclease 
technology, and characterised the possible effects of MRM1 depletion on 
mitochondrial translation and mitoribosome biogenesis. We demonstrated that 
neither the enzyme nor the modification is required for human mitoribosomal 
assembly and translation in our experimental setup. 
Secondly, we identified a novel mitochondrially-targeted putative RNA endonuclease, 
YbeY. Using YbeY knockout cell lines, we showed that depletion of YbeY leads to loss 
of cell viability and OxPhos function as a consequence of a severe decrease in 
mitochondrial translation. Northern blotting and transcriptomic analysis using next 
generation RNA-Seq revealed transcript-specific changes to steady state levels. This 
analysis identified mt-tRNASer as a potential target of YbeY. We investigated the effect 
of YbeY deficiency on mitoribosomal assembly by quantitative sucrose gradient 
fractionation and mass spectrometry. This analysis showed that the mt-SSU is 
viii	
depleted in YbeY knockout cells. Further, immunoaffinity purification identified 
MRPS11 as a key interactor of YbeY. We propose that YbeY is a multifunctional 
protein that performs endonucleolytic functions in the mitochondria and also acts as a 
mitochondrial ribosome biogenesis factor, assisting small subunit assembly through its 
interaction with MRPS11.  
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1 Introduction 
 
1.1 – The mitochondrion – evolution and structure 
The turning point in driving the success of the eukaryotic domain of life was the 
evolution of compartmentalisation in eukaryotic cells. This allowed the development 
of specialised compartments within the cell that could perform more complex 
functions and, therefore, could be more tightly regulated. These compartments, called 
organelles, allowed the development of more specialised cells that could evolve to 
adapt to changing demands put on the cell and eventually evolve into multicellular 
organisms (Lane and Martin, 2010). One of these organelles is the mitochondrion. 
Mitochondria are double membrane-bound sub-compartments of the cells that that 
emerged during an endosymbiotic merger between an anaerobic archaebacterium 
and a protobacterium similar to the α-proteobacteria of the order, Rickettsiales 
(Williams et al, 2007; Anderson et al., 1981; Andersson et al., 1998; Sagan, 1967; 
Martin & Müller, 1998). 
In mammalian cells, these organelles have changed substantially since their 
protobacterial origins approximately 1.5 billion years ago. Over time, the 
mitochondrion has specialised through a drastic reduction of the genome, now 
encoding less than 1% of the proteins found in the mitochondria. About 99% of the 
proteins (~1500) are now encoded in the nucleus, synthesised in the cytosol and 
imported into mitochondria (Lopez et al, 2000; Calvo et al, 2016).  
The structure and function of mitochondria are closely linked. Even though 
mitochondria are normally depicted as small rod-like structures, they are a continually 
changing between dynamic network of reticula or a fragmented state, constantly 
dividing and fusing with other mitochondria, interacting with other organelles like the 
endoplasmic reticulum, and communicating with the cell. Mitochondria are a double 
membrane-bound structure, where the outer mitochondrial membrane (OMM) is 
partially permeable to small molecules (<5kDa) from the cytosol, and the inner 
mitochondrial membrane (IMM), enclosing the mitochondrial matrix, is extremely 
impermeable. The inner membrane is further specialised in that it is highly 
invaginated into structures called cristae, consisting of large complexes of the 
respiratory chain. This means that, to shuttle proteins synthesised in the cytosol, 
through the outer mitochondrial membrane, most nuclear encoded proteins carry a 
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N-terminal amphipathic helix mitochondrial targeting signal (MTS), and both 
membranes have evolved to contain multicomponent translocation machineries to 
recognise and import these proteins (Dudek et al., 2013). Furthermore, the inner 
mitochondrial membrane, being impervious to passive diffusion, contains a large 
variety of mitochondrial carriers to import substrates for the mitochondrial enzymes. 
 
1.2 – Functions of the mitochondria 
 
1.2.1 Powerhouse of the cell 
The mitochondria are often described as the ‘powerhouse of the cell’. However, this is 
an inadequate description of the function of the mitochondrion because it is not only 
responsible for the generation of a majority of the ATP required to drive the 
endergonic functions of the cell, but it is also the house for various other important 
cellular processes (figure 1.1). At least part of the biosynthetic pathways of iron-
sulphur clusters, haem and pyrimidines happen in the mitochondria (Pearce et al., 
2017).  
 
Figure 1.1 Summary of mammalian mitochondrial functions 
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A major function of the mitochondria is the production of ATP. A small proportion of ATP is derived 
through glycolysis. The pathway that generates ATP begins in the cytosol with the oxidation of glucose 
into pyruvate, producing 2 molecules of ATP per glucose molecule. However, a majority of ATP is 
derived from oxidative phosphorylation. This process begins with the import of into the mitochondrial 
matrix that is used by the pyruvate dehydrogenase complex to produce acetyl-CoA pyruvate (Bricker et 
al., 2012; Herzig et al., 2012). Mitochondria are also produce acetyl-CoA through β-oxidation of 
fatty acids. The acetyl-CoA is fed into the TCA cycle which through a series of sequential reactions 
leads to the reduction of NAD+ and FAD cofactors to NADH and FADH2, which are used in the 
electron transport chain. The electrons from these reduced cofactors are then consumed in the respiratory 
chain at NADH dehydrogenase (Complex I) and succinate dehydrogenase (Complex II). In the 
electron transport chain, the electrons are first passed onto ubiquinone. The lipid soluble ubiquinol 
product of ubiquinone reduction carries the electrons to cytochrome c (by Complex III), which itself 
passes the electrons to Complex IV (cytochrome c oxidase). Finally, the electrons are used to reduce 
molecular oxygen to produce water. The series of redox reactions and transfer of these electrons is 
tightly coupled to the transport of protons out of the mitochondrial matrix establishing an 
electrochemical gradient (proton motive force) across the IMM. This proton motive force created by the 
gradient of charge and proton concentration is used by the mitochondria to transport proteins into the 
mitochondria and drives the rotations of the central domain of the ATP synthase (Complex V). This 
rotary catalysis mechanism facilitates the generation of ATP from ADP and inorganic phosphate (Pi) 
(Walker, 2013). The ATP is then exported out of the matrix by adenine nucleotide translocators to be 
used in endergonic cellular processes. Mitochondria produce oxaloacetate for aspartate and asparagine 
synthesis, and 2-oxogluterate for glutamate, glutamine, arginine and proline synthesis. The 
mitochondria are also involved in the early and final steps of heme synthesis, and a part of pyrimidine 
biosynthesis and the urea cycle.   
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Figure 1.2 Schematic of the electron transport chain. Complex I and II reduce obiquinone to 
ubiquinol. Complex III oxidises ubiquinol and oxidises cytochrome c. Finally, the electrons are passed 
from cytochrome c on to molecular oxygen by complex IV producing H2O. The movement of electrons 
is used to catalyse the translocation of protons across the inner membrane which generates a proton 
gradient that is used to fuel ATP synthase activity. IMS, intermembrane space, IM, inner membrane; 
MM, mitochondrial matrix; Q, ubiquinone; QH2 
 
The respiratory complexes can also associate with each other to form 
‘supercomplexes’ such as the supercomplexes containing complex I+III, I+III+IV, 
and III+IV. Complex II does not seem to associate with any other complex and 
complex V dimerises with itself. Overall, these complicated superstructures facilitate 
efficient transport of electrons between them (Chaban et al., 2014).  
 
1.2.2 Mitochondria and programmed cell death 
Mitochondria also play a key role in programmed cell death. This is led by 
mitochondrial outer membrane permeabilization and cristae remodelling which cause 
the release of apoptotic factors such as cytochrome c, Diablo/SMAC and apoptosis 
initiating factor (Uren et al., 2005). Moreover, the mitochondria also maintain cellular 
calcium homeostasis by acting as a Ca2+ store and coordinating intracellular calcium 
signalling. Dysregulation of calcium homeostasis is associated with the formation of 
the permeability transition pore in the outer membrane, which releases the pro-
apoptotic factors that stimulate caspase-mediated apoptosis.  
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1.3 Mitochondrial DNA  
 
1.3.1 Organisation and Structure 
The mitochondria derive its genome from its protobacterial ancestor. Mammalian 
mitochondrion contains ~1000 copies of the mitochondrial genome, each ~16 kb in 
length. Mitochondrial DNA is tightly packed into nucleoprotein complexes called 
nucleoids, that are commonly associated with the inner membrane (Albring et al., 
1977, Brown et al., 2011). These mitochondrial nucleoids are focal points for mtDNA 
maintenance, replication and transcription, consisting of proteins such as 
Mitochondrial Transcription Factor A (TFAM), mitochondrial single-stranded DNA-
binding protein (mtSSB), DNA Polymerase γ and mtRNA polymerase (Garrido et al., 
2003, Bogenhagen et al., 2008). TFAM is a highly abundant mobility group box 
protein that facilitates the compact nature of the mtDNA. This core transcription 
factor causes the genome to undergo negative supercoiling causing the mtDNA to 
become severely compacted (Ngo et al., 2011; Rubio-Cosials et al., 2011). A recent 
study showed that nucleoids predominantly consist of a single mtDNA molecule 
compacted into the nucleoidal structure through the action of TFAM (Kukat et al., 
2015). In the absence of TFAM, the mtDNA becomes unstable and mitochondrial 
transcription is impaired (Larsson et al., 1998; Matsushima et al., 2003).  
The double stranded mitochondria DNA (mtDNA) is divided into the heavy strand 
(H-strand) and light strand (L-strand). The heavy strand is rich in guanine nucleotides, 
and this difference in composition results in different bouyancies in caesium chloride 
gradients, as one is heavier than the other. The circular genome encodes 13 
polypeptide components of the respiratory complexes (I, III, IV and V), and 
functional RNAs, 22 tRNAs and 2 rRNAs of the translation machinery that are 
required to synthesise these proteins (figure 1.2). Unlike the nuclear genome, no 
introns are found in the mitochondrial genome.   
An important region of the genome is a ~1.1 kb major non-coding region (NCR) 
containing the H- strand (HSP) and L- strand (LSP) promoters of transcription and 
the H-strand origin of replication (OH). On the other strand, the L-strand origin of 
replication (OL) lies two-thirds along the circular genome in a cluster of five tRNAs. A 
large portion of the NCR is a three-stranded region called the D-loop containing a 
third 7S DNA strand necessary for mtDNA replication (figure 1.3).  
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Figure 1.3 Schematic representation of the mammalian mitochondrial genome. The DNA can be 
divided into a heavy strand (light green) and light strand (dark green). Protein coding regions are 
generally punctuated by tRNAs (Dark red bars in circular genome). The major non-coding region 
(above) of the genome contains the D-loop where replication of the H-strand begins showing the 7S 
DNA, supposed heavy strand promoters (HSP1, HSP2, LSP), three conserved sequence boxes 
(CSB1-3), Heavy strand origin or replication (OH) and termination associated sequence (TAS). The 
light strand origin of replication (OL) is also indicated two-thirds along the genome in a non-coding 
region in a cluster of 5 mt-tRNAs (W, A, N, C, Y).  
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1.3.2 Mitochondrial replication 
 
1.3.2.1 The mitochondrial replisome 
In vitro experiments showed that the mtDNA replisome can be fundamentally 
separated into to three main components, Polγ, Twinkle and mtSSB (Korhonen et al., 
2004). Polγ is a heterotrimeric complex consisting of a catalytic subunit (PolγA) 
consisting of the 5’-3’ DNA polymerase and 3’-5’ proofreading exonuclease, and a 
homodimer (PolγB) that ensures high binding affinity. The Twinkle helicase is 
responsible for the mtDNA duplex denaturation stimulated by single-strand binding 
protein, mtSSB (Spelbrink et al., 2001; Melenkovic et al., 2013, Tiranti et al., 1993). 
The tetrameric mtSSB binds to single stranded DNA stabilising the replication fork 
(Korhonen et al., 2003; Korhonen et al., 2004). 
However, other factors have also been shown to be involved in replication in living 
cells. The mitochondrial RNA polymerase POLRMT (Fusté et al., 2010), RNaseH1 
(Cerritelli et al., 2003), DNA ligase III (Gao et al. , 2011; Simsek et al. , 2011) and 
MGME1 (Szczesny et al., 2013; Kornblum et al. 2013, Nicholls et al., 2014). 
Recently, a DNA polymerase-primase called PrimPol was also identified that 
facilitates the progression of the mtDNA replication fork at lesions, replication blocks 
or DNA damaged sites and may be responsible for mtDNA repair (Garcia-Gomez et 
al., 2013; Matinez-Jimenez et al., 2015).  
 
1.3.2.2 Models of mtDNA replication 
There are three competing models of mtDNA replication – the strand displacement 
model (SDM), ribonucleotide incorporation throughout the lagging strand (RITOLS) 
and strand-coupled replication. 
In the strand displacement model, replication begins at OH in the NCR primed by 7S 
DNA. The 7S DNA is produced when transcription initiated from the LSP transitions 
to DNA synthesis. There are three conserved sequence blocks (CSB) within this region 
that facilitates the switch from RNA synthesis to DNA synthesis (figure 1.2) (Chang 
and Clayton, 1985). CSB2, in particular, produces G-quadruplexes, which terminate 
transcription of the 7S RNA, allowing synthesis of 7S DNA (Wanrooij et al., 2010; 
Wanrooij et al, 2012). The termination of 7S DNA is associated with the termination-
associated sequence (TAS) in the D-loop. However, the mechanism for the synthesis 
of the 7S DNA is still being elucidated (figure 1.2).  
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During H-strand synthesis, extension of 7S DNA proceeds unidirectionally producing 
the H-strand until it passes the OL, two-thirds along the circular DNA (Clayton, 
1982). Concurrently, mtSSB binds to the displaced ssDNA strand, preventing the 
recruitment of POLRMT and the initiation of L-strand synthesis at a wrong site. The 
formation of a stem loop structure at the OL hinders mtSSB binding, stimulating 
POLRMT to produce an RNA primer for the initiation of L-strand replication by 
Polγ. The replication of both strands then progresses until they terminate at their site 
of origin (Fuste et al., 2010; Wanrooij et al., 2012).  
The RITOLS model of mtDNA replication progresses very similarly to the SDM 
model. However, it does not require mtSSB to bind to the displaced strand during H-
strand synthesis. Instead, RNA intermediates produced during transcription bind to 
the ssDNA stabilising it, until the RNA is displaced or degraded during lagging strand 
DNA synthesis (Yasukawa et al., 2006; Reyes et al., 2013). Unlike asynchronous 
replication at the OH and OL proposed by SDM and RITOLS, the strand coupled 
replication suggests a bidirectional replication bubble initiating in a 5000 bp ‘Ori-z’ 
zone spanning MT-CYB, mt-ND6 and mt-ND5 (Holt et al., 2000, Bowmaker et 
al.,2003; Reyes et al., 2005). 
Before the completion of H-strand synthesis, the 7S RNA is degraded by RNaseH1, 
and the 7S DNA upstream of the OH is removed by MGME1 (Cerritelli et al, 2003; 
Holmes et al., 2015; Kornblum et al., 2013; Nicholls et al., 2014; Uhler and 
Falkenberg, 2015). Finally, mtDNA replication is terminated when the 5’ and 3’ ends 
are ligated together by DNA ligase III (Lakshmipathy et al., 1999; Puebla-Osorio et 
al., 2006).  
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1.4 Mitochondrial transcription 
The transcription of the mitochondrial genome produces polycistronic RNA 
molecules which encode 22 tRNAs, 13 polypeptides of the oxidative phosphorylation 
system and 2 rRNAs. Eight of these tRNAs and the ND6 gene are produced from the 
light strand template transcribed under a single light strand promoter (LSP) (Montoya 
et al 1982; Montoya et al 1983).  
 
1.4.1 Initiation and termination 
Transcription of the mitochondrial genome is led by separate promoters for the light 
and the heavy strand. The LSP contains the initiation site for 7S RNA production and 
also the promoter which initiates transcription along the light strand. The 
transcription of the H-strand is said to be under the control of two promoter sites, 
HSP1 and HSP2, located in the non-coding region (Figure 1.3) (Montoya et al, 1982; 
Montoya et al, 1983, Chang and Clayton, 1984). In the classical model, transcription 
initiating at HSP1, 19 bp upstream of tRNA-Phe produces tRNA-Phe, tRNA-Val and 
the two rRNAs (12S and 16S), terminating at the tRNA-Leu(UUR) gene. On the 
other hand, transcription initiating at HSP2, begins just upstream of the 12S mt-
rRNA gene and does not terminate at the tRNA-Leu(UUR) site, instead producing a 
transcript spanning the entire genome, encoding two rRNAs, 12 mRNAs and 14 
tRNAs. This transcript terminates at an A/T-rich region of the NCR named D-
TERM (Camasamudram et al, 2003). However, this two-promoter model of 
transcription of the H-strand and termination at tRNA-Leu(UUR) is not supported by 
more recent in vivo (Terzioglu et al., 2013) and in vitro results (Litonin et al, 2010).  
 
1.4.2 Transcription machinery 
Transcription in the mitochondria is driven by POLRMT, a DNA-dependent RNA 
polymerase homologous to RNA polymerases in T3 and T7 bacteriophages (Tiranti 
et al., 1997). The C-terminal domain contains the functionally important, highly 
conserved, catalytic domain. In yeast, POLRMT contains a unique N-terminal 
sequence that is dispensable for transcription initiation but is important for mtDNA 
replication (Wang and Shadel, 1999). This has not been demonstrated in mammals. 
The mechanism by which the N-terminus contributes to POLRMT function is 
unclear. In bacteriophages, the N-terminal domain is responsible for recognition and 
binding to the promoter region. However, in mitochondria, POLRMT uses 
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additional factors to perform this function (Ringel et al., 2011). In yeast, an additional 
N-terminal extension is present, which is responsible for interacting with other 
proteins required for intron splicing (Rodeheffer et al., 2001). However, due to the 
compact nature of the mammalian mitochondrial genome, there are no introns to be 
spliced. Yet, a similar N-terminal extension is observed in POLRMT. This extension 
contains two penticopeptide repeat (PPR) domains that may function to provide site-
specific RNA interactions. However, the function of these PPR domains remains to be 
elucidated (Ringel et al., 2011).  
As mentioned earlier, POLRMT works in concert with a collection of proteins to 
control mitochondrial transcription. Activation and initiation of mitochondrial 
transcription requires the association of POLRMT with mitochondrial transcription 
factors B2 (TFB2M) and TFAM (Shi et al., 2012). Produced through a gene 
duplication event, TFB1M and TFB2M are both homologous to a bacterial SSU 
rRNA methyltransferase (Cotney and Shadel., 2006). Both these proteins retain their 
methyltransferase activity. However, it has been shown that the primary function of 
TFB1M is the dimethylation of mtSSU rRNA (see Section 3.1.1), and the primary 
function of TFB2M is to induce promoter melting required for initiation of 
transcription (Falkenberg et al., 2002; McCulloch et al., 2002; Seidel-Rogol et al., 
2003). Transcription begins with the binding of TFAM to the DNA causing bending 
and melting. Then, a POLRMT+TFB2M complex is recruited to the initiation site 
with TFAM acting to stabilize the DNA-protein complex for initiation of transcription 
(Posse and Gustafsson, 2017; Ramachandran et al., 2017). 
TFAM, in addition of being a mitochondrial transcriptional activator, has non-specific 
DNA binding capabilities that allows it to function as a DNA packaging protein in the 
nucleoid (Fisher and Clayton, 1985; Parisi and Clayton, 1991). TFAM has been 
shown to interact with TFB1M and TFB2M (Dairaghi et al., 1995; McCulloch and 
Shadel, 2003).  It has also been suggested that phosphorylation, acetylation and 
targeted degradation of TFAM by the Lon protease may lead to dynamic regulation 
of TFAM-mediated transcription (Lu et al., 2012; Matsushima et al., 2010; Bestwick 
and Shadel., 2013). In vitro reconstitution of mitochondrial transcription shows that 
TFAM concentrations can determine promoter-specific transcription. TFAM can 
activate transition from HSP1 and LSP. However, high concentration of TFAM can 
suppress transcription from the supposed HSP2 site (Lodiero et al., 2012; Zollo et al, 
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2012). And since H-strand replication is tightly linked to transcription from the LSP 
promoter, it could be envisaged that TFAM levels could be linked to replication.  
Elongation of transcripts in mitochondria is coordinated by mitochondrial 
transcription elongation factor, TEFM. Transcription from the LSP is often 
prematurely terminated at the conserved sequence block 2 in the major non-coding 
region. Though this process is required to prime replication of the mtDNA, this is 
inhibitory to the progression of transcription (Tan et al., 2016). This protein interacts 
with POLRMT with its conserved C-terminal domain, without interacting with 
initiation factors TFB2M and TFAM. Moreover, reduction in TEFM causes a 
depletion of promoter-distal elongation products (Minczuk et al., 2011). TEFM allows 
POLRMT to pass this region and allows the transcription of the L-strand primary 
transcript (Posse et al., 2015). TEFM has been shown to facilitate communication 
between transcription and replication in vitro (Agaronyan et al., 2015). However, this 
has not been demonstrated in vivo. 
MTERF1 (mitochondrial transcription termination factor 1) is the protein responsible 
for termination of transcription. It was initially suggested that MTERF1 binds to the 
HSP1 promoter site and the site of termination in tRNA-Leu(UUR), thereby 
facilitating termination of transcription by base flipping and DNA unwinding, and the 
recycling of the transcription machinery back to the promoter site. (Martin et al., 
2005, Yakubovskaya et al., 2010; Jimenez-Menendez et al., 2010).   This model was 
put forward to explain the 50-fold abundance of the rRNAs in the mitochondrial 
relative to other mitochondrial RNAs (Martin et al., 2005). However, studies in 
MTERF knockout mice do not show differences in the supposed rRNA products of 
HSP1 transcription (Terzioglu et al., 2013). This suggests that the high abundance of 
rRNA is a consequence of their higher stability and half-life rather than due to 
additional transcription from an alternative promoter. Recent evidence states that 
MTERF instead plays a role in preventing the progression of the replication fork into 
the rRNA sequence while it is being transcribed, and prevents the transcription of the 
anti-sense sequence of the rRNAs (Hyvarinen et al., 2010; Terzioglu et al., 2013; Shi 
et al., 2016).  
Additional factors that have been implicated in transcription regulation include a mt-
LSU component, MRPL12, which interacts with POLRMT and activates 
transcription in vitro (Surovtseva et al., 2011; Wang et al., 2007). A depletion of 
MRPL12 leads to a depletion in POLRMT (Nouws et al., 2016). This suggests a 
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possible communication between the translation apparatus and transcription 
machinery.  
 
1.5 Maturation of transcription products 
 
1.5.1 Cleavage of the primary transcript 
The mitochondrial genome is transcribed as long polycistronic molecules. The genes 
coding for mRNA and rRNA are punctuated by tRNA-coding regions. Removal of 
the tRNA from these molecules generates RNA products for translation and assembly 
into the ribosome (Anderson et al., 1981; Ojala et al., 1981). This model that defines 
the processing of this primary transcript is called the ‘tRNA Punctuation Model’.   
A majority of tRNA excision and mt-RNA processing is performed by RNase P and 
RNase Z (ELAC2). In eight out of thirteen polypeptides encoded in the mitochondrial 
genome, the mRNA sequences immediately precede tRNA-coding sequences (Ojala 
et al., 1981). The RNase P enzyme is responsible for the 5’-end maturation of tRNA 
precursors and is vital for the endonucleolytic activity required for the release of 
different RNA species from the primary transcript. Unlike previously characterised 
RNAse P enzymes in the cytoplasm or bacteria, the mitochondrial version contains no 
RNA component. RNase P is a heterotrimer composed of three entirely proteinaceous 
subunits (mitochondrial RNase P proteins 1, 2, and 3 (MRPP1-3)) that independently 
have separate functions but moonlight as components of the heterotrimeric RNase P 
complex (Holzmann et al., 2008).  
MRPP1 (TMRT10C or RG9MTD1) is the mammalian homologue of yeast tRNA 
m1G9-methylase Trm10, which in RNase P, is responsible for tRNA binding. MRPP2 
(17β-hydroxysteroid dehydrogenase type 10 (HSD10) or SDR5C1) is a 2-methyl 3-
hydrobutyryl-coA-dehydrogenase (MHBD) involved in isoleucine metabolism. 
Together, MRPP1 and MRPP2 also form a heterodimer that methylates adenines or 
guanines in position 9 of mt-tRNAs. This modification is vital for mt-tRNA folding 
and is independent of the mtRNA processing activity. Patients with a recessive 
mutation in MRPP1 that lacks precursor processing, show a retention of 
methyltransferase activity suggesting that endonucleolytic activity is independent of 
the methyltranferase activity of the protein (Metodiev et al., 2016).   
The catalytic domain of RNase P lies in the third MRPP3 subunit. It interacts with 
MRPP1 and MRPP2 in a salt-labile manner, and without this interaction, the 
	13	
catalytic site of MRPP3 cannot present a correct conformation (Holzmann et al., 
2008, Rossmanith and Karwan, 1998). The C-terminal of MRPP3 contains two 
pentatricopeptide repeats (PPR) motifs which assist in RNA binding, and a 
metalloprotease domain containing a Mg2+ ion required for the hydrolysis of the RNA 
phosphodiester bond.  
Together, the three components of RNase P recognise and cleave the nascent 
precursor transcript at the 5’ end of tRNA (Holzmann et al., 2008; Rossmanith & 
Holzmann, 2009). Knockdown of the different protein components of RNase P causes 
an accumulation of precursor molecules (Holzmann et al., 2008). MRPP1 knockdown 
reduces steady state levels of mature tRNAs which has a detrimental effect on 
translation. Knockdown of MRPP1 or MRPP3 leads to a reduction in mature 
mRNAs, bicistronic mRNAs and rRNAs. However, knockdown of MRPP1 or 
MRPP3 affects the precursor levels to different extents, suggesting different level of 
contribution of the components to tRNA processing. Moreover, overexpression of 
these proteins does not have any effect on steady state levels of these RNAs indicating 
that their concentration is not the rate-limiting step in catalysis (Lopez Sanchez et al., 
2011).  
The release of tRNAs from the primary transcript also required the action of RNaseZ 
at the 3’ end of the tRNA sequence. ELAC2 is an endonuclease which exhibits RNase 
Z activity on both nuclear and mitochondrial pre-tRNAs in vitro (Rossmanith, 2011). 
Consequently, depletion of ELAC2 causes the accumulation of tRNA precursors. 
However, mt-mRNA and mt-rRNA levels, and translation are not significantly 
affected (Brzezniak et al 2011; Sanchez et al 2011). In patients with missense 
mutations in ELAC2, increased levels of RNA processing precursors are observed, 
which leads to translational dysfunction and respiratory defect (Haack et al., 2013). 
Interestingly, RNase Z endonuclease activity is dependent on RNase P activity. 
ELAC2 only cleaves 5’-processed mt-tRNA cleavage products of RNase P suggesting 
a hierarchical processing of RNA (Brzezniak et al., 2011; Rackam et al., 2016).  
Other factors have also been identified in the precursor RNA processing, namely G-
rich sequence factor 1 (GRSF1) and penticopeptide repeat-containing proteins, 
PTCD1 and PTCD2. GRSF1 is an RNA-binding protein that binds to L-strand 
transcripts at consensus sequences in ND6 mRNA and the non-coding regions near 
ND5 and Cytb. The protein is strongly linked with early stage processing of the RNA 
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precursor as it is shown to interact with RNase P in RNA granules (see section 1.8) 
and knockdown of GRSF1 leads to an accumulation of RNA precursors produced by 
the inactivity of RNase P (Jourdain et al., 2013).   Depletion of GRSF1 leads to 
instability of mt-RNA, decreased expression of mitochondrially-encoded polypeptides, 
impaired ribosomal assembly and mitochondrial dysfunction (Antonicka et al., 2013; 
Jourdain et al., 2013).  
Both PTCD1 and PTCD2 are PPR-containing proteins that confers the ability to 
bind RNA (Small and Peeters, 2000). PTCD1 has been shown to interact with 
ELAC2. A deficiency in PTCD1 accompanies a dysregulation of 3’ tRNA processing, 
especially mt-tRNA-Leu(UUR) and mt-tRNA-Leu(CUN). Therefore, it is possible 
that PTCD1 also plays a role in sequence-specific tRNA metabolism (Lopez Sanchez 
et al., 2011; Rackham et al., 2009). PTCD2, on the other hand, has been implicated 
in the processing of the non-canonical cleavage site between ND5 and CytB (Figure 
4.5), as the junction does not contain a mt-tRNA. A depletion of PTCD2 in mouse 
models causes an accumulation of the precursor and a reduction in the activity of 
complex III (ubiquinol-cytochrome c reductase), where CytB is the catalytic core (Xu 
et al., 2008) 
 
1.5.2 Exceptions to the tRNA punctuation model  
Out of approximately forty-three cleavage events observed in the mitochondrial 
polycistronic transcript, there are various elements that do not follow this ‘tRNA 
punctuation model’. These include the overlapping reading frames of ND4/4L, and 
ATP8/6, and other bicistronic transcripts like ATP8/6-CO3 that are not separated 
by tRNAs. The 5’ end of CO1 and CytB, and the 3’ end of ND6 show cleavage sites 
that do not depend on the presence of tRNAs (Temperley et al., 2010). The 3’ end of 
ND6 shows multiple ends and is found approximately 500 nt (nucleotides) 
downstream of the translation termination codon (Slomovic et al., 2005).  
The accuracy of cleavage at the junction between genes is variable. The 5’ ends of 
ATP8/6-CO3, ND1 and CO1 have been observed with 1-3 nt long untranslated 
regions (UTR). CO1, ND6 and ND5 have 3’ UTR that code for genes in the 
antisense strand. The 3’ end of 12S rRNA has been seen with minor truncations and 
with the addition of 3-4 nt. A majority of 16S rRNA molecules seem to show 
additional residues at the 3’ end, whether it be oligoadenylation, or nucleotides from 
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the 5’ end of the downstream tRNA-Leu(UUR) gene (Temperley et al., 2010, Pearce 
et al., 2017). 
There are no common sequence motifs within CO1, CO3 and CytB that signal a 
common mechanism of cleavage, suggesting that the different sites might have 
different nucleases acting on them. It has been suggested that ELAC2 and RNase P 
might contribute to processing of these sites. However, knockdown of the proteins and 
analysis using northern blotting shows no effect on the levels of the non-conventional 
cleavage sites (Brzezniak et al., 2011). On the other hand, knockdown and qPCR 
shows that RNase P is required for 5’ end endonucleolytic activity on CO1 mRNA, 
which, if true, might be due directed by tRNA-like secondary structures present at the 
5’ end (Sanchez et al., 2011).  
FASTKD2 has been implicated as one of the enzyme involved in non-canonical 
cleavage. A depletion of the protein leads to the accumulation of various precursors 
with the non-canonical cleavage sites (Antonicka and Shoubridge, 2015). Knockout of 
FASTKD2 leads to an accumulation of misprocessed precursors of 16S rRNA and 
ND6 mRNA. CLIP-based analysis of the RNA targets of FASTKD2 identify both 
16S rRNA and ND6 as its targets (Popow et al., 2015). As described earlier, PTCD2 
has been implicated in the processing of the ND5-CytB precursor. However, the 
mechanism of cleavage of the precursor transcripts of FASTKD2 and PTCD2 needs 
to be investigated further. 
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1.5.3 Post-cleavage maturation of RNA  
 
1.5.3.1 Polyadenylation 
After being released from the primary transcript, the mitochondrial mRNAs, except 
for ND6, undergo 3’ polyadenylation (Slomovic et al., 2005). Compared to nuclearly-
encoded transcripts which have poly(A) tails ranging between 150-200 nucleotides, 
mt-mRNAs have a significantly shorter poly(A) tail at roughly 45-55 nucleotides 
(Ojala et al., 1981; Proudfoot, 2011). In mammals, mitochondrial rRNAs contains 
little to no adenylation at the 3’ ends, while in Drosophila melanogaster, ND6 and both 
rRNAs are polyadenylated (Stewart et al., 2009; Bratic et al, 2011). 
Poladenylation in mitochondria is catalysed by a homodimeric polyadenylic acid 
RNA polymerase (mtPAP) (Tomecki et al., 2004; Bai et al., 2011; Lapkouski and 
Hallberg., 2015). The function of polyadenylation in RNA stability in mitochondria is 
unclear. They might serve to complete stop codons because seven of thirteen mt-
mRNAs have lost their 3’ stop codon and require 3’ adenylation to complete the open 
reading frame.  
In various other systems, polyadenylation of RNA is used to control stability of the 
molecule. In bacteria and plant mitochondria, the poly(A) tail decreases stability of the 
transcript (Schuster and Stern, 2009). However, whether the presence of a poly(A) tail 
has any effect on mammalian mitochondrial RNA stability is unclear.  Knockdown of 
mtPAP causes a mRNA-specific effect on steady state levels, causing an increase in 
complex I mRNAs, ND1 and ND2, a decrease in complex IV transcripts and no 
difference in the steady state levels of the other transcripts (Tomecki et al., 2004; 
Nagaike et al., 2005). Defective mtPAP in patient cells also showed differential 
sequence-specific changes to RNA steady state levels (Wilson et al., 2014). However, 
in all the cells studied, a short oligoadenyl tail was still observed in the absence of 
mtPAP (Slomovic et al., 2005).  
A knockout of mtPAP in D. melanogaster causes a complete loss of all poly(A) tails 
except 12S rRNA, suggesting the presence of an alternative 12S-specific 
oligoadenylase. In these deadenylated mRNAs, the lack of poly(A) tails made the 
molecules susceptible to 3’ end degradation. Moreover, no overall change in steady 
state level of processed transcripts was observed, regardless of whether the 3’ stop 
codon was encoded or not (Bratic et al., 2016). This suggests that polyadenylation in 
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mitochondria is not a determinant of steady state level but may protect the 3’ 
terminus of the sequence from being exonucleolytically degraded.   
The polyadenylation status of some RNAs in the mitochondria is controlled by 
PDE12. PDE12 is a mitochondrially-targeted member of the exonuclease/ 
endonuclease/ phosphate family (Poulson et al., 2011; Rorbach et al.,2011). In vitro 
assays show 3’-5’ poly(A)-specific (and to a lesser extend poly(U)) exonuclease activity 
(Rorbach et al., 2011). As such, overexpression of PDE12 in vivo leads to 3’ 
deadenylation of poly(A) tails. Similar to experiments in which mtPAP was depleted, 
mRNAs for ND1 and ND2 showed increase in steady state levels while steady state 
levels of complex IV increased. This suggested that polyadenylation has different 
effects on the steady state levels of different mRNAs. Knockout of PDE12 from 
human cells does not have any significant effect on the mt-mRNA poly(A) lengths or 
its stability. However, PDE12 was shown to be required for the maturation of the 3’ 
end of 16S mt-rRNA and certain mt- tRNAs by the removal of spurious 3’ 
adenylation. Depletion of PDE12 caused a strong mitochondrial dysfunction as a 
result of impaired protein synthesis. However, this translation defect was not caused 
by misassembled ribosomes. On the contrary, spurious oligoadenylation at the 3’ end 
of 16S rRNA did not affect its assembly into the ribosome. Instead, translation was 
impaired by the ribosomal stalling caused by dysfunctional polyadenylated tRNAs. 
Therefore, it can be concluded that PDE12 is required in the mitochondria to 
counteract excessive mistargeted adenylation (Pearce et al, 2017) 
A translational defect was also observed in cells where exogenous expression of 
deadenylases were used to remove poly(A) tails (Wydro et al., 2010). However, 
deadenylation caused as a by-product of ablation of LRPPRC (see section 1.6.1), does 
not affect levels of translation (Ruzzenente et al., 2012). Therefore, it can be 
concluded that the translational defect is not directly caused by lack of a poly(A) tail, 
but due to the lack of a stop codon. The function of a long poly(A) tail still remains to 
be elucidated. 
Polyadenylation also seems to be associated with RNA processing. Patient cell lines 
with a μΔ9205 deletion which removes the termination codon from the bicistron 
encoding ATP6, does not show any effect on the processing of the junction between 
ATP8/6 and CO3, or the stability of processed CO3 mRNA. However, it does 
produce a truncated mRNA caused by excessive exoribonuclease activity, and leads to 
the decreased stability of the processed ATP8/6 molecule. Unlike mRNA from 
	18	
control cell lines, which show a poly-A tail of about 45-56 nt, the patient cell line 
showed three discrete populations of mRNA with normal poly-A tails (A45-56), 
shorter poly-A tails (A26-37) and severely truncated 3’ termini (A[-1]-11) (Temperley 
et al., 2003). This suggests that polyadenylation and 3’ end of the transcript are linked 
and processing and polyadenylation may happen concurrently in RNA granules (see 
section 1.8). 
 
1.5.4 Mitochondrial tRNA Maturation  
The 22 mitochondrial tRNAs produced from the action of RNase P and ELAC2 
undergo a series of extensive maturation steps comprising of chemical modifications, 
polymerase activity and processing. Major chemical modifications that have been 
identified in tRNAs include methylation, pseudouridylation, taurine modification, 
formylation, isopentenyl modification and methylthio modification. The modifications 
have a structural role in making additions to the sequence which are not coded in the 
genome and stabilisation of the tRNA structure, and a functional role in expanding 
anticodon-codon recognition, and ensuring efficiency and accuracy of this 
recognition. Many of the enzymes involved in these modifications have been 
identified. However, many are yet to be discovered. 
The encoded tRNA sequence is not always complete and requires additional 
polymerase activity to produce a functional unit. Mitochondrial tRNAs do not encode 
a 3’ CCA sequence which is required for aminoacylation by aminoacyl-tRNA 
synthetases. In humans, this CCA is post-transcriptionally added on by tRNA-
nucleotidyltransferase 1 (TRNT1), which specifically selects CTP and ATP for 
polymerisation without the need for a template sequence, terminating polymerisation 
immediately after CCA addition (Nagaike et al., 2001). Similarly, unlike bacteria, 
yeast and mammalian mitochondrial tRNA-His does not encode a 5’ guanine which is 
required for the recognition and activity of its cognate aminoacyl-tRNA synthetase. 
This is performed by a 3’-5’ polymerase activity (Nakamura et al., 2013; Powell et al., 
unpublished data).  
The tRNA exists as a cloverleaf structure with four distinct base-paired stems - the 
acceptor stem, T-stem, anticodon stem and the D-stem, with three non-base paired 
loops. The L-shaped tertiary structure of tRNAs is formed by the interactions of the 
distal loops. This structure positions the acceptor stem perpendicular to the anticodon 
stem. There are two exceptions to the common tRNA structure in the mitochondria. 
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Mitochondrial tRNA-Ser(UCN) contains a longer acceptor arm, a reduced D-loop 
and a reduced linker region between the acceptor and D-stems. However, alternative 
interactions allow the tRNA to still maintain the required conformation (Watanabe et 
al., 1994). Similarly, mitochondrial tRNA-Ser(AGY) is highly shortened, completely 
lacking the D-arm. However, a more flexible core allows the molecule to mould to the 
correct structural dimensions (Frazer-Abel and Hagerman, 2008). The strong 
conservation of the tRNA conformation illustrates its importance in its function. The 
high efficiency of translation is enabled by the chemical modifications that stabilise 
this conformation (Perret et al., 1990; Harrington et al., 1993, Helm et al., 1998; 
Helm et al., 1999). These modifications work collaboratively to fine-tune the structure 
and functional fidelity of the individual tRNAs (Motorin and Helm, 2010). Hence, 
deficiencies are not necessarily observed on removal of a modification and may 
require combinatorial deficiencies of multiple chemical modifiers and additional 
translational inhibitors before a deficit in translation is observed (Alexandrov et al., 
2006; D’Silva et al., 2011; Okamoto et al., 2014).  
Methylation and pseudouridylation are the two main ways of influencing structural 
conformation. Methylation of tRNA is used to block hydrogen bonding and to 
prevent the formation of helices. This is seen in TRMT1 which dimethylates G26 and 
inhibits base pairing with cytosine, and the methylation of A9 by the 
MRPP1/MRPP2 (TRMT10C/HSD17B10) subcomplex (two components of the 
RNase P complex (see section 1.4.1)), which inhibits base pairing with U64 in the T-
stem (Voigts-Hoffmann et al., 2007; Vilardo et al., 2012). TRMT61B is responsible 
for the m1A58 modification of multiple mt-tRNAs, and TRMT5 methylates G37 in 
mt-tRNAs (Chujo and Suzuki, 2012; Powell et al., 2015). In bacteria and yeast, 
m1G37 prevents frameshift-based errors at the ribosome (Urbonavicius et al., 2001). 
However, the function of these modification in mitochondria is still unknown (Brule et 
al, 2004; Chujo and Suzuki, 2012).  
Instead of disrupting hydrogen bonds, modifications can also be made to encourage 
hydrogen bonding, as seen in the isomerisation of uracil to pseudouridine. This 
presents an extra hydrogen bond donor on the Watson-Crick base pairing edge of the 
nucleotide. This stronger bond is used by the tRNA to strengthen and stabilize the 
structure (Davis, 1995; Newby and Greenbaum, 2002). PUS1 is a well characterised 
pseudouridine synthetase, which in mitochondria modifies U27 and U28 on tRNAs 
and various other non-coding RNAs (Patton et al., 2005, Zhao et al., 2004). Loss of 
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PUS1 leads to defect in mitochondrial translation, and in patients leads to symptoms 
associated with mitochondrial dysfunction, such as lactic acidosis, myopathy and 
sideroblastic anemia (Patton et al., 2005; Zeharia et al., 2005; Fernandez-Vizarra et 
al., 2007). Recently, a RNA-granule localising (See section 1.8) pseudouridine 
synthetase, RPUSD4, was identified, that pseudouridylates 16S mt-rRNA at position 
1397, which is suggested to be required for the stability of 16S rRNA and the 
assembly of the mt-LSU (Antonicka et al., 2017; Zaganelli et al., 2017). CLIP-based 
analysis identified that RPUSD4, in addition to 16S rRNA, also interacts with tRNA-
Phe and tRNA-Met. However, knockdown of RPUSD4 only caused a reduction of 
ψ39 on tRNA-Phe but no change in pseudouridylation of tRNA-Met. Overall, a loss 
of RPUSD4 led to a defect in ribosomal biogenesis and therefore, mitochondrial 
translation (Zaganelli et al., 2017).  
During translation, tRNAs communicate the information from the triplet codon on 
the mRNA to the peptidyl transferase centre. This requires the tRNA to correctly 
recognise the mRNA codon and provide the appropriate amino acid. However, there 
is a high degree of degeneracy of the genetic code in mitochondria. That is, many 
codons can code for the same amino acid. The tRNA compensates for this by 
chemically modifying the third position of the cognate anticodon (position 34). The 
post-transcriptional modification of this ‘wobble’ base encourages non-conventional 
base pairing and diversifies the possible scenarios in which the tRNA can be used. 
Moreover, conversely, the unmodified uracil is also naturally ‘wobbly’ and so, 
modification of the base can restrict its codon recognition. 
For example, in tRNAs for Leu(UUR), Trp, Lys, Gln and Glu, the encoded uridine at 
position 34 is modified to 5-tauromethyluridine (Suzuki and Suzuki, 2014). This is 
performed by GTP binding protein 3 (GTPBP3) and mitochondrial tRNA 
optimisation 1 (MTO1) (Villarroya et al., 2008; Li et al., 2002). Of these five modified 
uridines, tRNAs for Lys, Gln and Glu undergo further thiolation to 5-taurinomethyl-
2-thiouridine by TRMU (MTU1). Patients and animal models lacking these 
modifications and their modifying enzymes have been shown to present deficiencies in 
the respiratory chain (Suzuki et al., 2002; Ghezzi et al., 2012; Gaignard et al., 2013; 
Kopajtich et al., 2014; Becker et al., 2014). Deletion of the yeast homologs of 
TRMT1, GTPBP3 or MTO1 in yeast do not cause respiratory deficiencies if knocked 
out on their own. However, a combinatorial double or triple knockout of the three 
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genes leads to complete loss of tRNAs and mitochondrial protein synthesis (Wang et 
al., 2010).  
Similarly, the cytosine found at the wobble position of mt-tRNAMet is formylated. This 
is because, in mitochondria, the codons encoding methionine are expanded to also 
include AUA, alongside AUG (Fernley and Walker, 1987). The modification that 
allows this expansion of recognised codons is a two-step process, which includes the 
methylation of the position by NSUN3 and further oxidation to a formyl group by 
ABH1 (Haag et al., 2016; Nakano et al., 2016; Van Haute et al., 2016; Van Haute et 
al., 2017) 
The other nucleotides surrounding the anticodon triplet are also modified. Position 37 
is found downstream of the anticodon triplet, namely position 36, which base pairs 
with the first position of the codon triplet on the mRNA. TRIT1 (tRNA 
isopentenyltransferase 1) catalyses the formation of isopentenyladenosine and, in some 
cases, this can be further methylthiolated by CDK5RAP1 (Cyclin-dependant kinase 5 
regulatory subunit associated protein 1) (Yarham et al., 2014; Reiter et al. 2012; Wei 
et al., 2015). This is particularly important in cases where position 1 of the codon 
triplet is a uridine. This modification stabilises the weak A-U base pairing between the 
codon and the anticodon, increasing accuracy and fidelity (Lamichhane et al., 2013).   
 
1.6 Mitochondrial RNA turnover 
 
1.6.1 Regulation of mitochondrial RNA stability  
The steady state levels of transcripts in the mitochondria are maintained by two RNA-
binding proteins, LRPPRC and SLIRP. LRPPRC (Leucine-rich penticopeptide rich 
domain containing protein), is a highly abundant protein that localises to the 
mitochondria (Sterky et al., 2010). Loss of LRPPRC leads to a loss of steady state 
levels of mt-mRNAs, but not mt-rRNAs and mt-tRNAs. This is accompanied by a 
defect in translation and consequently, a loss of assembled respiratory complexes 
(Gohil et al., 2010; Sasarman et al., 2010a; Sondheimer et al., 2010; Ruzzenente et 
al., 2012; Mourier et al., 2014). A LRPPRC knockout mouse model exhibits a loss of 
stability of all H-strand-derived transcripts, loss of long poly(A) tails and a severe 
translational defect (Ruzzenente et al., 2012). 
Similarly, SLIRP (Stem-loop interacting RNA binding protein) is an RNA-binding 
protein that, when knocked down, leads to a destabilisation of mRNA transcripts in 
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cells, which causes disassembly of the OXPHOS subunits and OXPHOS deficiency 
(Baughman et al., 2009). However, this is not observed in a knockout mouse model 
(Lagouge et al., 2015). In the mitochondria, LRPPRC forms a complex with SLIRP 
which controls the stability of mRNAs, independent of the transcriptional and 
translational apparatuses (Sasarman et al., 2010b; Ruzzenente et al., 2012; Harmel et 
al., 2013). Moreover, the steady state levels of both proteins are linked to the steady 
state levels of the other. Knockdown of one of the protein leads to destabilisation of 
the other (Chujo et al., 2012; Ruzzenente et al., 2012). It has been suggested that the 
LRPPRC/SLIRP complex associates with the mRNAs, especially, translationally-
inactive transcripts, suppressing degradation by the PNPase/SUV3 degradosome 
(Chujo et al., 2012; Ruzzenente et al., 2012; Lagouge et al., 2015)). Moreover, this 
binding activity prevents secondary structures from forming, thus making the 3’ ends 
available for polyadenylation by mtPAP. As such, a decrease in polyadenylated 
mRNAs is observed in cells where LRPPRC and to a small extent when SLIRP are 
reduced. Conversely, an increase in the levels of the complex, in vitro, leads to an 
increase in polyadenylated mt-mRNAs (Chujo et al., 2012; Wilson et al., 2014). 
Recently, FASTKD3 was also implicated in RNA stability. Loss of FASTKD3 leads 
to an increase in stability of mRNAs for ND2, ND3, CYTB, COX2, and ATP8/6 
without affecting steady state levels of unprocessed precursors. In addition, it has also 
been shown to be necessary for the translation of complex IV subunit CO1 through 
regulation of translation. Unlike other members of the FASTK family, FASTKD3 
does not co-localise in the RNA granule (see section 1.8), suggesting that its role is not 
at the level of the nascent transcript (Boehm et al., 2016).  
 
1.6.2 Mitochondrial RNA degradation 
In yeast mitochondria, RNA degradation is mediated by an RNA degradosome 
consisting of helicase SUV3 and RNase Dss1. This degradasome is required for the 
removal of introns and misprocessed RNA (Dziembowski et al., 2003; Malecki et al., 
2007). In these degradosomes, SUV3 unwinds the RNA secondary structure in an 
ATP-dependent manner, making ssRNA available for Dss1 3’-5’ ssRNA 
exoribonuclease activity. In humans, the homolog of Dss1 has not been identified. 
However, the human homolog of helicase SUV3 (hSUV3) has been localised to the 
mitochondrial matrix (Michal et al., 2002). Knockout of SUV3 in Drosophila 
melanogaster leads to an increase in abundance of mt-mRNA, while rRNAs are not 
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affected and tRNA levels are reduced. This suggests that the degradosome may not be 
responsible for rRNA turnover. Moreover, an accumulation of tRNA precursors 
suggests that SUV3 helicase activity may have a role to play in the punctuation model 
(Clemente et al., 2015). 
The RNase component of the mitochondrial degradosome has been assigned to 
PNPase. PNPase is a mitochondrially-targeted enzyme that contains both 3’-5’ 
exonuclease activity and 5’-3’ polymerase activity (Piwowarski et al., 2003). PNPase 
has been localised to the mitochondrial matrix (Borowski et al., 2013). However, its 
function in the mitochondria is constantly under debate. Some have shown that 
PNPase is vital for mRNA and precursor stability and control of polyadeylation, while 
others have observed no effect of PNPase depletion (Nagaike et al, 2005; Slomovic 
and Schuster, 2008; Wang et al., 2010). However, in vitro assays show PNPase 
heterodimerising with matrix SUV3 helicase to form a mitochondrial ssRNA 
degradation complex (Wang et al., 2014). In vivo assays localise PNPase to the 
mitochondrial matrix in RNA granules (see section 1.8) forming a degradosome with 
hSUV3 (Borowski et al., 2012). Both the components of the degradosome have also 
been shown to be vital for the removal of 3’ UTR of ND6, reinforcing the idea of a 
collaborative role in RNA turnover (Jourdain et al., 2015). 
PNPase was also localised to the intermembrane space suggesting a role for PNPase in 
this region. PNPase has been implicated in transporting cytoplasmic RNA across the 
inner membrane, however, evidence for the presence of cytoplasmic RNA in the 
matrix is inconclusive and contradictory (Wang et al., 2010; Matilainen et al., 2017; 
Sato et al., 2017). The RNA import function of PNPase suggests that PNPase import 
RNA component of RNase P and the 5S rRNA into the mitochondria. However, 
both these RNA components have been shown to be obsolete in the mitochondria. 
The RNase P in the mitochondria is completely composed of a homotrimeric protein 
complex which functions without the need of an RNA component (Holtzmann et al., 
2008), and the 5S rRNA in the mt-LSU has been replaced by tRNA-Val or tRNA-
Phe (Amunts et al., 2015; Greber et al., 2015; Rorbach et al., 2016). 
It has been suggested that polyadenylation of transcripts in the mitochondria are 
linked to their stability. The PNPase/hSUV3 complex has been shown to directly 
interact with mtPAP and thus, indirectly control levels of polyadenylation (Wang et 
al., 2014). Consequently, a depletion in PNPase has been shown to lead to a 
lengthening of poly(A) tails, though the strength of this effect differs between different 
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publications (Nagaike et al., 2005; Slomovic and Schuster, 2008). Furthermore, a 
depletion in hSUV3 leads to an extension of poly(A) tails (Szczesny et al., 2010). It is 
not clear whether an increase in polyadenylation causes an increase in stability, or 
whether an increase in stability of the transcripts allows for more opportunities for 
polyadenylation. Knockdown of mtPAP results in an increase in stability of mt-
mRNAs for ND1, ND2, ND3 and ND4/4L, and a decrease in stability of CO3 and 
ATP8/6, even though a reduction in polyadenylation is observed (Piechota et al., 
2006). This suggests that the effect of polyadenylation on stability is transcript-specific. 
This differential polyadenylation-dependent pattern of stability is observed in various 
studies where mtPAP was depleted (Piechota et al., 2006; Nagaike et al., 2005; Nagao 
et al., 2009; Crosby et al., 2010; Bratic et al., 2016) and where mitochondrially-
targeted deadenylases (PARN and PDE12) were overexpressed in cell lines (Wydro et 
al., 2010; Rorbach et al., 2011).  
The mitochondrial degradosome is incapable of degrading short RNA molecules. 
Therefore, REXO2, a mitochondrially-targeted exoribonuclease has been attributed 
the function of completing RNA degradation (Bruni et al., 2013). In vitro, REXO2 is 
able to perform 3’-5’ degradation of ssRNA and DNA fragments (Nguyen et al., 
2000). Interestingly, a reduction of REXO2 causes a deficiency in mt-DNA 
replication, transcription and translation, suggesting that it plays a more fundamental 
role in nucleic acid metabolism in the mitochondria (Bruni et al., 2013).  
In addition to the degradosome and REXO2, LACTB2 has been identified as a 
mitochondrially-localised ssRNA endonuclease, homologous to ELAC2 (Levy et al., 
2016). Knockdown of the protein causes an accumulation in mt-RNAs, as identified 
via qPCR, and a general mitochondrial dysfunction (Levy et al., 2016). However, its 
RNA targets and its function within the mitochondria are still to be elucidated.   
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Figure 1.4 Summary of major steps and players in RNA processing and maturation in the 
mitochondria. The mtDNA is transcribed from the LSP and HSP promoters. The polycistronic 
transcript is mostly processed through the excision of punctuating tRNA sequences. Other mRNAs are 
also released through non-canonical cleavage and processing. The mt-LSU and mt-SSU rRNAs are 
chemically modified by various methyl transferases and pseudouridylases during folding and assembly 
of mitoribosomal protein components, coordinated by various trans-acting assembly factors. The 
tRNAs are processed through 5’ and 3’ polymerase activity and chemical modification before being 
aminoacylated by aminoacyl-tRNA synthetases (aaRS). The mRNAs undergo polyadenylation and 
deadenylation. The stability of mt-RNAs are controlled by various factors including RNA-stabilising 
complexes, degradosome, endonucleases and exonucleases. 
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1.7 Mitochondrial translation 
Mitochondrial translation requires a large plethora of nuclearly-encoded factors 
including initiation, elongation and termination factors. 
In eubacteria, translation is initiated through the action of three initiation factors – 
IF1, IF2 and IF3. Of these, IF1 and IF2 are present in all domains of life and 
commonly referred to as ‘universal translation initiation factors’ (Choi et al., 1998, 
Lee et al., 1999). However, in the mammalian mitochondria, IF1 is absent. 
Translation is initiated through the action of IF2 and IF3. A 37-amino acid insertion 
into IF2 compensates for the loss of IF1 (Figure 1.5). A bacterial strain lacking IF1 and 
IF2 can be complemented with mitochondrial IF2, and if the 37 aa insert is lost, 
requires IF1 to be present (Gaur et al., 2008). 
Prokaryotic translation elongation is mediated through three factors that are all found 
in mammalian mitochondria – mt-EFTu, mt-EFTs and mt-EFG (Hammarsund et al., 
2001; Ling et al., 1997). In addition to these, in mitochondria, two homologs of mt-
EFG (1 and 2) exist. However, mt-EFG2 may be dispensable as depletion, in yeast, 
does not lead to a translation defect. It may be responsible for ribosome recycling 
(Tsuboi et al., 2009).  
Termination of translation in bacteria is under the control of four factors, release 
factors RF1, RF2, RF3 and ribosome recycling factor (RRF) (Bertram et al., 2001). 
RF1 and RF2 catalyse stop codon-specific hydrolysis of peptidyl tRNA, while RF3 
acts to stimulate these release factors and their release from the ribosome. In the 
mitochondria, three termination factors have been identified, namely mtRF1, 
mtRF1a and mtRRF (Nozaki et al., 2008; Soleimanpour-Lichaei et al., 2007; Zhang 
et al., 1998; Rorbach et al., 2008). Analogous to bacterial RF1, mtRF1 terminates 
translation at the UAA and UAG stop codon (Soleimanpour-Lichaei et al., 2007).  
Transcript-specific regulation of translation has also been observed. In yeast, these 
translational activation factors have been observed for all the eight mitochondrially-
encoded genes. These are generally membrane-associated and facilitate the co-
translational insertion of the proteins (Towpik, 2005; Chacinska and Boguta, 2000; 
Zeng et al., 2007). Mdm38 controls the synthesis of CO1 and CytB by binding to 
Mba1 (see section 1.7.1.5). A loss of Mba1 and Mrm38 (paralog of human protein, 
Letm1) in yeast cells causes a loss of biogenesis of cytochrome reductase and 
cytochrome oxidase, independent of a defect in membrane association. This suggests 
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the synthesis of the mitochondrially-encoded polypeptides can  be regulated in an 
mRNA-specific manner (Bauerschmitt et al., 2010).  
The difference between yeast and mammalian transcripts is that yeast mRNAs 
contain 5’ UTRs to which the translational activators can bind. In mammalian 
mitochondrial, this is absent and therefore, any activator would have to modulate 
translation in a different way. As such, various factors have been identified that can 
regulate the synthesis of complex IV subunit CO1. CCDC44 (TACO1) was identified 
as a regulator of mitochondrially-encoded CO1, as depletion of the protein led to a 
loss of CO1 translation and complex IV deficiency, despite no changes to levels of 
CO1 mRNA (Weraarpachai et al., 2009). Similarly, depletion of components of the 
mitochondrial translation regulation assembly intermediate of cytochrome c oxidase 
(MITRAC), C12orf62 and MITRAC12, leads to a reduction of CO1 synthesis, 
possibly through an associated loss in the assembly of the complex (Szklarczyk et al., 
2012; Weraarpachai et al., 2012).  
Due to the lack of a 5’ UTR or cap that would allow the ribosome to identify the 
mRNA, the mitoribosome must have evolved mechanisms for recognition of these 
transcripts. Recent cryo-EM structures have identified the recruitment of an RNA-
binding PPR protein, mS39 at the entrance to the mRNA entry site (figure 1.8) 
(Amunts et al., 2015; Greber et al., 2015). Initiation begins with the association of the 
mRNA with the free mt-SSU. This is mediated by mt-IF3 which inhibits the 
premature association of the mt-LSU and facilitates the positioning of the AUG start 
codon at the peptidyl site (Bhargava and Spremulli; 2005; Liao and Spremulli; 1989; 
Haque et al., 2008). This initiation complex also requires the entry of fMet-tRNA-Met 
which is facilitated by mtIF2 in a GTP-dependant manner. The interaction between 
mtIF2 and fMet-tRNA-Met is strengthened by the association with mt-mRNA. The 
formation of a stable complex leads to the assembly of the monosome (Liao and 
Spremulli, 1990; Ma and Spremulli, 1996). Similar to their bacterial equivalents, 
dissociation of the initiation factors is accompanied by the hydrolysis of GTP (figure 
1.5). In the case of ND4/ND4L and ATP8/6 mRNAs, the open reading frames of 
both genes are overlapping. The mechanism by which the ribosome identifies and 
begins translation of the second ORF is unclear. 
Mitochondrial translational elongation is very similar to elongation in prokaryotic 
systems. This begins with the mtEFTu which forms a complex with GTP and amino-
acyl tRNA. After a proofreading step, mtEFTu carries the tRNA to the acceptor (A) 
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site where it binds to the mRNA through codon-anticodon interactions on the mt-
SSU. This stimulates the hydrolysis of GTP which releases the elongation factor and 
moves the tRNA into the peptidyl (P) site. This catalyses peptide bond formation. 
mtEFTu is recycled through the action of nucleotide exchange proteins that replace 
the GDP for a GTP. Then, mtEFG1 (bound to GTP) moves the tRNAs in the A and 
P site to the P and exit (E) sites respectively. This also causes the mRNA to move 
along by one codon, making the next codon available for recognition (figure 1.5). In 
the mitoribosome, the E site is not well defined, as many of the residues involved with 
interactions between the bacterial ribosome and the tRNA in the E-site, have been 
lost in the mitochondria (Sharma et al., 2003; Mears et al., 2002; Mears et al., 2006). 
Cryo-EM studies of the ribosome have identified the presence of an altered binding 
pocket which may serve an alternative E-site (Amunts et al., 2-15; Greber et al., 2015). 
Termination of translation is triggered by the presence of a stop codon in the A site. 
This causes the hydrolysis of the bond between the tRNA and the nascent 
polypeptide, allowing it to be released. In the case of mRNAs for CO1 and ND6, the 
sequence ends with AGA and AGG, instead of the conventional UAA and UAG stop 
codons. However, this issue can be resolved by a -1 frameshift which brings a UAG 
stop codon into frame possibly caused by the action of the mt-LSU component ICT1 
(Temperley et al., 2010a, Temperley et al., 2010b). Recent data suggests that ICT1 
behaves like a release factor as it is capable of hydrolysing peptidyl-tRNA on stalled 
ribosomes (Feaga et al., 2016). However, contradictory data suggests ICT1 may not 
be directly involved in termination of translation of these transcripts (Chrzanowska-
Lightowlers and Lightowlers, 2015). Finally, the release factors, mtRF1, mtRRF and 
mtEFG2 catalyse the release of the mRNA and the deacetylated tRNA, and the 
dissociation of the ribosome, making the translation apparatus available for reuse. The 
hydrolysis of GTP then catalyses dissociation of the release factors (Bhargava et al., 
2004). 
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Figure 1.5 Schematic diagram of mitochondrial protein synthesis consisting of three phases of 
initiation, elongation and termination. The key indicates the identity of the factors and RNAs involved. 
Hydrolysis of GTP is indicated by a change of colour from purple to yellow. GTPases are shown 
attached to GTP. The formylmethionine amino acid starting the polypeptide chain is shown in red. 
The large subunit is shown in orange and the small subunit is shown in light orange. The structure of 
the mammalian mitoribosome is shown for reference at the top right (PDB: 5AJ4) 
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1.8 Mitochondrial ribosome  
The mammalian mitoribosome is a large ribonucleoprotein complex required for 
translation of the 13 polypeptides encoded in the mitochondrial genome. It consists of 
a large 39S (mt-LSU) and a small 28S (mt-SSU) subunit. The large subunit, the site of 
the peptidyl transferase activity, is a ribonucleoprotein complex containing a catalytic 
16S RNA component, encased in approximately 50 protein components and an 
additional tRNA component. The small subunit, the site of mRNA binding and 
decoding, contains a smaller 12S catalytic RNA component encapsulated by 30 
protein components.  
 
1.8.1 Specialisation of the mitochondrial ribosome  
 
1.8.1.1 Architecture of the mitochondrial ribosome 
Despite evolving from a eubacterial ancestor, the mammalian mitoribosome is unique 
in structure and composition from its bacterial, yeast mitochondrial and cytoplasmic 
equivalents. This is seen in the mammalian mitoribosomes’ substantially lower 
sedimentation coefficient. While the bacterial, yeast mitochondrial and cytoplasmic 
ribosomes sediment with a coefficient of 70S, 74S and 80S respectively, the 
mammalian mitoribosome sediments at a coefficient of 55S (figure 1.6). The yeast 
mitoribosome contains a larger 37S mt-SSU with a 15S rRNA component and 38 
mitochondrial ribosomal proteins (MRPs), and a larger 54S mt-LSU consisting of a 
21S rRNA and 46 MRPs (Smits et al., 2007; Herrmann et al., 2012). In yeast, 12 SSU 
MRPs (MRPSs) and 16 LSU MRPs (MRPLs) are specific to the mitoribosome and 
not homologous to bacterial ribosomal proteins (Smits et al., 2007; Amunts et al., 
2014). Similarly, the mammalian mitoribosome has substantially smaller rRNA 
components, and 14 MRPSs and 22 MRPLs that do not have homologs in bacteria. 
These proteins are generally found attached at the periphery of the complex while the 
core of the complex is highly conserved (figure 1.7) (Sharma et al., 2003; Greber et al., 
2014; Brown et al., 2014; Greber et al., 2014; Kaushal et al., 2014). 
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Figure 1.6 Overview of the protein and RNA composition of the ribosomes in bacteria, the eukaryotic 
cytosol, human mitochondria and yeast mitochondria. Pink, LSU rRNA; blue, SSU rRNA; maroon, 
LSU; green, SSU. The number of protein components of the SSUs and LSUs is indicated in the 
circles. Data was acquired from Greber and Ban (2016). 
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Figure 1.7 Mammalian mitochondria-specific components. Protein components of the LSU (above, 
orange) and the SSU (below, wheat) that do not have bacterial homologs have been coloured (PDB: 
5AJ4) 
 
1.8.1.2 Replacement of rRNA domains in the mitoribosome with protein components 
This diminution of the mitoribosome is a consequence of the reductive evolution of 
the mitochondrial genome. In particular, this is seen in the halving of the core RNA 
component of the mitoribosome. To compensate for this, the mitoribosome has 
undergone extensive remodelling. New protein subunits and protein-mediated 
interactions have been recruited to replace the lost functional domains. For example, 
the bacterial ribosome contains various zinc-binding proteins that coordinate a zinc 
ion to stabilize the quaternary interactions and architecture of the complex, such as 
bS18. In the mitoribosome, the abundance of these motifs is increased. Mitochondria-
specific MRPs such as MRPS18b (bS18m), MRPL10 (uL10m), MRPS6 (bS6m), 
MRPS16 (bS16m) and MRPS25 (mS25) all contain zinc-binding residues that 
coordinate three zinc ions between them (Greber and Ban, 2016). Moreover, various 
RNA-RNA bridges have also been substituted with RNA-protein or protein-protein 
interactions. For example, in bacteria, the uL24 subunit interacts with domain I of 
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23S rRNA. However, this lost domain in the mitoribosome is replaced by the protein-
protein interactions between the mL45 and uL29m subunits (Sharma et al., 2003; 
Amunts et al., 2014). 
 
1.8.1.3 A structural tRNA in the mammalian mitochondrial ribosome 
In all three domains of life, the mt-LSU contains a second smaller 5S rRNA 
component in the central protuberance (Magalhaes et al., 1998; Smirnov et al., 2011). 
This 5S rRNA acts as a scaffold connecting the large subunit to the small subunit and 
the tRNAs in the intersubunit space (Yusupov et al., 2001). However, recently, cryo-
EM structures of the human and porcine mitoribosome identified that, in mammals, 
this moiety has been replaced (Amunts et al., 2015; Greber et al., 2015). In the 
absence of an RNA import mechanism, the mitoribosome has incorporated a tRNA 
in its place. Interestingly, further studies identified this component to be either tRNA-
Val or tRNA-Phe depending on the species or context. It was shown that the 
incorporated tRNA is a tRNA-Val in human and rat tissues, and tRNA-Phe in 
porcine and bovine tissues. Moreover, when the steady state levels of tRNA-Val are 
reduced in human tissues, the mitoribosomes incorporate tRNA-Phe in its place to 
produce functional ribosomes (Rorbach et al., 2016). These tRNAs are encoded 
proximal to the rRNAs in the genome and transcribed concurrently with the rRNAs. 
This allows for a stoichiometric expression of the tRNAs and the rRNAs, and co-
transcriptional maturation and assembly into the mitoribosome.  
The mitoribosome has also evolved synchronously with the mt-tRNAs. In the 
mitochondria, the D and T-stems of the mt-tRNAs show a high level of variability. To 
accommodate this, the mitochondria has lost the ribosomal structures that interact 
with these regions on the tRNAs. For example, the A-site finger (consisting of uL25m 
and rRNA helix H38), and uL5m and the H48 helix in the P-site are absent. 
Therefore, the mitoribosome has evolved a P-site finger structure protruding from the 
central protruberance connecting the A and P site tRNAs and compensating for the 
absence of the A-site finger. The tRNAs in the P site bind more strongly with the P-
site finger via their T-loop, than in the bacterial P-site. Conversely, the mitoribosome 
has retained regions that bind to conserved sections of the tRNAs. This includes 
regions involved in the interactions with the 3’ CCA, the anticodon loop, the mRNA 
decoding region and the peptidyl transferase centre (Greber et al., 2014; Greber et al., 
2015; Amunts et al., 2015). 
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The mitoribosome has also recruited a GTPase, MRPS29 (mS29) in the mt-SSU that 
sits in the interface between the two subunits. Here, the protein may use its GTPase 
activity to facilitate intersubunit bridge formation (Suzuki et al., 2001). However, this 
has not been proven experimentally. 
 
1.8.1.4 Adaptation in the mRNA channel in the mitoribosome 
Mitochondrial transcripts also differ from their bacterial and cytoplasmic counterparts 
by not having a 5’ UTR with a Shine-Dalgarno sequence or a 5’ cap. In the cases 
where there are overlapping genes, the second protein could be considered to have a 
long untranslated region. These motifs help the ribosome identify the start codon for 
translation. However, in the mitoribosome, the ORF can begin directly at the 5’ end. 
This means that the start codon needs to be identified by the mt-SSU or other 
initiation factors (Herrmann et al., 2013). To facilitate the entry of the mRNA into the 
ribosome, the site of entry of the mRNA has been remodelled (figure 1.8). Bacterial 
ribosomal component uS4 and an mRNA helicase domain of uS3 have been lost 
(Amunts et al., 2015). Instead, mitochondrial uS5m has an extension which forms a 
‘latch’ across the mRNA channel and PPR-domain containing MRP, mS39 is 
positioned close to this entry site (Amunts et al., 2015; Greber et al., 2015). Whether 
the RNA-binding properties of the PPR domain is recruited for mRNA threading is 
yet to be elucidated. However, depletion of mS39 leads to a defect in translation 
(Davies et al., 2009). 
	36	
 
Figure 1.8 Changes to the polypeptide exit pore and mRNA entry site. (Above) Ribosomal proteins 
surrounding the polypeptide exit site are shown in shades of blue. Two additional components have 
been recruited in the mitoribosome including mL45 which assists in ribosome-membrane association 
(figure 1.9). (Below) Ribosomal proteins surrounding the mRNA entry site have been coloured in 
shades of green. No mitochondria-specific proteins have been recruited at the site. However, substantial 
changes have occurred in the orientation and the size of the proteins surrounding the mRNA entry site 
(Bacterial ribosome, PDB: 4V4Q; Mammalian mitoribosome, PDB: 3J9M).  
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1.8.1.5 Adaptations in the exit tunnel in the mitoribosome 
Unlike other ribosomes, the mammalian mitoribosome specifically caters to the 
production of the 13 polypeptides encoded in the mammalian mitochondrial genome. 
All these proteins are highly hydrophobic and form components of the membrane-
spanning respiratory complexes. Since the biochemical properties of all the 
polypeptides are similarly hydrophobic, the exit tunnel of the mitoribosome is lined 
with hydrophobic residues (especially from MRPL22(uL22m)) to regulate the 
efficiency of exit of the newly synthesized polypeptide from the mitoribosome (Brown 
et al., 2014). 
Moreover, the mitoribosome assists with co-translational assembly of the proteins by 
associating with the membrane and feeding the newly synthesised polypeptides into 
the inner membrane (Liu et al., 2000; Ott et al., 2006; Pfeffer et al., 2015). 
Biochemical studies have shown that a significant proportion of the mitochondrial 
ribosome is found associated to the inner membrane via electrostatic interactions 
between the membrane, membrane-bound proteins and MRPs (Liu and Spremulli, 
2000). One of the proteins identified that perform this function is OXA1L which 
controls the insertion of proteins into the inner membrane (Hennon et al., 2015). The 
c-terminus of mitochondrial OXA1L binds to MRPL13 (uL13m), MRPL20 (bL20m), 
MRPL28 (uL28m), MRPL48 (mL48), MRPL49 (mL49) and MRPL51 (mL51) 
(Haque et al., 2010). However, these MRPs are not located near the polypeptide exit 
site. In addition, similar to OXA1L, LetM1 was also identified as a protein that 
interacts with the mitoribosome (via MRPL36 (bL36m)) and has yeast homologs that 
facilitate mitoribosome-inner membrane anchoring (Piao et al., 2009).  
Compared to the bacterial ribosome, in yeast mitoribosomes, the newly synthesised 
polypeptides take a new path to the exit site. This new exit site is surrounded by 
bacterial bL33, and mitochondria-specific MRPs, MRPL44 (mL44) and MRPL50 
(mL50). These two MRPs form a protuberance that extends out towards the inner 
membrane and may facilitate interactions with the membrane (Greber et al., 2014; 
Brown et al., 2014). Cryo-EM tomography showed that, in yeast, the Mba1 protein 
spatially orientates the translation machinery to the inner membrane with the 
insertion machinery (Pfeffer et al., 2015). In the mammalian mitoribosome, a 
homolog of Mba1, MRPL45 (mL45) binds to the ribosome at the exit tunnel and has 
been proposed to perform the same function as Mba1 (figure 1.9) (Greber et al., 
2014).  
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Figure 1.9. Hypothetical membrane association of the mt-LSU via mL45 (yeast homolog of Mba1). 
(Left) MRPL45 (Dark blue) is located adjacent to the polypeptide exit tunnel in the mammalian 
mitoribosome. Cyan, mitoribosome; yellow, small subunit; dark blue, MRPL45. (Right) MRPL45 
superimposed onto Mba1, yeast homolog of MRPL45 which mediates interaction with the inner 
membrane. Cyan, large subunit; yellow, small subunit. Cryo-EM tomographic reconstruction (grey 
surface) of the yeast mitoribosome (EMD identification number 2826). Cyan, yeast mt-LSU 
structure; PDB: 3J6B; Figure adapted from Greber and Ban (2016) 
 
1.8.2 Ribosomal biogenesis in bacteria 
Assembly of the bacterial ribosome has been well characterised. Since the 
mitoribosome is derived from a common eubacterial ancestor, the steps in the 
biogenesis of the bacterial ribosome may inform the biogenesis of the mitoribosome. 
The E. coli ribosomal RNAs are transcribed on one polycistronic transcript. They are 
released by the action of five nucleases. From this primary transcript, RNase III 
produces a 16S rRNA precursor (17S rRNA), 23S rRNA precursor and a 5S rRNA 
precursor (9S rRNA) (Dunn and Studier, 1973; Nikolaev et al., 1973; Ginsburg and 
Steitz, 1975). The 17S rRNA is further matured by RNase E and RNase G (Li et al., 
1999a). The maturation of the 5’ and 3’ end of the 16S is finally completed through 
the removal of transcribed spacer regions by endoribonuclease YbeY (Davies et al., 
2010). Similarly, YbeY also facilitates the 5’ end maturation of the 23S (Davies et al., 
2010). RNase T, then performs the final maturation of 23S rRNA (Li et al., 1999b). 
RNase T and RNase E, along with YbeY complete the maturation of the 5S rRNA 
(Figure 1.10) (Misra and Apirion, 1978).  
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Figure 1.10 Maturation of precursor bacterial rRNA showing nuclease endonuclease activity of RNase 
G, RNase E, RNase III, YbeY and RNase T. Blue lines indicate the rRNA regions. Red lines 
indicate non-ribosomal RNA sequences in the precursor. Adapted from Shajani et al. (2011) 
 
Following this, the 16S rRNA undergoes 11 chemical modifications including one 
pseudouridylation and 10 methylations, and the 23S rRNA undergoes 25 chemical 
modifications (1 unknown, 14 methylations, 9 pseudouridylations and 1 methylated 
pseudouridylation) (Kaczanowska and Ryden-Aulin, 2007; Chow et al., 2007; 
Decatur and Fournier, 2002). Interestingly, the modified 16S rRNA can be assembled 
in vitro to produce a catalytically active ribosome. But, this is not the case for modified 
23S rRNA (Krzyzosiak et al., 1987; Green and Noller, 1999) 
Numerous in vitro assembly experiments with individually purified proteins 
(Mizushima and Nomura, 1970; Held et al., 1973), recombinant ribosomal proteins 
(Culver and Noller, 1999; Culver and Noller, 2000) and in vitro transcribed 16S 
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rRNA (Krzyzosiak et al., 1987) identified that the assembly of the bacterial ribosome 
happens in a hierarchical and parallel manner. The 30S small subunit (with 16S 
rRNA) can be divided into three domains, namely the 5’ body, the central platform 
region and the 3’ head. First, primary proteins (uS4, uS7, uS8, uS15, uS17, bS20) 
bind the 16S rRNA, which drives conformational changes on the RNA. This causes 
more secondary and then, tertiary components to assemble onto the ribosome (Traub 
et al., 1968; Held et al., 1973; Sieber et al., 1978; Stern et al., 1989). The bS16 and 
bS18 were shown to be required for assembly but not function (Held and Nomura, 
1975). However, further studies identified that ribosome assembly can occur through 
multiple different parallel pathways leading to a heterogenous population of assembly 
intermediates (Adilakshmi et al., 2008; Talkington et al., 2005; Mulder et al., 2010; 
Bubunenko et al., 2006; Sykes et al., 2010). This is confirmed by the observation that 
the assembly of a primary 23S component uS15 can be circumvented by alternate 
assembly pathways, suggesting that there may not be one definitive assembly pathway 
(Bubunenko et al., 2006). 
Different components of the bacterial ribosome are dispensable for assembly. This 
includes uL9, uL15, bL21, uL24, bL27, uL29, uL30, bL34, uS9, and uS17. However, 
it is suggested that they are necessary for accurate and efficient translation (Shoji et al., 
2011). Furthermore, in vivo SILAC labelling, sucrose gradient fractionation and mass 
spectrometric analysis, and aptamer-based RNA-tagging and affinity purification, 
have been used to identify assembly intermediates and their composition (Li et al., 
2013; Sashital et al., 2014; Gupta and Culver, 2014). These methods have also 
identified that bacterial SSU assembly occur through various different pathways that 
happen concurrently in the cell. 
The 50S large subunit was also reconstituted in vitro under non-physiological 
conditions. This identified three intermediates - 33S (23S rRNA + 22 proteins), 41-
43S (induced by change in temperature and ionic conditions) and 48S (+11 proteins). 
The conversion from one intermediate stage to another relied on the addition of 
certain specific ribosomal proteins, changes to temperature and ionic conditions. For 
example, the maturation of the 33S to the 41-43S intermediate require the addition of 
uL4, uL13, bL20, uL22, uL24 and 23S rRNA (Spillman et al., 1977).  
Earlier in vivo analysis of ribosomal intermediates identified 32S (23S rRNA + 16 
proteins), 43S (+8 proteins) and immature 50S (+6 proteins) intermediates. Analysis of 
the assembly pathways of the LSU showed that functionally important domains like 
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the tRNA-binding sites remain immature until the final stages of assembly. This is 
probably to prevent the ribosome from beginning protein synthesis with an immature 
ribosome. More recent investigations identified two 45S intermediates that differ only 
in their interaction with 5S rRNA. The final maturation step of these 45S 
intermediates is the assembly of the central protuberance (Li et al., 2013; Jomaa et al., 
2014). 
 
1.8.3 Mitoribosomal biogenesis in yeast 
In S. cerevisiae, the mitochondrial genome encodes 8 polypeptides, 7 of which are 
components of the respiratory complex, and one is a component of the mtSSU (Var1). 
The genome is transcribed as polycistronic molecules from 11 promoters, containing 
intronic regions. Very little is known about the stages of and factors involved in the 
biogenesis of the yeast mitoribosome. All the precursors contain 5’ and 3’ extension 
which require further processing. This is carried out by RNase P (encoded by RPMI) 
and tRNase Z (encoded by TRZ1) activity (Morales et al, 1992; Chen et al., 1988). 
The mt-LSU 21S rRNA precursor contains a 1.2 kb intronic region and a 3’ 
extension that requires SUV3 to be processed (Stepien et al., 1995). The mt-SSU 
15.5S rRNA precursor also contains a 5’ extension and a tRNA-Trp. However, the 
mechanism of processing of this precursor is still unclear (Osinga et al., 1981). The 
assembly of the large subunit (54S) occurs at the inner membrane. Here, a pre-54S 
intermediate is proteolytically matured by YtA10/Yta12 with the final incorporation 
of MRPL32 (bL32m) (Nolden et al., 2005; Kaur and Stuart, 2011).   
 
1.8.4 Mitoribosomal biogenesis in mammals 
The assembly pathway of the mammalian mitoribosome is still mostly unknown. The 
maturation of the rRNA involves ten conserved chemical modifications of the rRNA. 
The mt-SSU is methylated at positions 429, 839, 841, 936 and 937. The mt-LSU is 
methylated at positions 947, 1145, 1369 and 1370, and pseudouridylated at position 
1397. The enzymes involved in introducing these modifications and the function of 
these modifications are further elaborated in section 3.1.1.  
The assembly of the RNA and proteins components of the mitoribosome into a 
functional ribosome involves a combination of spontaneous interactions and folding, 
and the assistance of additional ribosome assembly factors. These include GTPases 
and ATP-dependent RNA helicases which force the conformation of the assembling 
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ribonucleoparticle in a specific direction. Four GTPases have been identified as 
factors that associate with the mitoribosome during biogenesis. These include 
mitochondrial GTPBP7, MTG2/ObgH1 and C4ORF14, which are found in yeast 
and humans, and mitochondria-specific ERAL1.  
 
1.8.4.1 GTPases 
MTG1 (or GTPBP7) is a conserved protein related to bacterial RbgA. In bacteria, 
RbgA assists in the assembly and maturation of the large subunit. It associates with 
the immature LSU, connecting the helix 38 and the central protuberance, and only 
dissociates after it hydrolyses GTP, after the assembly of a 50S LSU. Depletion of 
RbgA causes an accumulation of an immature 50S assembly intermediate and leads 
to the inhibition of cell growth (Matsuo et al, 2006; Achila et al., 2012; Matsuo et al., 
2007; Uicker et al, 2006). In yeast, loss of mtg1 leads to a reduction in mt-LSU 21S 
rRNA levels and severe translation defect (Kotani et al., 2013). This phenotype can be 
partially rescued with human MTG1, suggesting a conservation of function. In 
humans, the equivalent of helix 38 is not present and therefore, the mechanism of 
MTG1 action is not clear (Barrientos et al., 2003).  
MTG2/ ObgH1 (or GTPBP5) is related to bacterial ObgE. In E. coli, ObgE binds to 
both the SSU and the LSU. Lack of ObgE causes an impairment of 70S ribosome 
assembly, leading to the accumulation of free subunits and the accumulation of 
immature 50S assembly intermediates (Sato et al., 2005). Sucrose gradient 
sedimentation of Mtg2 in yeast showed that it interacts with the mt-LSU and can be 
used to alleviate the symptoms of mrm2 depletion. This suggest that, in yeast, mtg2 
may perform its role ahead of mrm2 modification. Since, both these proteins are 
conserved in the mammalian mitoribosome, it is possible that their role and order of 
activity in the maturation of the mitoribosome may be conserved. Both MTG1 and 
MTG2/ObgH1 are found associated with the mt-LSU at the inner membrane, and 
require their GTPase activity to facilitate this interaction, suggesting a membrane-
associated maturation of the mt-LSU. However, a knockdown of MTG2/ObgH1 did 
not lead to a defect in mt-LSU assembly (Kotani et al., 2013). Therefore, the exact 
role of these factors in mitoribosomal biogenesis remains unclear.  
C4ORF14 (MTG3 or NOA1) is a member of the YqeH protein family. In bacteria, 
YqeH binds to the SSU, depending on the GTP:GDP ratio, and facilitates the 
assembly of the small subunit, and thus the 70S ribosome (Anand et al., 2010). It does 
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this by controlling the maturation of the 15S rRNA. Depletion of Mtg3 also leads to 
the accumulation of misprocessed 15S precursors in yeast mitochondria (Paul et al., 
2012). Sucrose gradient sedimentation analysis showed that in humans, C4ORF14 
binds to the small subunit (Al-Furoukh et al., 2013). However, knockdown of human 
C4ORF14 leads to misassembly of the mt-LSU and a translational defect (He et al., 
2012; Kolanczyk et al., 2011). Furthermore, overexpression of the GTPase leads to 
increased oxidative phosphorylation and ATP production in a GTP-dependent 
manner (Heidler et al., 2011). Similar to other GTPase involved in mitoribosomal 
biogenesis, the hydrolysis of GTP is required for its dissociation from the mt-SSU. 
Moreover, it is found associated with the mitochondrial nucleoid, suggesting the mt-
SSU assembly may occur at this site (He et al., 2012). 
ERAL1 is a mitochondrial GTPase with RNA-binding properties. It is a homolog of 
Era in E. coli, which binds to a 3’ stem-loop structure (helix 45) of the 16S SSU rRNA 
and is required for ribosomal assembly (Sharma et al., 2005). In bacteria, this highly 
conserved 3’ helix binds to the Shine-Dalgarno sequence. In humans, the anti-Shine 
Dalgarno sequence and helix is lost. Instead, ERAL1 binds to a different 33-
nucleotide 3’ terminal stem-loop of the mt-SSU 12S rRNA. This region contains the 
two adenine residues dimethylated by TFB1M. Furthermore, these modifications may 
be necessary for ERAL1 binding and SSU maturation, as knockout of TFB1M leads 
to a similar phenotype as ERAL1 depletion (Uchiumi et al., 2010). Patients with 
defective ERAL1 show compromised 28S SSU assembly and lower steady state levels 
of 12S rRNA, leading to a translation defect (Dennerlein et al., 2010; Chatzipyrou et 
al., 2017). 
Investigation of protein interactors of ERAL1 identified mitoribosomal proteins, 
transcription factor A, TFAM, which is required for nucleoid formation, and 
mitochondrial ribosome recycling factor, mtRRF (Dennerlein et al., 2010; Uchiumi et 
al., 2010). Moreover, the removal of ERAL1 and the subsequent targeted degradation 
of ERAL1 is required for the control of 28S SSU assembly. In the absence of this 
degradation pathway, ERAL1 is accumulated and strongly associates with the 
assembling subunit preventing maturation (Szczepanowska et al., 2016).  
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1.8.4.2 RNA helicases involved in mitoribosome biogenesis 
RNA helicases bind and unwind RNA and ribonucleoprotein complexes using NTP 
hydrolysis. They contain a helicase core domain that binds RNA and external 
domains that confer specificity. A common group of ribosomal RNA helicases fall in 
the DEAD box family of helicases, recognised by a common Asp-Glu-Ala-Asp motif. 
The helicase core in these proteins contains two domains connected by a linker. When 
these two domains come together, they form a cleft which hold the RNA and ATP at 
either end. Helicase activity is linked to ATP hydrolysis. In many cases, substrate 
specificity may be specified by additional co-factors that bind to the helicase (Linder et 
al., 2011; Cordin et al., 2006; Fairman-Wiliams et al., 2010; Young et al., 2013).   
Members of the DExD/H-box ATP-dependent RNA helicase family participate in a 
large number of RNA metabolism pathways. In E. coli, four out of the five identified 
DExD/H-ATPases play a role in ribosome biogenesis, RNA degradation or 
translation (Kaberdin et al., 2013). The RhlE helicase activity is required at early 
stages of ribosome assembly to direct rRNA folding (Nierhaus, 1991). After this, SrmB 
leads the maturation of the 23S intermediate to the 32S intermediate of 50S LSU 
maturation. Then, the DeaD/CsdA helicases direct the late stage assembly stage. Loss 
of DeaD/CsdA and SrmB leads to an accumulation of a 40S assembly intermediates 
and reduction in ribosome biogenesis (Peil et al., 2008; Charallais et al., 2003). DbpA 
is another DEAD box ATP-dependent helicase that is specifically activated by 
interaction with helix 92 of the 23S SSU rRNA. Knockout of the protein does not 
affect ribosome biogenesis. However, an accumulation of 45S assembly intermediates, 
lacking key proteins near the peptidyl transferase centre, can be induced through the 
expression of a dominant negative mutant (Fuller-Pace et al., 1993; Diges et al., 2001; 
Sharpe Elles et al., 2009).  
Mitoribosome assembly has recruited a different set of helicases to control biogenesis. 
In yeast mitochondria, helicase Mrh4 was identified as essential for mt-LSU 
biogenesis. In the presence of a catalytically inactive Mrh4, mt-LSU is halted, causing 
an accumulation of a pre-54S particle lacking MRPs, MRPL9(bL9m), 
MRPL16(uL16m), MRPL33(bL33m), similar to the dbpa dominant mutant in E. coli. 
Sucrose gradient experiments show that Mrh4 co-sediments with the pre-54S particle. 
This assembly intermediate contains a fully matured 21S rRNA, suggesting that Mrh4 
activity occurs later in the assembly pathway. This is further corroborated by the 
interaction of Mrh4 with 21S mt-LSU rRNA, subassemblies of the mitoribosome and 
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the fully-assembled ribosome (De Silva et al., 2013). Interestingly, the MTG1 and 
MTG2 GTPases also co-sediment with the pre-54S particle (De Silva et al., 2013). 
This indicated that they may function earlier in the assembly of the mt-LSU. In 
mammals, Mrh4 is closely related to helicase DDX28, an RNA-sensitive ATPase, 
which dually localises to the mitochondria and the nucleolus (Valgardsdottir et al., 
2001; Valgardsdottir et al., 2003). Similar to Mrh4, DDX28 interacts with 16S mt-
LSU rRNA and the mt-LSU. Knockdown of the protein leads to a decrease in steady 
state level of 16S rRNA and mt-LSU MRPs, mtLSU assembly and consequently, 
protein synthesis. However, loss of DDX28 does not have any effects on mRNA 
stability and 16S rRNA processing or modification. This suggests that DDX28 
functions at an earlier stage of mt-LSU assembly, but after 16S processing (Tu and 
Barrientos, 2015) 
DHX30 was recently identified as another mtLSU assembly factor. Knockdown of the 
protein leads to an absence of assembled ribosomes, which results in a severe 
inhibition of protein synthesis. It was shown to interact with mt-LSU, mt-SSU and 
monosome, suggesting that it plays a role in all stages of assembly. Intriguingly, 
DDX38 and DHX30 are both found in RNA granules (see section 1.9). This suggests 
that they act on the nascent transcript and have an early influence on mitoribosome 
biogenesis (Antonicka and Shoubridge, 2015). 
 
1.8.4.3 Additional factors in mitoribosomal biogenesis 
MTERF3 (MTERFD1) and MTERF4 are members of a family of mitochondrial 
transcription termination factors that have been implicated in mitoribosomal 
biogenesis. A depletion of MTERF3 not only causes an activation repression of 
mitochondrial transcription, but also leads to instability of the mt-LSU (Wrendenberg 
et al., 2013). MTERF4, on the other hand, functions in combination with a 
methyltransferase, NSUN4 (Camara et al., 2011). NSUN4 can modify the 12S rRNA 
independent of MTERF4 interactions. However, it requires MTERF4 to facilitate 
monosome formation (Spahr et al., 2102; Metodiev et al., 2014). 
Recently, NGRN, a highly conserved protein with a Pfam domain was localised to the 
mitochondria. The protein was shown to bind to 16S mt-LSU rRNA and its precursor 
but not 12S mt-SSU rRNA. In addition, depletion of the protein leads to a reduction 
of MRPs and a deficiency in translation. This suggests that NGRN may play a role in 
the early stages of mitoribosome biogenesis. Analysis of the interactome of NGRN 
	46	
identified WBSCR16, FASTKD2 (see below) and pseudouridine synthases, RPUSD3, 
RPUSD4 (see section 3.1.1) and TRUB2, which were required for 16S rRNA stability 
and mitochondrial translation (Arroyo et al., 2016).  
MALSU1 (or C7orf30) is another mitoribosome biogenesis factor that specifically 
associates with the large subunit through uL14 (Rorbach et al., 2012, Fung et al., 
2013, Wanschers et al., 2012). Sucrose gradient analysis identified that MALSU 
interacts with the free 39S subunit and not with the assembled ribosome. 
Furthermore, depletion of MALSU inhibits assembly of the mt-LSU which leads to a 
translation phenotype and respiratory incompetence (Rorbach et al., 2012; Wanschers 
et al., 2012). As a member of the DUF143 family of nucleotidyltransferases, 
MALSU1, similar to other members of the family, may facilitate the interaction of 
various subunits of larger complexes. As such, in the mitoribosome, MALSU1 may 
inhibit assembly of the immature assembly intermediate into a monosome until it is 
properly matured (Rorbach et al., 2012). Recently, a cryo-EM structural analysis of 
the human mitoribosomal large subunit identified two assembly factors L0R8F8 and 
mt-ACP which associate with MALSU forming a 65 Å module in the subunit 
interphase and possibly preventing the premature subunit from forming a monosome. 
L0R8F8 is a eukaryote-specific protein that is synthesized from an alternate open 
reading frame in a bicistronic transcript that encodes a outer mitochondrial 
membrane transmembrane protein, MID51. Mt-ACP a protein that acts as a scaffold 
in fatty-acid synthesis. However, in mt-LSU biogenesis, they together interact with 
MALSU sterically blocking association of the mitoribosomal subunits (Brown et al., 
2017). 
FASTKD2 is a mitochondrially-targeted RNA-binding protein. iCLIP analysis of 
RNA targets of the protein identified the 16S mt-LSU rRNA and NADH 
dehydrogenase (Complex I) subunit 6 (ND6) mRNA. Depletion of the protein led to 
the accumulation of precursors of these transcripts. In addition, loss of the protein 
leads to instability of the mt-LSU and the monosome, and a respiratory defect 
(Antonicka and Shoubridge, 2015; Popow et al., 2015). However, the mechanism of 
action of the protein is still unknown. Another member of the FATK family, 
FASTKD3, has been recently shown to selectively regulate CO1 translation without 
affecting CO1 mRNA stead state levels. However, unlike other members of the 
FASTK family like FASTKD2, it does not co-localise the mitochondrial RNA 
granules. (Boehm et al., 2016).  
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MPV17L2 is an integral inner membrane protein that co-sediments with mt-LSU and 
the monosome. Knockdown of the protein leads to a decrease in mt-LSU and mt-
SSU stability, and a translation defect. In these cells, the mt-SSU is unable to associate 
with the mt-LSU, suggesting a role of the protein in monosome formation (Dalla Rosa 
et al., 2014). The mechanism of this function still remains to be elucidated. Similar to 
C4orf14, MPV17L2 is associated with the mitochondrial nucleoid, suggesting that 
28S mt-SSU assembly may happen at the nucleoid (He et al., 2012; Dalla Rosa et al., 
2014) 
GRSF1 is an integral component of mitochondrial RNA granules (Section 1.9). In the 
RNA granule, it interacts with the mt-SSU, as identified by sucrose gradient 
fractionation (Tu and Barrientos, 2015). A depletion of GRSF1 leads to reduced mt-
SSU biogenesis and a translation defect (Antonicka et al., 2013; Jourdain et al., 2013). 
Its presence in the RNA granules suggests that it acts on the newly transcribed 12S 
rRNA at an early stage of mitoribosome biogenesis. 
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Assembly 
factors 
12S 
rRNA 
mt-
SSU 
16S 
rRNA 
mt-
LSU Monosome References 
ERAL1  ü     
Uchiumi et al. (2010), 
Dennerlein et al. 
(2010) 
C4ORF14  ü     
Al-Furoukh et al. 
(2013) 
GRSF1  ü     Tu and Barrientos (2015) 
NGRN   ü    Arroyo et al. (2016) 
FASTKD2   ü    Popow et al. (2015) 
DDX28   ü  ü   Tu and Barrientos (2015) 
MALSU    ü   Rorbach et al. (2012), 
Fung et al. (2013) 
L0R8F8 –  
mt-ACP 
   ü   Brown et al. (2017) 
MTG1    ü   Kotani et al. (2013) 
MTG2    ü   Kotani et al. (2013) 
MPV17L2    ü  ü  Dalla Rosa et al. 
(2014) 
DHX30  ü   ü  ü  Antonicka and 
Shoubridge (2015) 
 
Table 1.1 Summary of co-sedimentation experiments, showing the ribosomal subassemblies that the 
assembly factors have been shown to interact with. It must be noted that absence of a tick only 
indicates insufficient evidence and not absence of interaction. In addition, some proteins have been 
located in MRGs (GRSF1, DHX30, DDX28) and nucleoids (MPV17L2, C4ORF14), indirectly 
suggesting that they may be involved at early stages of assembly. However, this information has not 
been included in the table. 
 
1.9 Mitochondrial RNA granules 
Several recent studies have identified the colocalization of proteins involved in gene 
expression in distinct foci called mitochondrial RNA granules (MRGs). These 
subcompartments bring together RNA processing enzymes onto nascent transcripts to 
allow only fully mature RNA molecules to be released for use by the translation 
apparatus. As seen in the ribonucleoparticles in stress granules and processing bodies 
in the cytosol (Anderson and Kedersha, 2009; Jourdain et al., 2016), this spatial, 
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temporal and functional delineation of RNA maturation is hypothesised to allows for 
more efficient and accurate gene expression. 
By studying the co-localisation of 5’-bromouridine-incorporated nascent transcripts 
and RNA-processing proteins, it was shown that MRGs are found near but distinct 
from nucleoids (Jourdain et al, 2013; Antonicka et al., 2013). Proteins in these 
granules include GRSF1 (Jourdain et al, 2013; Antonicka et al., 2013), RNase P 
subunits (Jourdain et al., 2013), mtPAP (Wilson et al., 2014), nucleotide modifying 
enzymes (MRM2, MRM3 (Lee et al., 2013), TFB1M, PUS1 (Antonicka et al.,2015)), 
and TRMT10C (MRPP1) (Vilardo et al., 2012).Of these, GRSF1 (RBP G-rich 
sequence factor 1) was shown to be an essential component of the MRGs, as loss of 
GRSF1 leads to aberrant processing of mt-RNAs and translation defects (Jourdain et 
al, 2013). Recently, a systematic analysis of the MRG proteome has identified more 
factors involved in mt-RNA metabolism, including Fas-activated serine/threonine 
kinase (FASTK) proteins, FASTK and FASTK5 (Antonicka et al., 2015; Jourdain et 
al., 2015) which have been implicated in non-canonical processing of the primary 
transcript (Antonicka and Shoubridge, 2015). 
Moreover, MRGs are also considered as centres for mitoribosomal biogenesis as they 
contain such assembly factors as MTERF3/MTERFD1, ERAL1, DDX28, FASTK-
family proteins (Antonicka and Shoubridge, 2015; Tu and Barrientos, 2015) and mt-
rRNA and mitoribosomal proteins (Hu et al., 2012; Bogenhagen et al., 2008). This 
suggests that the MRGs facilitate co-transcriptional assembly of the ribosome 
(Bogenhagen et al., 2014; Rackham et al., 2016).  
Similarly, D-foci are said to contain the mitochondrial degradosome components, 
PNPase and SUV3 (Jourdain et al., 2015; Borowski et al., 2012; Minczuk et al., 2002; 
Piwowarski et al., 2003; Szczesny et al., 2010). The D-foci are found in close 
proximity to MRGs and is involved in co-transcriptional degradation of non-
functional antisense RNAs and misprocessed RNAs, RNA maturation which requires 
3’ end exonuclease activity like ND6, and RNA turnover (Jourdain et al., 2013).  
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1.10 Aim 
 
Of the numerous chemical modifications present in the cytoplasmic and bacterial 
ribosomal RNAs, only a few are conserved in the mammalian mitochondria. This 
work aims to identify the function of one such modification at G1145 on the 16S 
rRNA of the large subunit through identification of interactors of the responsible 
methyltransferase, MRM1 using immunoaffinity purification, the generation of 
knockout cell lines, the analysis of changes to the mitoribosomes composition and 
function using proteomic approaches upon loss of MRM1, and any consequential 
effects on mitochondrial function upon loss of MRM1.  
 
This work also aimed to characterise a homolog of bacterial endonuclease, YbeY that 
is predicted to localise in the mitochondria. This involved the confirmation of location 
of YbeY to the mitochondria and analysis of the role of the endonuclease in the 
processing of the non-canonical cleavage site between the mRNAs encoding ATP8/6 
and CO3. Analysis of the YbeY-deficient cells showed a severe defect in 
mitochondrial function, particularly in mitochondrial translation. Therefore, this work 
aimed to elucidate the role of YbeY in mitochondrial translation through the analysis 
of mitochondrial RNA metabolism via northern blotting and RNA-Seq, the 
identification of protein interactors of YbeY using immunoaffinity purification, and 
the role YbeY plays in mitoribosome biogenesis using proteomic approaches.  
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2 Material and methods 
2.1.1 Chemicals and reagents 
1 kb plus DNA Ladder, Hygromycin, Lipofectamine 2000, Lipofectamine RNAiMax, 
Cyquant NF cell proliferation assay kit, NativePAGE reagents, NuPAGE MOPS 
SDS running buffers, NuPAGE LDS sample buffer, random hexamers, SimplyBlue 
Safe Stain, SYBR Safe, TaqMan gene expression master mix and UltraPure agarose 
were purchased from Invitrogen. 
5’ Terminator exonuclease and 5’ RNA polyphosphatase were purchased from 
Epicentre. 
[32P]-labelled a-UTP, a-dCTP and g-ATP were purchased from Hartmann Analytic. 
[35S]-labelled methionine was purchased from Perkin Elmer. 
Acrylamide/Bis solution (19:1) , DC assay kit and Precision Plus Protein Kaleidoscope 
prestained protein standard were purchased from Bio-Rad. 
Alpha Select Silver Efficiency Competent Cells was purchased from Bioline Reagents. 
All restriction enzymes, Klenow polymerase, T4 DNA Ligase, T4 Polynucleotide 
Kinase and T4 RNA Ligase were purchased from New England Biolabs. 
Amaxa Nucleofector Kit V was purchased from Lonza. 
Ammonium persulphate, b-mercaptoethanol, CompoZr zinc finger nucleases, DDM, 
DNA oligonucleotides, doxycycline, emetine dihydrochloride, FCCP, glucose, 
galactose, L-glutamine, mannitol, MMS, oligomycin, phenol, PMSF, rotenone, 
TEMED, Trizma base, hexadimethrine bromide and uridine were purchased from 
Sigma-Aldrich. 
Ampicillin sodium salt and DTT were purchased from Melford Laboratories.  
Benzonase Nuclease and Immobilon-P PVDF membrane were purchased from 
Merck Millipore. 
Blasticidin and Zeocin were purchased from Invivogen. 
Bromophenol blue, disodium phosphate, DMSO, EDTA, ethidium bromide, 
formaldehyde, glycerol, glycine, HEPES, hydrochloric acid, isopropanol, 
magnesium chloride, methanol, orthophosphoric acid, potassium chloride, sodium 
chloride, sucrose, mMessage mMachine T7 transcription kit and Triton-X100 were 
purchased from Fisher Scientific. 
BSA, sodium hydroxide and urea were purchased from VWR International. 
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DMEM (Dulbecco’s Modiefied Eagle’s Medium) variants, Iscove’s Modified 
Dulbecco’s Medium (IMDM), RPMI (Roswell Park Memorial Institute) medium, 
Glutamax, Opti-MEM, D-PBS (phosphate buffered saline), Penicillin-Streptomycin 
(10,000 U/ml), sodium pyruvate and trypsin-EDTA (0.25%) were purchased from 
Gibco. 
DNeasy Blood and Tissue kits, miRNeasy RNA isolation kits, Omniscript reverse 
transcription kits, QIAquick Gel Extraction kits, QIAquick PCR Purification kits, 
QIAprep Miniprep kits and QIAzol were purchased from QIAGEN. 
dNTPs, ECL, ECL prime, Hybond N+ nylon membrane and storage phosphor 
screens were purchased from GE Healthcare. 
Gel Loading Buffer II, Glycoblue Coprecipitant, nuclease-free water, RNaseZap, T7 
Maxiscript In Vitro Transcription Kit, TRIzol and TRIzol LS were purchased from 
Ambion. 
Hap1 control and knockout cells (Product ID: HZGHC002765c022) were purchased 
from Horizon Discovery. 
High Sensitivity D1000 Screentape was purchased from Agilent Technologies. 
Hybond-N+ membrane was purchased from Amersham. 
Low-melt agarose was purchased from Biogene. 
Milk Powder was purchased from Marvel. 
Proteinase Inhibitor tablets were purchased from Roche. 
Tetracycline-free fetal bovine serum (FBS) was purchased from Biochrom AG. 
TruSeq Stranded Total RNA LT Kit and MiSeq reagent kits were purchased from 
Illumina. 
X-Ray film was purchased from Fujifilm. 
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2.1.2 Solutions 
ACA BUFFER: 1.5M aminocaproic acid, Bis-Tris (pH 7) 
BUFFER A: 2M HEPES pH 6.6 
BUFFER B: 1.25 M Tris-HCl pH 8, 125 mM MgCl2, 1.8% 2-mercaptoethanol, 0.5 
mM dATP, 0.5 mM GTP, 0.5 mMTTP 
FREEZING MEDIUM: 20 % v/v DMSO, 80 % FBS  
GRADIENT BUFFER: 50 mM Tris–HCl (pH 7.2), 20 mM Mg(OAc)2, 80 mM 
NH4Cl, 0.1 M KCl, 1 mM PMSF 
GTB BUFFER (20x): 1.78 M tris base, 0.57 M taurine, 10 mM EDTA. 
HYBRIDISATION BUFFER: 7 % SDS, 0.25 M Sodium Phosphate (pH 7.6) 
LYSIS BUFFER 1: 50 mM TRIS HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton, 1 x 
Roche Protease Inhibitor Tablet  
MITOBUFFER: 0.6 M mannitol, 10 mM Tris HCl pH 7.4, 1 mM EDTA 
MOPS BUFFER (10 X): 200 mM MOPS, 10 mM EDTA, 50 mM Sodium Acetate 
(pH 7.0).  
MOPS RUNNING BUFFER: 5 ml of 10 x MOPS, 5 mL of 37 % formaldehyde (0.3 M 
fc), 10 μg/mL EtBr, and 220 mL of water 
PIC: 1 x PBS, 1 x tablet of Roche protease inhibitor/ 50 ml 
PBSS: 5% FBS v/v, 95% PBS 
PBS-T (1x): 1x PBS, 0.1 % (v/v) Triton X-100 
SILAC MEDIUM: 10% dialysed FBS (20% for YbeY (-/-) cells), 200 mg/L proline, 
0.398 mM arginine, 0.798 mM lysine (Light-R0K0, Heavy-R10K8)  
SOC MEDIUM: 0.5 % (w/v) yeast extract, 2 % (w/v) tryptone, 10 mM NaCl, 2.5 mM 
KCl, 10 mM MgCl2, 20 mM MgSO4, 20 mM glucose 
SONICATION BUFFER: 20 MM Tris HCl PH 7.5, 200 mM NaCl, 10% ethylene 
glycol, 1 x Roche Protease inhibitor tablet/ 50 ml 
SSC (20 X): 3 M NaCl, 0.3 M sodium citrate (pH 7.0).  
WASH BUFFER: 50 mM HEPES pH 8.0, 150mM NaCl, 0.05% DDM, 2 mM DTT, 
2 mM EDTA, 1 Roche protease inhibitor tablet/50 ml 
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2.2 Basic techniques 
2.2.1 Cloning 
A plasmid containing the open reading frame of YbeY was purchased as an IMAGE 
cDNA clone (IRAUp969G02109D; GeneScript Item number: SC1010) from Source 
Bioscience, and then cloned into pcDNA5/FRT/TO constructs. 
 
Primers: 
YBEY + FLAG 
Overhang+BamH1+FP CTTTCTTGGATCCAATGAGTTTGGTGATTAGAA
ATCTGCAGCG 
Overhang+Not1+Flag+RP CTCTCCGCGGCCGCCTACTTATCGTCGTCATCC
TTGTAATCGCTCCCTCCGAAGAGGCC 
YBEY (FLAG + STREP) 
Overhang + Age1 + RP CTCTCCACCGGTGCTCCCTCCGAAGAGGC 
YBEY (R59A catalytic mutant) 
RP for site directed 
mutagenesis 
GCACATCGGTTGGGACATTTCTATCCGCGTAGA
TTCTATTAATGTGC 
FP for site-directed 
mutagenesis 
GCACATTAATAGAATCTACGCGGATAGAAATGT
CCCAACCGATGTGC 
YBEY (H117A mutant) 
RP for site directed 
mutagenesis 
CCTGACTGTGACGGCCACCGCAGGACTCTGTCA
CTTGCTGGGATTCACA 
FP for site-directed 
mutagenesis 
TGTGAATCCCAGCAAGTGACAGAGTCCTGCGGT
GGCCGTCACAGTCAGG 
 
DNA concentrations were determined using a Nanodrop 1000 Spectrophotometer. 
MRM1 cloned into pcDNA5/FRT/TO was kindly gifted by Dr Joanna Rorbach.  
pBMN plasmid was kindly gifted by Luther Davis. 
 
 2.2.2 Sanger sequencing 
PCR products or plasmid sequencing was performed by Source Bioscience 
sequencing service. 96-well plates of bacterial colonies were sequenced by GENEWIZ 
sequencing service. 
 
2.2.3 TBE-agarose gel electrophoresis 
PCR products of restriction enzyme digestion products (with 1 x SYBR Safe DNA 
statin) were resolved on a 1% agarose gel prepared in 1 x TBE buffer. The gel was 
run at 95V for 40 minutes. Bands were visualised using UV light and bands were cut 
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out (if necessary) using scalpels. DNA was extracted from the gels using QIAquick gel 
extraction kit, according to manufacturer’s instructions. 
 
2.2.4 Restriction digestion  
Restriction digests of PCR products and plasmids were performed using 
manufacturer’s (New England Biolabs) instructions. 1 x NEBuffer (1.1, 2.1 or 3.1) was 
added to 1 µg of plasmid or the PCR mix with 10 units of the restriction 
endonuclease. The reaction was incubated at 37° for 1 hour. 
 
2.2.5 DNA ligation 
PCR-generated, restriction endonuclease-cleaved PCR products were mixed with the 
restriction endonuclease-cleaved vector at a molar ratio of 1:3. This was added to a 20 
µl reaction mix containing 1 x T4 DNA ligase and 400 units of T4 DNA ligase. The 
ligation mix was incubated at 16 °C overnight. This vector was then transformed into 
chemically competent bacteria for expansion. 
 
2.2.6 Transformation of chemically competent E. coli 
DNA was added to 50 µl of α-select chemically competent E. coli cells (defrosted on 
ice), and incubated on ice for 10 minutes. Cells were then heated to 42°C for 45 
seconds and chilled in ice for 2 minutes. 500 ml of SOC MEDIUM was added to the 
cells. The mixture was incubated in a shaking incubator at 37°C for 1 hour. The 
mixture was centrifuged at 2000g for 3 minutes. 250 µl of medium was removed. The 
cells were resuspended in the rest of the medium and spread onto pre-warmed LB 
agar plates containing either 50 mg/ml ampicillin or 50 mg/ml kanamycin, 
depending on selection requirements. The plates were incubated at 37°C overnight.  
 
2.2.7 Western blotting 
A confluent 9 cm dish of HEK293 or Hap1 cells was washed with PBS and pelleted at 
1200 rpm for 3 minutes. The cells (or isolated mitochondria) were resuspended in 100 
µl of LYSIS BUFFER 1 and kept on ice for 15 minutes. Then, the lysed cells were 
centrifuged at 8000 rpm for 5 minutes. The supernatant was transferred to a new 
tube. Protein concentration was determined using the BCA kit according to 
manufacturer’s instructions.   
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25 µg of cell lysate were boiled at 95oC for 5 minutes with 33.3% NuPAGE LDS 4 x 
sample buffer containing 200 mM DTT. The boiled solution was loaded onto 4-12% 
Bis-Tris NuPAGE polyacrylamide gels and run at 200 V for 30 minutes. The proteins 
were transferred onto nitrocellulose membranes with the Bio-Rad Trans-Blot SD 
Semi-Dry Transfer Cell at 1 mA/cm2 for 90 minutes, or the iBlot 2 Dry Blotting 
System using protocol ‘P0’. Gels were then stained using SimplyBlue Safestain to 
confirm equal loading. The nitrocellulose membrane was blocked using 5% non-fat 
milk in PBS-T at room temperature on rollers. The blocking solution was removed 
and replaced with the primary antibody solution (diluted in PBS-T). The membrane 
was incubated with the antibodies overnight on rollers at 4°C. The membrane was 
washed 3 times for 10 minutes on rollers with PBS-T and incubated with secondary 
antibody diluted in PBS-T. The membrane was washed again, three times, as before. 
Finally, the membrane was developed using ECL and exposed to X-ray film in a dark 
room. 
The antibodies used are detailed in table 2.1. 
 
Primary antibodies 
Epitope Source Species Dilution 
TOM22 Abcam ab10436 Mouse 1:2000 
GAPDH Abcam ab10436 Mouse 1:2000 
YbeY Atlas HPA018162 Rabbit 1:500 
Histone H4 Abcam ab10158  Rabbit 1:1000 
MRM1 Atlas HPA021598 Rabbit 1:1000 
Flag  Sigma F3165  Mouse 1:1000 
MRPL12 Proteintech 14795-1-AP Rabbit 1:2000 
MRPL3 Atlas HP043665 Rabbit 1:2000 
MRPS18b Proteintech 16139-1-AP Rabbit 1:2000 
MRPS17 Proteintech 18881-1-AP Rabbit 1:2000 
b-actin Sigma A2228 Mouse 1:50,000 
NDUFS1 Abcam ab169540 Rabbit 1:2500 
OXPHOS 
cocktail 
Abcam ab110411 Mouse 1:1000 
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Secondary antibodies 
Epitope Source Dilution 
Goat anti-rabbit IgG 
HRP 
Promega W4011 1:1000 
Goat anti-mouse IgG 
HRP 
Promega W4021 1:2000 
 
Table 2.1 Antibodies for western blotting 
 
2.2.8 Mitochondrial isolation using Dounce homogeniser (and cell fractionation) 
This method was used predominantly for cell fractionation to identify protein 
localisation. Text in bold indicate fractions that need to be kept aside for western blot 
analysis. All steps of the mitochondrial isolation were carried out at 4 °C. 15 plates of 
confluent 15 cm dishes of HEK293 cells were harvested and washed with 1 x PBS. 
The cell pellet was resuspended in 15 ml of MITOBUFFER containing 0.1% BSA (100 
µl was kept aside for total fraction). 2 ml of this suspension was put in a Dounce 
homogeniser and homogenised with 15 strokes with a tight pestle. This homogenised 
solution was transferred to a new 2 ml tube. This was repeated with all the remaining 
resuspended cells. The tubes were centrifuged at 400g for 10 minutes. The 
supernatant was kept aside. The pellet from each tube was resuspended in 2ml of 
MITOBUFFER containing 0.1% BSA. The homogenisation and centrifugation steps 
were repeated. The supernatant was put into new 1.5 ml tubes (100 µl was kept aside 
as debris fraction). All the supernatant kept aside was centrifuged at 400g for 5 
minutes. The supernatant from these centrifuged tubes was transferred to a new tube 
and centrifuged at 11,000g for 10 minutes. The supernatant was removed (100 µl was 
kept aside as the cytoplasmic fraction). The pellet was resuspended in 1 ml of 
MITOBUFFER. 50U/ml of Benzonase was added to this and incubated for 15 
minutes. The suspension was centrifuged at 11,000g for 10 minutes. The 
mitochondrial pellet can be lysed in the same manner as cell lysis (section 2.2.7).  
For cell fractionation, the mitochondrial pellet was resuspended in 120 µl of 
MITOBUFFER. This was divided into 3 aliquots. The first aliquot was used as the 
mitochondrial fraction. The second aliquot was incubated with 4 µg/mg of Proteinase 
K and incubated for 30 minutes. This was the Proteinase K fraction. The third 
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aliquot was incubated with Proteinase K as described, and 0.2 µl of Triton X. This 
was the proteinase K and Triton-X fraction. The three fractions were centrifuged at 
11,000g for 5 minutes. The pellet was resuspended in WASH BUFFER containing 1 
µM PMSF. The pellets and the fractions collected were then lysed and analysed by 
western blotting (section 2.2.7).  
 
2.2.9 Mitochondrial isolation using Balch homogeniser 
A minimum of 10 x 15 cm confluent dishes of HEK293 or Hap1 cells were harvested 
and washed with cold 1 x PBS. All further steps were performed at 4 °C. The Balch 
homogeniser was kept on ice. 2 ml of HYPOTONIC BUFFER was introduced into the 
assembled homogeniser containing the ball bearing (10 µm clearance for Hap1 cells 
and 12 µm clearance for HEK293 cells). The cells were resuspended in 3 ml of 
HYPOTONIC BUFFER per gram of cells and incubated for 10 minutes. The cells were 
passed through the homogeniser chamber between two syringes repeatedly (3 passes 
for HEK293 cells/ 7 passes for Hap1 cells). The homogenised cells were put in a new 
50 ml falcon and neutralised with 2.5 x MSH buffer (0.68 ml/ml of cells). The final 
homogenised cell suspension was diluted in up to 50 ml of 1 x MSH buffer. This was 
centrifuged at 1000 g for 10 minutes. The pellet was discarded. The supernatant was 
again centrifuged at 1000 g for 10 minutes. The pellet was discarded and the 
supernatant was transferred to a new tube and centrifuged at 8500 rpm for 10 
minutes. Again, the supernatant was transferred to a new tube and centrifuged at 
8500 rpm for 10 minutes. The pellets from the 8500 rpm spins were pooled and 
resuspended in 1 ml of 1 x MSH. 50U/ml of Benzonase was added to this and 
incubated for 15 minutes. The suspension was centrifuged at 8500 rpm for 10 
minutes.  
The pellet was reusupended in 1 x MSH. This was loaded onto a 1.5 M – 1 M – 0.5 
M step sucrose gradient (prepared in 10 mM HEPES pH 7.8 containing 5 mM 
EDTA) (tube number: 344060). The tube was centrifuged at 26,000 rpm for 60 
minutes in a SW40Ti rotor. The mitochondria formed a pellet in the interface 
between the 1 M and 1.5 M solutions. The pellet was extracted and diluted in 4 
volumes of 1 x MSH and centrifuged at 8,000 rpm for 10 minutes at 4 °C. The pellet 
was the isolated mitochondria. This can be lysed for immunoaffinity purification or 
western blot analysis, in the same manner as cell lysis.  
	59	
2.2.10 Polymerase Chain Reaction (PCR) 
All PCR reactions were performed using Novagen KOD Hot Start DNA polymerase 
as per manufacturer’s instructions. PCR was performed for 35 cycles, using a Tm of 
58-65 °C depending on the primers. 
 
2.3 Cell Culture 
 
2.3.1 Maintenance of cell lines 
All cell lines were maintained at 5% CO2 and 37oC in humidified incubators. The 
HEK and HeLa cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM), 
containing 4.5 g/L glucose, 110 mg/L sodium pyruvate, supplemented with 10 % 
(v/v) foetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin. 
Hap1 cells were cultured in Iscove’s Modified Dulbecco’s Medium (IMDM) 
containing 4.5 g/L glucose, 110 mg/L sodium pyruvate, supplemented with 10 % 
foetal bovine serum (v/v) (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin. In 
the case of the YbeY knockout Hap1 cells, 20% of foetal bovine serum was used. 
Flp-In T-Rex HEK293 cells were gown supplemented DMEM containing 15 μg/ml 
blasticidin and 100 μg/ml Zeocin (BZ MEDIUM). After transfection, 15 μg/ml 
blasticidin and 50 μg/ml hygromycin were used instead (HB MEDIUM). 
 
2.3.2 Freezing and thawing cell lines 
A confluent 9 cm dish was trysinised, neutralised with medium (DMEM or IMDM, 
depending on the cell type), centrifuged at 1200 rpm for 3 minutes, washed with 
phosphate buffer saline (PBS) and re-centrifuged. The pellet was resuspended in 1ml 
of FBS and transferred into a cryovial. 1 ml of FREEZING MEDIUM was added to 
the cryovial. The solutions were mixed by inversion. The cryovials were transferred to 
a Mr Frosty isopropanol container at -80oC. The vials could be transferred to liquid 
nitrogen tanks after 24 hours. 
For thawing cells, cells were quickly defrosted in a 37°C water bath. The contents of 
the cryovial were transferred to 10 ml of non-selective supplemented medium, mixed 
by inversion and centrifuged at 1200 rpm for 3 minutes. The supernatant was 
aspirated. The cells were resuspended in 1 ml of supplemented DMEM and plated in 
a 9 cm dishes with 10 ml of supplemented medium.  
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2.3.3 Lipofectamine 2000 transfection 
2 µg of DNA was incubated in 100 µl of optimem for 5 minutes, while 3 µl of 
Lipofectamine 2000 was also incubated in 100 µl of optimum for 5 minutes at room 
temperature. They were mixed and incubated at room temperature for 10 minutes. 
Then, they were added to the cells in supplemented DMEM and mixed by swirling. 
 
2.3.4 Transient DNA transfection for immunofluorescence imaging 
HeLa or HEK cells were plated on coverslips in a well of a 6 well tissue culture plate 
until 80% confluency for 24 hours. 2 µg of pcDNA5 vector containing the relevant 
gene were transfected into the cells using lipofectamine 2000. 24 hours later, the cells 
were prepared for immunocytochemistry. 
 
2.3.5 Immunocytochemistry 
All the steps were performed at room temperature. 
The cells were grown on coverslips in a well of a 6-well plate. After 24 hours of 
transfection, the cells were washed with PBS. The PBS was aspirated and the cells 
were incubated in 4 % formaldehyde in 1x PBS for 15 minutes. The formaldehyde 
was removed and the cells were washed with PBS. 0.1 % Triton-X in PBS (PBS-T) 
was added for 5 minutes to permeabilise the cells. Cells were incubated for 1 hour in 
PBSS buffer and then primary antibodies (diluted in PBSS) were applied for 1.5 hours. 
The cells were washed in PBSS for 5 minutes on a rocker, three times and secondary 
antibodies (diluted in PBSS) were added for one hour. Following this incubation, cells 
were washed two times in PBSS and one time in PBS (5 minute washes), and mounted 
in Vectashield mounting medium. The cells were then visualised by fluorescence 
microscopy. Immunofluorescence images were captured using a Zeiss LSM 510 
META confocal microscope.  
Primary antibodies 
Epitope Source Dilution 
Flag Sigma F3165 1:200 
Tom20 Santa Cruz sc-11415   1:500 
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Secondary antibodies 
Epitope Source Dilution 
Alexa Fluor 488-conjugated goat anti-mouse Molecular Probes A1101 1:1000 
Alexa Fluor 594-conjugated goat anti-rabbit Molecular Probes A11037 1:1000 
Table 2.2 Antibodies for immunocytochemistry 
 
2.3.6 Stable DNA transfection of Flp-In 293 T-Rex cell lines 
Prior to transfection, parental Flp-In 293 T-REx HEK (HEK293) cells were grown to 
50% confluency in a well of a 6 well tissue culture plate in BZ MEDIUM. Just before 
transfection, the medium was changed to supplement non-selective DMEM. 0.2 µg 
pcDNA5/FRT/TO construct and 1.8 µg pOG44 vector were stably transfected into 
cells using Lipofectamine 2000. After 24 hours, media was replaced with non-selective 
media. After another 24 hours, cells were plated in selective HB MEDIUM in a 9 cm 
dish. The medium was replaced every three days until colonies were formed. Clones 
were isolated and grown in new 9 cm dishes. The selected clones were induced with 
100 ng/ml doxycycline for 24 hours and harvested for screening by western blotting 
using antibodies against epitope tags (flag) or against endogenous proteins. 
 
2.3.7 Lentiviral infection (Complementation of YbeY (-/-) Hap1 cells) 
Phoenix-AMPHO cells were plated at 20 % confluency in 2 x 10 cm dishes in 
supplemented Roswell Park Memorial Institute (RPMI) medium (with 10% (v/v) FBS, 
100 U/ml penicillin and 100 μg/ml streptomycin, 4.5 g/L glucose, 2 mM L-
glutamine). After 24 hours, the medium was changed to supplemented RPMI medium 
(without penicillin and streptomycin). The Phoenix cells were transfected with 140 µg 
of pBMN plasmid containing the wildtype YbeY or catalytic mutant YbeY) using 
Lipofectamine 2000. To do this, 50 µl of Lipofectamine 2000 was incubated in 3 ml 
of Optimem for 5 minutes. Simultaneously, 140 µg of the pBMN vector (in 14 µl 
nuclease free water) was incubated in 1.5 ml of Optimem for 5 minutes. After 5 
minutes, 1.5 of the lipofectamine-containing Optimem was added to each of the 1.5 
ml of plasmid-containing Optimem. This was incubated at room temperature for 20 
minutes. 3 ml of the Optimem containing the lipofectamine-DNA complexes were 
added to the Phoenix cells and incubated for 24 hours in a 32 °C incubator. After 24 
hours, the medium was replaced with warmed supplemented IMDM medium.  
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Meanwhile, YbeY (-/-) knockout cells were cultured to 50 % confluency in a 10 cm 
dish. After 24 hours, 15 µl of 1000 x polybrene (5mg/ml hexadimethrine bromide in 
1x PBS) was added to 3 ml of IMDM medium in two tubes. 12 ml of medium from 
the Phoenix cell plates was transferred into the tubes through a 0.45 µm Millex 
syringe filter and mixed by inversion. This was applied to the YbeY (-/-) cells and 
incubated in a 37 °C incubator. After 24 hours, the medium was changed to 
supplemented IMDM medium (containing 200 µg/ml hygromycin selection) and 
allowed to recover for 1 week in a 37 °C incubator.  
 
2.3.8 siRNA transfection 
In a well of a 6 well plate, 250 µl of optimum was mixed with 2 µl of Lipofectamine 
RNAiMAX. To this, 2.5 µl of 20 mM siRNA was added. This was incubated for 5 
minutes at room temperature. Meanwhile, 50,000 cells were pelleted. Then, the cells 
were resuspended in 1.5 ml of medium and added to the well. This was mixed by 
swirling and incubated for 72 hours. The siRNA could be repeated again after this 
period for further depletion of the protein, before cells were harvested for analysis.  
 
siRNA Product code 
siRNA 1 HSS147611 
siRNA 2 HSS147612 
siRNA 3 HSS182431 
 
2.3.9 Growth rate measurement using Incucyte 
A confluent 9 cm dish of cells was trypsinised for 3 minutes at 37°C and the trypsin 
was neutralised using medium. The cells were centrifuged at 1200 rpm for 3 minutes 
and the pellet was resuspended in 4 ml of medium. For HEK293 cells, glucose-free 
DMEM medium was used. For Hap1 cells, supplemented IMDM was used.  
For HEK293 cells, 2 ml of pre-warmed glucose-free medium was plated in wells of a 6 
well plate. Glucose or galactose was added to these cells to a final concentration of 4.5 
g/L and 0.9 g/L respectively. For IMDM, 2 ml of pre-warmed, supplemented IMDM 
(20 % (v/v) FBS) was put in each well.  
10,000 cells were counted using the Countess automated cell counter and added to 
each well. The plates were placed in the Incucyte High Definition Imaging Mode. 
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Growth rate was measured as a function of changing cell confluency at 4 hour 
intervals.  
 
2.3.10 Measurement of cellular oxygen consumption 
24 hours prior to the beginning the assay, 200 µl of calibrant solution was put in each 
well of the bottom plate of a 96 well sensor cartridge and incubated in a 37 °C non-
CO2 incubator.   
For HEK293 cells, the XF 96-well cell culture microplates (Seahorse Bioscience) were 
coated with poly-L-lysine (20 minutes of 20 µl of 0.1 mg/ml poly-L-lysine in PBS for 
20 minutes followed by a PBS wash and air drying for 2 hours). Cells were counted 
using the Countess automated cell counter and 15,000 cells were plated per well 24 
hours prior to beginning the assay. 
For Hap1 cells, the cells were plated at 40,000 cells per well 4 hours before beginning 
the assay. Both cell types were incubated at 37 °C in 5% CO2 incubators. 
One hour before the assay, the growth medium was removed, washed with 200 µl 
SEAHORSE ASSAY MEDIUM and 175 µl of the SEAHORSE ASSAY MEDIUM was 
added to each well and incubated for 1 hour in a 37 °C non-CO2 incubator. Analysis 
of oxygen consumption was measured using a XF96 Extracellular Flux analyser 
(Seahorse Bioscience). The wells were sequentially injected with 2 µM oligomycin 
(ATP synthase inhibitor), 0.2 µM Bam15 (uncoupler) and 1 µM Antimycin and 
Rotenone (Complex III and I inhibitors respectively). Oxygen consumption was 
measured every 5 minutes before and after injection.  
To quantify cell density per cell, for HEK293 cells, the Cyquant NF cell proliferation 
assay kit as per manufacturer’s instructions. For Hap1 cells, 20 µl of LYSIS BUFFER 1 
was added to each well and incubated at 37 °C for 30 minutes. 10 µl of this solution 
was used for Pierce BCA assay. Quantification of cell density was used to normalise 
the oxygen consumption rate.  
 
2.3.11 Generation of HEK293 knockouts using zinc-finger nucleases 
 
2.3.11.1 Transfection and single cell cloning 
Transient transfection of the two ZFNs were performed into Flp-In T-Rex 293 HEK 
cells by nucleofection. The cells were harvested by trypsinisation and 1,000,000 cells 
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were counted using the Countess automated cell counter. These cells were pelleted by 
centrifugation at 200 g for 10 minutes. The cell pellets were resuspended in 100 µl of 
Nucleofector solution. 2.5 µg of each ZFN was added to the cell suspension. This was 
transferred to a nucleofection cuvette and into an Amaxa Nucleofector. Program A-23 
was run. The cell suspension was immediately transferred to a 9 cm dish containing 
supplemented DMEM and incubated in a 37 °C 5% CO2 incubator.  
After 72 hours, the cells were trypsinised and counted in a Countess automated cell 
counter. 8 x 96 well plated were plated at a cell density of 1 cell per 5 wells. This 
ensured that colonies produced would be derived from a single colony. These plates 
were incubated again for about 2 weeks until colonies were visible. These colonies 
were then plated into 24 well plates until confluent. These were allowed to expand to 
>80% confluency. Then, these were split into three 24 well plates, one for freezing, 
one for gDNA extraction and one for protein extraction. Then, these plates were 
allowed to grow. One plate was frozen by resuspending the cells in each well in 400 µl 
of FBS containing 10% DMSO. Plates were sealed and placed on dry ice for 5 
minutes and then transferred to -80 °C for long term storage.  
 
2.3.11.2 Screening using western blotting and sequencing 
For western blotting, cells were resuspended in 100 µl of LYSIS BUFFER 2 per well 
and incubated on ice for 15 minutes. 7 µl was used from each well was used for 
western blotting (section 2.2.7). 
For sequencing, 50 µl of Lysis for Blood (Sigma) reagent was added to each well and 
plate was heated at 75 °C for 15 minutes. 450 µl of water was added to each well. 4 µl 
from each well was used for PCR (section 2.2.10). Primers are detailed in table 2.3. 
The PCR products were sent for sequencing using the forward primer as the 
sequencing primer. The sequences for each clone were manually assessed for a lack of 
consensus in the sequence trace at and beyond the ZFN target site.  
If western blotting and sequencing identified possible candidates for knockout, the 
PCR products were cloned into pCR4 vectors using the Zero Blunt TOPO PCR 
Cloning Kit and sequenced using the M13 forward sequencing primer.  
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Name Sequence 
YbeY forward AAAGTGATCTGATTGCGCGT 
YbeY reverse CTGGGAAGATGGGCTAGACA 
MRM1 forward CTGGAGCTTCTGTTTGGCAT 
MRM1 reverse TGACCTTATCCACTCCGAGG 
Table 2.3 Primers used to screen for successful knockouts 
 
2.4 RNA-related assays 
 
2.4.1 RNA extraction 
Total cell RNA from a confluent well of a 6 well plate at 80% confluency was 
extracted using 500 µl Ambion TRIzol Reagent using the manufacturer’s instructions.  
 
2.4.2 Terminator assay 
For phosphatase treatment, 10 µg of RNA was treated with RNA 5’ polyphosphatase 
(Epicentre) according to manufacturer’s instructions. The Terminator exonuclease 
(epicentre) was a 5’-phosphate dependant exonuclease. 5 µg of Total HEK293 cell 
RNA or 10 µl of the polyphosphatase reaction was used in a 20 µl reaction as per 
manufacturer’s instructions. The RNA was resolved on a low resolution 
polyacrylamide gel and analysed by northern blotting (section 2.4.8).  
 
2.4.3 End labelling 
50 pmol of DNA oligonucleotide substrate was 5’ end labelled in a 20 µl reaction 
using T4 polynulceotide kinase and 2 µl of [g32P]-ATP (111 TBq/mmol) using the 
manufacturer’s instructions. 
 
2.4.4 Primer extension  
 
2.4.4.1 In vitro transcription for negative control for primer extension 
PCR products were generated with 5’ T7 promoter and in vitro transcribed using the 
mMessage mMachine T7 transcription kit (Thermo Fisher Scientific) as per 
manufacturer’s instructions (mRNA synthesis, DNase treatment, RNA purification 
with phenol chloroform extraction). Primers detailed in table 2.4. 
	66	
Name Sequence 
Negative control PCR forward primer   CCAGTGAAATTGACCTGCCC 
Negative control PCR reverse primer   TGTCCTTTCGTACAGGGAGG 
Primer extension Primer 1 TGGGTTCTGCTCCGAGGTCGC 
Primer extension Primer 2 GTTGGGTTCTGCTCCGAGGTC 
Table 2.4 Primers used for the construction of the negative control and as primers for 
reverse transcription 
 
2.4.4.2 Hybridisation and reverse transcription 
In this procedure, reverse transcription is limited by the omission of a specific dNTP 
which is required for extension after the modification. This causes all the primers 
extended after the modification to be completely stalled. This required the primer to 
be designed such that the specific dNTP is not required before the modification.  
For primer extension, DNA oligonucleotides, which bind upstream to the site of the 
modification being investigated, are used as primers for reverse transcriptase. These 
oligonucleotides are 5’ end labelled as described in section 2.4.3. Extension is paused 
at the site of modification and stalled when a specific dNTP requirement is not met.  
25 nmoles of labelled oligonucleotide was added to total 1 µl of RNA in a 10 µl 
reaction containing 10 mM Tris-HCl (pH 8.0) and 1 mM EDTA. The sample was 
heated to 80 °C for 2 minutes and the temperature was slowly lowered at the rate of 
0.02 °C/s to 45 °C where it was held for 1 minutes, followed by a 0.02 °C/s decrease 
to 4 °C.   
This was mixed with a 10 µl reverse transcription mix (1 x RT buffer, 40 nM dNTP 
of each of the three dNTPs required for primer extension, 0.5 µl RNasin inhibitor, 1 
µl Omniscript Reverse Transcriptase, 4.5 µl nuclease free water) and incubated at 37 
°C for 1 hour. After this incubation step, 4 µl of Gel loading buffer II was added and 
the DNA was resolved on a 10 % high-resolution polyacrylamide gel as per section 
2.4.5. Gels were dried at 80 °C overnight and scanned using a Typhoon 9410 
scanner. Bands were quantified using Image J. The ratio of the pausing at the 
modification to the stalled primer extension is used to quantify the level of 
modification of RNA.  
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2.4.5 High-resolution polyacrylamide gel electrophoresis 
21 g (7.3M) Urea was dissolved in a 50 ml solution containing 1 x GTB BUFFER, 25% 
v/v of 40% 19:1 Acrylamide:Bis stock solution. Polymerisation was activated using 
400 µl of 10 % APS and 20 µl TEMED, mixed and immediately injected into a 
Sequi-Gel GT tank. This was left to polymerise for 45 minutes and gel was warmed 
by pre-running it for 2 hours at 50 W in 1 x GTB BUFFER. After the temperature of 
the gel reached 50 °C. 12 µl of the sample was run in well at 50 W for approximately 
between 1 – 2 hours depending on the size of the product length being analysed.  
The gel was them transferred onto a sheet of Whatman 3 MM blotting paper and 
dried using a Bio-Rad Model 583 gel dryer at 80 °C overnight. The dried gel was 
then removed, wrapped in cling film, exposed to a storage phosphor screen and 
scanned using a Typhoon 9410 scanner. Bands were quantified using Image J. 
 
2.4.6 Riboprobe generation 
Templates were generated using PCR (primers detailed in table 2.5) from HeLa total 
cell DNA (section 2.2.10) with a T7 promoter introduced at the 5’ terminus of the 
reverse primer. 100 ng of the PCR product was then transcribed using the MaxiScript 
T7 transcription kit (1 x transcription buffer, 500 μM ATP, 500 μM GTP, 500 μM 
CTP, 30 units of T7 polymerase) as per the manufacturer’s instructions using [a32P]-
UTP (2.5 µl) instead of the UTP provided in the kit. 
For 5S rRNA loading control for northern blots, a DNA oligo was radiolabelled and 
used as a probe. The oligos were end-labelled using T4 polynucleotide kinase and 
[g32P]-ATP (section 2.4.3). 
One these were prepared, they were added to 10 ml of HYBRIDISATION BUFFER in 
the hybridisation tube containing the membrane. 
 
Transcript  Sequence 
ND3 Forward ATAAACTTCGCCTTAATTTTAATAATC 
 Reverse TAATACGACTCACTATAGGGATTCGGTTCAGTCT 
AATCCTTTTTGTAG 
ND6 Forward GGGGTTTTCTTCTAAGCCTTC 
 Reverse TAATACGACTCACTATAGGGCCCCCGAGCAATCT 
CAATTAC 
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CO3 Forward CCTGAGAACCAAAATGAACG 
 Reverse TAATACGACTCACTATAGGGGCCAGGGCTATTGG 
TTGAATG 
Table 2.5 Primers for the constructions of PCR templates for ssRNA probe 
generation 
 
2.4.7 DNA probe generation 
BUFFER A and BUFFER B were mixed (‘OLB’) in a ratio of 5:2. 50 ng of the PCR 
product (primers detailed in table 2.6) were denatured at 95 °C for 5 minutes in a 20 
µl solution and immediately placed on ice for 2 minutes. The labelling reaction was 
setup containing 10 µl OLB, 2 µg of BSA, 5U Klenow polymerase and 3 µg of 
Invitrogen Random Hexamers. The denatured DNA was mixed with the labelling 
reaction and 3 µl of [a32P]-dCTP was added. The reaction was incubated at 37 °C 
for 1 hour. The labelled probe was denatured at 95 °C for 5 minutes and immediately 
placed on ice for 2 minutes before being added to the hybridisation tube. 
 
Transcript  Sequence 
12S Forward CACTGAAAATGTTTAGACGGG 
 Reverse GGCTCCTCTAGAGGGATATG 
16S Forward TAGATATAGTACCGCAAGGG 
 Reverse GACTTGTTGGTTGATTGTAG 
ND1 Forward AACCTCAACCTAGGCCTCC 
 Reverse AATGCTAGGGTGAGTGGTAGG 
ND2 Forward TCCCAGAGGTTACCCAAG 
 Reverse GAGTAGTGTGATTGAGGTGGAG 
ND4/4L Forward ACTACCACTGACATGACTTTCC 
 Reverse GGAGTCATAAGTGGAGTCCG 
ND5 Forward GTAGCATTGTTCGTTACATGG 
 Reverse ACTGCTGCGAACAGAGTG 
CO1 Forward CTTATTCGAGCCGAGCTG 
 Reverse GGTATAGAATGGGGTCTCCTC 
CO2 Forward GCGCAAGTAGGTCTACAAGACGC 
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 Reverse GCATGAAACTGTGGTTTGCTCC 
ATP8/6 Forward CCCATACTCCTTACACTATTCC 
 Reverse GTTAGCGGTTAGGCGTAC 
CytB Forward CTACCTTCACGCCAATGG 
 Reverse TTTGTTAGGGACGGATCG 
Table 2.6 Primers for the constructions of PCR templates for dsDNA probe 
generation 
 
2.4.8 Northern blotting 
 
2.4.8.1 Low-resolution polyacrylamide gel electrophoresis 
A 50 ml gel containing 1.2 % UltraPure agarose, 1 x MOPS BUFFER and 1.11% 
formaldehyde was cast in a Bio-Rad Mini-Sub cell GT set. The gel was run in 250 ml 
of MOPS RUNNING BUFFER. The RNA sample containing 50% Gel Loading 
Buffer II was heated for 10 minutes at 55 °C, cooled on ice for 2 minutes and then 
loaded onto the gel. The gel was run at 80 V for 2 hours and 20 minutes, at 4 °C. The 
gels were semi-dry blotted onto moistened positively-charged nylon membrane 
(Hybond – N+) with 3 x 3 mm Whatmann paper. 3 to 5 cm of absorbent paper was 
placed on top of this followed by an additional 1 kg of weight. Gels were left to blot 
overnight. Then, the RNA was cross-linked to the membrane by exposing it to 120 
mJ/cm2 of 254 nm UV light. 
 
2.4.8.2 Hybridisation and washes 
For hybridisation, the membrane was placed in a hybridisation tube and washed with 
20 ml of HYBRIDISATION BUFFER for 90 minutes at 65 °C in a hybridisation oven. 
The buffer was then replaced with 10 ml of HYBRIDISATION BUFFER. The 
riboprobe or DNA probe was added to the buffer and allowed to hybridise overnight 
at 65 °C.  
The following day, the probe was removed and the membrane was washed 5 times for 
20 minutes with 1 x SSC buffer. The membrane was then removed and wrapped in 
cling film and exposed to a storage phosphor screen and scanned using a Typhoon 
9410 scanner. Bands were quantified using Image J. 
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2.4.9 Circularisation reverse transcription PCR 
5 µg of total RNA was circularised using T4 RNA ligase (1 x T4 RNA ligase reaction 
buffer, 10 units of T4 RNA ligase, 1 mM ATP, 2 units Turbo DNase, 40 units 
RNasin) at 37 °C for 1 hour. This was diluted to 100 µl in nuclease free water and 
subjected to phenol:chloroform (1:1) extraction. For this, 100 µl of phenol:chloroform 
was added and the mixture was vigorously vortexed for 20 seconds. The mixture was 
centrifuged at 16,300 g for 30 seconds at room temperature. 100 µl of the aqueous 
phase was removed and the DNA was precipitated at -80 °C for 1 hour in 1/10th 
volume of 3 M NaOAc at pH 5.2,3 volumes of 100 % ethanol and 1 µl of Glycoblue 
coprecipitant.  
The circularised RNA was pelleted by centrifugation at 20,000 g for 30 minutes at 4 °C. 
The pellet was resuspended in 20 µl nuclease free water. 5 µl of this solution was used (in 
a 20 µl reaction) for reverse transcription across the circularised junction using the 
Ominiscript reverse trascriptase kit as per the manufacturer’s instructions. 5 µl of this 
reaction was used for PCR to amplify the reverse transcribed junction sequence using 
Omniscript reverse transcriptase as per manufacturer’s instrcucitons. The PCR product 
was then resolved on a 1% agarose gel (section 2.2.3). Concatenation of tRNAs can lead 
to incrementally larger products. Hence, gel extraction of the PCR product at the 
predicted product size was required. The DNA was extracted from the gel slice using the 
QIAquick Gel Extractionkit and then cloned into a Zero Blunt TOPO PCR cloning kit 
according to their respective manufacturers’ instructions. The insert was then sequenced 
using the M13 forward sequencing primer.  
Primers are given in table 2.7. Note that the reverse primer was used for the reverse 
transcription and the PCR. 
Transcript  Sequence 
12S Forward AAACTTAAGGGTCGAAGGTG 
 Reverse GGTTAATCACTGCTGTTTCC 
16S Forward GCAGCCGCTATTAAAGGTTC 
 Reverse GCGGTACTATATCTATTGCGC 
Ile Forward TAATAGGAGCTTAAACCCCC 
 Reverse CTCTATCAAAGTAACTC 
Gln Forward ATTCTCAGGGATGGGTTCGA 
 Reverse CCAAAATTCTCCGTGCCACC 
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Leu(UUR) Forward CAGTCAGAGGTTCAATTCC 
 Reverse GTTTTATGCGATTACCGGGC 
Ser(AGY) Forward CCCATGTCTAACAACATGGC 
 Reverse GGCATGAGTTAGCAGTTCTTG 
Table 2.7 Primers used for reverse transcription and PCR across the junction caused 
by circularisation of RNA 
 
2.4.10 RNA-seq  
 
2.4.10.1 Library preparation 
RNA was extracted (section 2.4.1) from isolated mitochondria (section 2.2.9). 1 µg was 
used to prepare a RNA-seq library using the Illumina TruSeq Stranded Total RNA 
LT Kit A as per the manufacturer’s instructions. Ribosomal RNA was depleted using 
RiboZero Gold kit treatment. The library was quantified using the Agilent 
TapeStation and the High Sensitivity D1000 Screentape with a v2 MiSeq Reagent 
kit. The library was sequenced on the MiSeq Illumnia sequencer using a paired-end 
500 cycle run (2 x 250 cycles). 
 
2.4.10.2 Bioinformatic analysis 
Adapter sequences from the generated FASTQ file were trimmed using Tim_Galore!. 
The reads were then filtered to remove any sequences that were below 20 nt in length. 
The remaining reads were mapped to the revised Cambridge reference sequence for 
mtDNA using TopHat (Trapnell et al., 2009). 12S and 16S rRNA reads were then 
removed by the Samtools filter (Li et al., 2009). Then, Bedtools was used to generate 
strand-specific coverage files for each sample (Quinlan and Hall, 2010). Rsubread was 
used to produce count tables for the sense and antisense mitochondrially-encoded 
transcripts to determine steady state levels for each of the transcripts (Liao et al., 
2013). DESeq2 was then used to analyse differential gene expression statistically (Love 
et al., 2014). 
Reads per kilobase of transcript per million mapped reads = 109C/N*L, where, 
C = Number of reads mapped to a gene, N = Total mapped reads in an experiment 
and L= mt-mRNA length in base pairs 
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2.5 Analysis of mitoribosomes 
 
2.5.1 Sucrose gradient fractionation 
2 ml of 10-30% linear sucrose gradients in 1 x GRADIENT BUFFER were prepared in 
11 x 35 mm thin wall polypropylene ultracentrifuge tubes using Biocomp Gradient 
station. 750 µg of cell lysate or mitochondrial lysate was loaded onto the top of the 
tube. The tube was centrifuged for 2 hours and 15 minutes at 100,000 g at 4 °C 
(39,000 rpm, Beckman Coulter TLS-55 rotor). 100 µl fractions were taken from the 
top of the gradient. 7 µl from each fraction were used for Western blotting (section 
2.2.7).    
 
2.5.2 Quantitative- gradient fractionation – mass spectrometry (qGFMS) 
For qGFMS, 6 x 15 cm dishes of Hap1 control and YbeY (-/-) Hap1 cells were grown 
in heavy SILAC MEDIUM and 6 of both were grown in light SILAC MEDIUM. The 4 
different conditions (heavy control, heavy knockout, light control, light knockout) were 
harvested and pelleted by centrifugation at 1200 rpm for 3 minutes, washed with 1 x 
PBS and re-pelleted. The cells were resuspended in 20 ml of 1 x PBS and quantified 
using the Pierce BCA protein assay kit as per manufacturer’s instructions. The 
induced heavy cells were mixed with light uninduced cells in equal concentrations. 
Similarly, uninduced heavy and induced light cells were mixed in equal 
concentration. 50 µg of the heavy cells was kept aside. The cells were pelleted and 
mitochondria were isolated using the Balch homogeniser (section 2.2.9). The 
mitochondria were lysed with 100 µl of LYSIS BUFFER 1 and incubated on ice for 15 
minutes. This was centrifuged at 8000 rpm for 5 minutes at 4 °C. 750  µg of lysate 
was run on a 10-30% sucrose gradient as described in section 2.5.1. The fractions 
were run 4 mm into 4-12% Bis-Tris polyacrylamide gel (section 2.2.7). The gel was 
stained for 1 hour in SimplyBlue Safestain and destained for 1 hour (20% methanol, 
10% acetic acid). The stained 4 mm region was cut and the slice was analysed by mass 
spectrometry as described in section 2.5.3.4. 
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2.5.3 Complexomic profiling 
 
2.5.3.1 Mitochondrial fractionation 
Cells of control and induced/ knockout cells were harvested and mitochondria were 
isolated using the Balch homogeniser (section 2.2.9). For SILAC-complexomic 
profiling, the different cell lines were grown in heavy or light SILAC MEDIUM for 7 
doublings and mixed in equal proportion as quantified using the Pierce BCA protein 
assay kit as per manufacturer’s instructions. The pellet was resuspended in 2.5 ml of 
SONICATION BUFFER and sonicated at amplitude 25% for 10 second bursts with 50 
second processing time until 100 J had been transferred into the sample, using a Q-
700 sonicator using a 1/8” microtip. The samples were centrifuged at 40,000 rpm 
using a MLA80 rotor for 30 minutes at 4 °C. The supernatant was stored on ice and 
is the soluble fraction. The soluble fraction and the pellet resuspended in 5 ml of ACA 
BUFFER were centrifuged at 40,000 rpm for 30 minutes. The pellet was then 
resuspended in 15 µl of ACA BUFFER and homogenised using a 100 µl Dounce 
homogeniser. This formed the membrane fraction.  The soluble fraction was 
concentrated further to a volume of 250 ml with a 3 kDA MWCO Sartorius Vivaspin 
2 centrifugal filter at 7,000 g at 4 °C. 
 
2.5.3.2 Blue native PAGE 
9 µg of soluble protein was made up to 10 µl ACA BUFFER. 25 µg of membrane 
protein was made up to 10 µl with ACA BUFFER and 0.45% DDM. This was 
incubated for 20 minutes on ice. Both the soluble and membrane fraction solutions 
were centrifuged for 30 minutes at 14,000 rpm at 4 °C. After this, the supernatant 
fraction and solubilised membrane fractions were transferred to new tubes and 
0.1125% Coomassie G250 was added to the membrane fraction. 10 µl of BN 
NativePage 4X sample buffer was added to both samples. The sample was run in 
duplicates in 3-12% Bis-Tris NativePAGE gels, in duplicate, for western blotting and 
complexomic profiling. The inner chamber of the gel tank was filled with 1 x 
NativePAGE running buffer with 1 x cathode buffer. The outer chamber was filled 
with 1 x NativePAGE running buffer. This gel was then run for 1 hour at 80 V. After 
one hour, the inner chamber buffer was replaced with 1 x NativePAGE running 
buffer with 0.1 x NativePAGE cathode buffer additive. The gel was run at 200 V until 
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the front of the gel has started to leave the bottom of the gel. For western blotting, the 
gel was briefly washed with methanol before transferring using the wet transfer onto 
methanol-activated polyvinylidene fluoride (PVDF) membrane in a Mini Trans-Blot 
electrophoresis transfer cell at a constant current of 300 mA for 60 minutes. For 
complexomic profiling, the gel was destained using destain (20% methanol, 10% 
acetic acid) for 1-2 hours. Each lane was then cut into 64 x 1 mm slices using a razor 
blade and transferred to 1.5 ml tubes (previously washed with 50% methanol and 
dried). 
 
2.5.3.3 In-gel tryptic digestion 
Each slice was washed with 100 µl HPLC water for 30 minutes and then washed 
again with 20 mM Tris-HCl (pH 8) for 60 minutes. The liquid was removed and the 
slice was incubated in 100 µl of 20mM Tris-HCl (pH 8) and 50% acetonitrile (ACN) 
for 1 hour at RT. The solution was removed and 20 µl 100 % ACN and incubated for 
15 minutes. The liquid was then removed and the gel was dessicated in a Thermo 
Savant SpeedVac at 37 °C. The gel was then resuspended in 12.5ng/ml trypsin 
containing 20 mM Tris HCl (pH 8), 5 mM CaCl2 and incubated at 37 °C overnight. 
The digested peptides were incubated with 15 µl of 60% ACN, 4% formic acid 
solution. The liquid from this reaction was centrifuged for 15 minutes. The liquid was 
then dessicated in a Speedvac (37 °C for 15 minutes). The residual pellet was 
resuspended in 14 µl of 2% ACN and 0.1% formic acid. 
 
2.5.3.4 Mass spectrometry and analysis 
The peptides were analysed with LC-MS/MS on a Thermo Scientific Orbitrap LTQ 
XL spectrometer with a nanospray inlet interface coupled with a Proxeon EasynLC 
nano chromatography. For accurate mass measurements, the internal ‘lock mass’ 
standard of 445.120m/z was used. 
For each lane, all samples were run starting with the highest molecular weight slice 
and, to ensure that chromatographic conditions were maintained throughout the 
batch, each sample was analysed with no intervening washes. 
To identify peptides, resulting data files were processed using Proteome Discoverer 
software (Thermo). Resulting spectra from the RAWfile were submitted to the in-
house Mascot server and peptides were assigned using the Uniprot Homo sapiens 
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protein database, specifying parameters for use of trypsin digest, allowing for the 
possibility of one uncleaved lysine or arginine residue per peptide, allowing for 
peptides to carry a deviation of 10 ppm around calculated peptide values to allow 
matches with experimentally observed values, and fragment size was set at 0.5 Da. 
Following quantification of each identified peptide using Protein Discoverer, a multi-
consensus report was generated, allowing the relative quantification of proteins to be 
obtained from the relative quantification of peptides. For this, the mean value for the 
three highest intensity peptides for each protein was taken and this was used as a 
representative value for that protein. This was performed for each gel slice and a 
profile for each protein for each lane can be determined. 
 
2.5.3.5 Analysis of SILAC samples 
Generally, SILAC (stable isotope labelling of amino acids in cell culture) was 
performed in duplicates with reciprocal labelling. Comparing protein ratios can then 
be compared from both experiments on a scatter plot. Proteins that behave differently 
in both experiments can be discarded.  
Proteins were identified using the ANDROMEDA algorithm of the MAXQUANT 
software package by comparing the proteins to the human UniProt database. The 
peptide information from both dataset pairs were combined and filtered using the 
PERSEUS software, removing proteins only identified by site, that matched a decoy 
database of random peptides deliberately introduced to identify noise, and those 
peptides identified as contaminants. Then, proteins identified by one peptides and 
those proteins that were identified by two or fewer peptides were removed. The 
reciprocal of the protein orientation was calculated for the reverse labelling 
orientation. Ratios for both samples and a base two logarithm were calculated. The 
processed data was plotted on a X-Y scatter plot using Prism 7. Preliminary 
assessment of heavy label incorporation was performed by manually processing the 
peptide information of the heavy-only lanes by MAXQUANT. 
 
2.6 qPCR to measure mtDNA copy number 
The DNA was extracted from Hap1 cells using DNeasy Blood and Tissue kit as per 
manufacturer’s instructions. Mitochondrial DNA copy number was quantified by 
measuring two mitochondrial amplicons relative to a nuclear control gene, B2M, 
using the 2-DDCT method. The average of the two amplicons was used as the mtDNA 
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copy number. 10 ng of gDNA was used as a template and all samples were amplified 
in quadruplicates in 25 µl reactions. The TaqMan gene expression master mix was 
used with 900 mM forward primer and 250 nM probe. The reaction was performed 
as per the manufacturer’s instructions. Sequence of the primers and probes are 
detailed in table 2.8. 
 
Primer/ Probe  Sequence 
B2M Forward TGCTGTCTCCATGTTTGATGTATCT 
Reverse TCTCTGCTCCCCACCTCTAAGT 
Probe Fam-TTGCTCCACAGGTAGCTCTAGGAGG-
Tamra 
mt3211 Forward CACCCAAGAACAGGGTTTGT 
mt3298 Reverse TGGCCATGGGTATGTTGTTAA 
mt3242 Probe Fam-TTACCGGGCTCTGCCATC T-Tamra 
mt9827 Forward CGT CATTATTGGCTCAAC 
mt9974 Reverse GATGGAGACATACAGAAATAG 
mt9852 Probe Fam-ACTATCTGCTTCATCCGCCACTAA-Tamra 
Table 2.8 DNA oligonucleotide and probe sequences used for qPCR 
 
2.7 [35S]-L-methionine labelling of mitochondrially-translated proteins 
Al incubation steps were performed at 37 °C and 5% CO2. HEK293 or Hap1 cells 
were grown in 6 well corning dishes to up to 80% confluency. Initially, the cells were 
washed twice with methionine and cysteine-free medium and incubated with this 
medium for 5 minutes. After 5 minutes, this was replaced with DMEM supplemented 
with 2 mM Glutamax, 110 mg/L sodium pyruvate, 96 mg/ml cysteine and 5% 
dialysed FBS and incubated for 20 minutes. Then, 100 µg of cytoplasmic translation 
inhibitor, emetine was added and the cells were incubated for 30 minutes at 37 °C. 
166.6 mCi/ml [35S]-L-methionine was added to each well and incubated for 30 
minutes (this incubation time was increase for time course assays). The cells were 
harvested and centrifuged at 5000 rpm for 3 minutes. The pellet was washed with 1 x 
PBS and centrifuged again.  
The pellet was resuspended in 20 µl of PIC buffer. 0.1 % DDM and 50 U Benzonase 
was added and incubate on ice for 20 minutes. 1% SDS was added and vortexed 
vigorously. This was left on ice for 30 minutes. The protein was then quantified using 
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the BioRAD DC assay kit as per manufacturer’s instructions. 30 µg of protein was 
made up to 15 µl loading volume with water, containing 1 x NuPAGE LDS Sample 
buffer. This was incubated at room temperature for 20 minutes. This was loaded onto 
a 10-20% Tris-glycine gradient SDS polyacrylamide gel and run at 85V for 3 hours 
or until the gel front has reached the bottom of the gel. The gel was briefly washed 
with water and stained with SimplyBlue Safestain for 1 hour. The gel was then 
destained with coomassie destain/fixer (20% methanol, 7% acetic acid, 3% glycerol) 
for 1 hour and dried using a Bio-Rad Model 583 gel dryer at 80 °C for 1 hour. The 
gel was exposed to a storage phosphor screen and scanned using a Typhoon 9410 
scanner  
 
Modifications to this protocol:  
For added chloramphenicol treatment, cells were incubated for 22 hours with 40 
mg/ml chloramphenicol, prior to the assay.   
 
2.8 Immunoaffinity purification (with and without SILAC) 
12 x 15 cm dishes of HEK293 cells containing the doxycycline-inducible flag/strep2-
tagged gene were grown in heavy and light SILAC MEDIUM each. After 7 doublings, 
6 plates of the heavy and 6 plates of the light-labelled cells were induced with 100 
ng/ml for 24 hours. The 4 different conditions (heavy induced, heavy uninduced, light 
induced, light uninduced) were harvested and pelleted by centrifugation at 1200 rpm 
for 3 minutes, washed with 1 x PBS and re-pelleted. The cells were resuspended in 20 
ml of 1 x PBS and quantified using the Pierce BCA protein assay kit as per 
manufacturer’s instructions. The induced heavy cells were mixed with light uninduced 
cells in equal concentrations. Similarly, uninduced heavy and induced light cells were 
mixed in equal concentration. 50 µg of the heavy cells was kept aside. The cells were 
pelleted and mitochondria were isolated using the Balch homogeniser (section 2.2.9). 
The mitochondrial were lysed with 500 µl of LYSIS BUFFER 1 and incubated on ice 
for 15 minutes. The solutions were centrifuged at 8000 rpm for 5 minutes. Anti-flag 
antibody coated beads were washed according to the Sigma-Aldrich FLAG 
immunoprecipitation kit manufacturer’s instructions. The supernatant was then 
incubated on the beads for 3 hours on a roller at 4 °C. The proteins were eluted as 
per the manufacturer’s instructions. All the protein and 25 µg of the heavy cell protein 
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was run on a 4-12% Bis-tris polyacrylamide gel as described in section 2.2.7. The gel 
was stained for 1 hour with SimplyBlue Safestain and destain for 1 hour (20% 
methanol, 10% acetic acid). All the lanes were cut into 10 equal slices. For the 
immunoaffinity purified proteins-containing lanes, all the 10 slices were submitted, 
while only three slices were sent for the heavy-only lanes. These gel slices were 
analysed as described in section 2.5.3.3 and 2.5.3.5. If proteins were not SILAC-
labelled, proteins were analysed according to section 2.5.3.3 and 2.5.3.4. 
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3 MRM1 – A strongly conserved large ribosomal RNA-
modifying enzyme  
 
3.1 MRM1 – A methyltransferase that modifies 16S rRNA of the mitochondrial large 
subunit 
 
3.1.1 Mitoribosomal epitranscriptome 
The ribosome consists of protein components encapsulating a catalytic RNA core. 
This ribosomal RNA (rRNA) core undergoes various post-transcriptional chemical 
modifications. The rRNA of bacterial and eukaryotic cytoplasmic ribosomes contain 
over 30 and 200 chemical post-transcriptional modifications, respectively, including 
base methylation, 2’-O-ribose methylation and pseudouridylation. However, of these, 
only a few modifications are conserved in mitochondrial ribosomes.  
In yeast, the mitoribosome is composed of a 37S small subunit with a 15S rRNA 
component, and a 54S large subunit with a 21S rRNA component. The 15S rRNA 
contains one known modification, a pseudouridylation of which the enzyme and the 
exact site of modification still need to be identified. The 21S mt-LSU RNA contains 
one pseudouridylation at position 2819 and two 2’-O-ribose methylations at G2270 
and U2791 in the peptidyl transferase centre of the ribosome (Klootwijk et al., 1975; 
Sirum-Connolly et al, 1995).  
The mammalian mitochondrial ribosome consists of a 28S small subunit with a 12S 
rRNA and a 39S large subunit with a 16S rRNA. Both rRNAs have five conserved 
modified nucleotides each. The small subunit undergoes methylations at U429, C839, 
C841, A936 and A937 (human numbering) (Figure 3.1.1). The large 16S rRNA 
contains three 2’-O-ribose methylations at G1145, U1369 and U1370, a 
pseudouridylation of U1397 and the base methylation of A947 (Figure 3.1.2). The 
exact function of the modifications is unknown, but it is suggested that they may be 
required for RNA recognition during translation, to induce and maintain correct 
RNA secondary structure or to facilitate inter-ribosome subunit association (Decatur 
and Fournier, 2002; Sirum-Connolly et al., 1995; Rorbach & Minczuk, 2012).  
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Figure 3.1.1 Chemical modifications of the 12S mt-SSU rRNA. (A) Schematic representation of the 
secondary structure of the mammalian 12S rRNA and the positions of the chemical modifications on 
it. (B) The tertiary structure of the 12S rRNA (facing the rRNA from the subunit interface) showing 
the close proximity of the modified residues to each other and to the subunit interphase where the 
recognition of the mRNA occurs. (PDB: 5AJ4) 
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The modifications on the mt-SSU rRNA occur at the site of mRNA recognition near 
the subunit interphase (Figure 3.1.1). The best characterized mt-SSU rRNA 
modifying enzyme is a dimethyladenosine transferase, TFB1M, which performs a 
highly conserved dimethylation at adenines residues, A936 and A937 (based on 
human numbering) on the 12S rRNA mammalian mitochondrial rRNA (Seidel-
Rodol et al.,2003). In bacteria (positions A1518 and A1519 modified by KsgA) and 
yeast cytoplasm (positions A1779 and A1770 modified by Dim1p), loss of the 
equivalent modifications from the rRNA does not cause a significant decrease in mt-
SSU biogenesis (LaFontaine et al., 1998; Xu et al., 2008). The modification is not 
present in yeast mitochondrial rRNA. However, in mammalian mitochondria, 
knockout of TFB1M causes a reduction in 12S rRNA steady state levels, mtSSU 
assembly and mitochondrial translation. A loss of TFB1M is embryonic lethal in mice. 
However, a conditional knockout of TFB1M leads to impaired mt-SSU biogenesis 
and translational defects (Metodiev et al., 2009). 
Another modifier of 12S rRNA is NSUN4, which methylates C841 in (human 
numbering). In bacteria, the NSUN4 homolog, YebU methylates at equivalent 
position 1407 of the SSU rRNA. It performs this function only after the rRNA has 
been assembled into the SSU. Loss of the protein leads to a growth phenotype and a 
loss of cell viability (Andersen and Douthwaite, 2006). Similar to TFB1M, loss of 
mammalian mitochondrial NSUN4 leads to embryonic lethality and a conditional 
knockout in mice leads to a severe translational defect (Metodiev et al., 2014). Unlike 
homologous methyltransferases in bacteria, NSUN4 does not have a RNA binding 
domain. Hence, NSUN4 forms a complex with a RNA-binding protein MTERF4, 
and together, the complex assists in mt-LSU assembly. Moreover, this function in mt-
LSU biogenesis is independent of the NSUN4 ability to catalyse the methylation of 
C841 (Camara et al., 2011; Metodiev et al., 2014; Spahr et al., 2012). Knockout of 
NSUN4 does not affect the modification of A936 and A937 by TFB1M suggesting 
that the two modifications happen independent of each other (Metodiev et al., 2014). 
The mammalian mt-SSU rRNA has two further modifications of which the 
responsible methyltransferases have yet to be identified (m5U429 and m4C839) 
(Rorbach and Minczuk, 2012). 
The catalysis of peptide bond formation in the ribosome occurs in the large subunit, 
namely at the peptidyl transferase centre. This region is divided into the A-site which 
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binds the aminoacyl tRNA and the P-site which binds the peptidyl-tRNA, and the 
rRNA domains that binds to the tRNAs in these sites are called the A-loop and P-loop 
respectively. Chemical modification of the rRNA conserved in the mitoribosome are 
concentrated on the A-loop and P-loop. 
The A-loop is modified at positions U1369 and G1370 (human numbering) which 
directly interacts with the aminoacyl-tRNA (Greber et al., 2015, Rorbach et al., 
2014). In E. coli, RrmJ methylates U2552 (equivalent to human mitochondrial U1369 
and yeast mitochondrial U2791). This modification occurs at later stages of ribosomal 
assembly (Caldas et al., 2000a; Caldas et al., 2000b). Absence of RrmJ causes a loss of 
programmed frameshifting, decreased translation and consequently, a growth defect 
(Caldas et al., 2000a). In yeast mitochondria, the equivalent methylation is performed 
by Mrm2p. Mrm2p associates with the assembled mt-LSU, suggesting that, similar to 
bacterial RrmJ, it is also involved with late stage maturation of the LSU. Additionally, 
a loss of Mrm2p in yeast leads to a thermosensitive growth defect (Pintard et al., 
2002). In the mammalian mitoribosome, MRM2, an ortholog of bacterial RrmJ and 
yeast Mrm2p, methylates U1369 on the A-loop. Sucrose gradient fractionation of 
mammalian mitochondria shows that MRM2 co-migrates with the mt-LSU and the 
fully associated ribosome. Moreover, depletion of MRM2 causes a loss of stability of 
the mt-LSU and leads to a translational defect and respiratory deficiencies (Rorbach 
et al., 2014).  
On the other hand, the G1370 modification is not conserved in bacteria or yeast 
mitochondria. In the mammalian mitoribosome, this residue in the 16S mt-rRNA, 
also found on the A-loop, is methylated by MRM3. Sucrose gradient fractionation 
and western blot analysis shows that MRM3 associates with the mt-LSU, but, unlike 
MRM2, it does not associate with the assembled ribosome. A loss of MRM3 and/or 
Gm1370 leads to instability of the mt-LSU and a defect in translation. Notably, the 
G1370 modification is reduced if the G1369 modification is not present. This suggests 
a hierarchical pathway of modifications that control mitoribosome biogenesis (Lee et 
al., 2013; Rorbach et al., 2014). However, not all modifications are hierarchical. As 
described earlier, the TFB1M modifications of the 12S rRNA are not dependent on 
NSUN4 modifications (Metodiev et al., 2014).  
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Figure 3.1.2 Chemical modifications of the 16S mt-SSU rRNA. (A) Schematic representation of the 
secondary structure of the 16S rRNA and the positions of the chemical modifications on it. The 
catalytically important P-loop in the peptidyl (P) site and the A-loop in the aminoacyl (A) site have 
been indicated. These loops are important in the recognition and binding to their respective tRNAs. (B) 
The tertiary structure of the 16S rRNA (facing the rRNA from the subunit interface) showing the close 
proximity of the modified residues to each other and to the subunit interface where the recognition of the 
mRNA occurs. It shows that even though A947 is not close to the A-loop in the secondary structure, it 
is brought close to the A-site after RNA folding. (PDB: 5AJ4) 
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Recently, analysis of the difference between RNA sequences and the DNA template 
sequence identified TRMT61B, a tRNA-modifying enzyme, as the enzyme 
responsible for the formation of m1A947 in the mt-LSU rRNA. In bacteria, mutation 
of this position causes a deficiency in translation (Bar-Yaacov et al., 2016). Analysis of 
the conservation of this modification through evolution suggests that it is not a 
universal modification. In about 10% of mammalian species, mitoribosomes and 
cytoplasmic ribosomes do not carry this modification and this nucleotide is replaced 
by a uridine. In bacteria, this position is replaced by an unmodified guanine. The 
adoption of a tRNA-modifying enzyme to control modification, instead of an encoded 
adenine or guanine at this site, suggests an additional level of control on the biogenesis 
of the ribosome. (Bar-Yaacov et al., 2016; Bohnsack and Sloan, 2017). However, the 
fact that this modification evaded detection until only recently suggests that there 
might be more rRNA modifications and modifying enzymes yet to be discovered. 
Mammalian 16S rRNA also has a pseudouridine conversion at position 1397. 
Recently, a potential candidate responsible for this modification was identified as 
pseudouridine synthase, RPUSD4 (Antonicka et al., 2017; Zaganelli et al., 2017). This 
enzyme was shown to bind to 16S rRNA, tRNAMet and tRNAPhe, and knockdown of 
the protein in human cells led to a reduction in the steady state levels of 16S rRNA 
and a defect in mt-LSU assembly, resulting in a loss of mitochondrial translation 
(Arroyo et al., 2016; Antonicka et al., 2017; Zaganelli et al., 2017). However, the 
corresponding modification in yeast is dispensable (Ansmant et al., 2000). 
 
3.1.2 MRM1 and the 16S rRNA modification Gm1145  
The P-loop of the 16S rRNA is an important part of mitoribosomal the peptidyl 
transferase centre, as it plays a role in the peptidyl-tRNA binding in the P-site. In 
human mitochondria, the P-loop undergoes a 2’-O-ribose methylation at G1145 (Baer 
& Dubin, 1981). In E. coli, the equivalent site on the LSU rRNA, G2251, is modified 
by the methyltransferase RlmB. Knockout of RlmB in E. coli showed no effect on 
ribosome assembly and function (Lovgren & Wikstrom, 2001). However, ablation of 
the homologous mitochondrial protein Mrm1p (Pet56p) in yeast causes a loss of the 
Mrp7p protein component of the mitochondrial ribosomal LSU (homologous to 
human mitochondrial L27 and E.coli 27 ribosomal protein) (Sirum-Connolly & 
Mason., 1993; Sirum-Connolly et al., 1995).  
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In mammalian mitochondria, this highly conserved modification is introduced by 
MRM1. Human MRM1 is a member of the SpoU superfamily. It is highly conserved 
except in certain fungal and metazoan clades (Figure 3.1.3). Like other 2’-O-
methyltransferases in this family, MRM1 contains a S-adenosyl-L-methionine 
(AdoMet)-binding motif and the SpoU-type guanosine 2’-O-methyltransferase 
domain. However, the importance of this methylation to cell viability and translation 
varies between organisms (Rorbach et al., 2014).  
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Figure 3.1.3 Conservation and phylogeny of MRM1. Evolutionary conservation of MRM1 was 
calculated using CLIME portal online web service (gene-clime.org). The bottom bar indicates the 
presence of the protein in the species indicated above on the evolutionary tree. Grey indicates absence of 
the protein while blue indicates presence of the protein. The length of the branches in the phylogenetic 
tree indicate divergence of the protein since a common ancestor. 
 
Mitochondrial localisation of MRM1 was shown by immunofluorescence. A strong 
co-localisation signal between transiently expressed MRM1 with mitochondria was 
observed. In addition, subcellular fractionation of HeLa cells in combination with 
western blotting confirmed that MRM1 is localised in the mitochondrial matrix 
(Rorbach et al., 2014).  
Recently, work using an alternative DNAzyme strategy showed that that MRM1 is 
required for the ribose methylation of G1145. This method relies on the ability of 2’-
O-ribose methylated RNA to resist site-specific cleavage by DNAzymes. This 
experiment showed that upon siRNA knockdown of MRM1, the sensitivity of the 16S 
rRNA to DNAzyme-cleavage at the G1145 site increases (Lee and Bogenhagen, 
2014).  
The function of MRM1 and the G1145 modification is still unclear. In the bacterial 
ribosome, G2252 and G2251 (equivalent to human mitochondrial G1146 and the 
MRM1 target G1145) in the P-loop form Watson-Crick base pairs with the C74 and 
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C75 positions at the 3’ end of tRNAs (Jenni & Ban, 2003). Analysis of the porcine 
mitoribosomal cryo-EM structure shows that this interaction is retained in mammals 
(Greber et al., 2015). The modification of G2251 may influence base pairing with the 
two tRNA cytidines, therefore ensuring efficient peptidyl transferase activity. G2251 
interacts with U2585 on domain V. Upon tRNA entry into the P-site, a local 
conformational change occurs. This disrupts the interaction between G2251 and 
U2585 and mediating progression of peptidyl-transferase activity (Green et al., 1997). 
2’-O-ribose methylations also serve various other roles depending on the context. It is 
a highly prevalent modification, found in tRNAs, rRNAs, mRNAs and miRNAs in all 
three domains of life. It provides stability to RNA in conditions of extreme 
temperature and pH by reducing the availability of the oxygen at the 2’ site and 
preventing nucleophilic attack and cleavage of the phosphodiester bond (Motorin and 
Helm, 2010). Methylation has also been implicated in regulation of gene expression, 
resistance to aminoglycoside antibiotics in bacteria, as markers of innate immunity, 
and as regulators of translation of viral mRNAs (Marchand et al. 2016).  
In many previous studies, knockout cell lines and mouse models were used to 
demonstrate the function of specific modifications within the larger context of 
mitochondrial translation and ribosomal biogenesis. Therefore, to identify the role of 
MRM1 and the Gm1145 modification in the human mitochondrial ribosome, we 
generated MRM1 knockout cell lines to characterise mitochondrial function in the 
absence of MRM1 and to elucidate the purpose of the MRM1 modification within 
the mitochondrial translation apparatus. 
 
3.2 Results – Identification of the function of MRM1 through the generation and 
characterisation of MRM1 overexpression and knockout cells  
 
3.2.1 Identification of MRM1 interactors using immunoaffinity purification 
Firstly, to deduce the function of MRM1 in the mitochondria, doxycycline-inducible 
MRM1 overexpressing cell lines were generated by transfecting HEK293T cell lines 
with pcDNA5 vector containing the cDNA for MRM1 with a flag tag and selecting 
for successful integration using hygromycin selection. Doxycycline induced expression 
was tested in several clones by Dr Joanna Rorbach (data not shown). Flag epitope 
immunoaffinity purification of overexpressed MRM1 was used to identify interactors 
of MRM1 in the mt-LSU. Mitochondria were isolated from 100 ng/ml doxycycline-
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induced cells expressing flag/strep2-tagged MRM1.  Mitochondrial lysate was 
incubated with flag immunoaffinity beads and eluted using flag peptide. Preliminary 
immunopurification identified various non-mitoribosomal associated protein 
interactors (HSP70, HSPD1, H2A, H2B, H4A, H2A, NDK), mt-LSU components 
(MRPL19, MRPL28, MRP49, MRPL41), mt-SSU components (MRPS30, 
MRPS18b, MRPS23, MRPS10, MEPS14, MRPS6, MRPS33), other RNA-binding 
proteins (LRPPRC, DHX30, PTCD3 and GRSF1) and a nucleotide diphosphate 
kinase (NME4) (Figure 3.2.1). However, immunoaffinity purification of MRM1 was 
repeated with SILAC labelling of cells to quantify the strength of interaction with 
MRM1 (Figure 3.2.2 A, B). Furthermore, Benzonase treatment was also applied to 
remove possible indirect interactions that may be caused via the MRM1’s interaction 
with RNA (Figure 3.2.3 A, B). This pulldown experiment did not identify 
mitoribosomal components but mitoribosome biogenesis factor ERAL1 was one of 
the proteins that were purified.  
 
Figure 3.2.1 Immunoaffinity purification of MRM1. Overexpression of MRM1-Flag/Strep2 was 
induced using 100 ng/ml doxycycline in a HEK293T Flp-In cell line. After 24 hours, the cells were 
harvested, mitochondria were isolated and the mitochondrial lysate was incubated with beads attached 
to antibodies against the flag epitope. The beads were washed and the bound proteins were eluted using 
flag peptide. 30 µg of the eluted protein was resolved on a 4-12% Bis-Tris SDS PAGE gel and the 
gel was stained using Coomassie Brilliant Blue stain. The prominent bands were cut and analysed 
using LC-MS/MS.  
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Figure 3.2.2 Proteins associated with MRM1. The doxycycline-inducible cell line was grown in light 
or heavy SILAC media, one of the two were induced using 100 ng/ml doxycycline, the induced and 
Uninduced labelled cell lines were mixed in equal proportion and mitochondria were isolated. The 
lysates were added to flag-affinity beads and eluted using flag peptide.  The eluted protein was run on 
an SDS PAGE gel. Sections of the gel were cut and analysed using LC-MS/MS. The proteins were 
separated based on stable isotope labelling. The samples were performed in duplicate with reciprocal 
labelling with each replicate shown on one axis. The graph was plotted using Excel. (A) Components 
of the mt-LSU are marked with red markers (B) Components of the mt-SSU are marked with red 
markers 
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Figure 3.2.3 Proteins associated with MRM1 after benzonase treatment. The doxycycline inducible 
cell line was grown in light or heavy SILAC media, one of the two were induced using 100 ng/ml 
doxycycline, the induced and Uninduced labelled cell lines were mixed in equal proportion and 
mitochondria were isolated. The mitochondrial lysate was split into two, and one sample was treated 
with 50 U/ml benzonase. The lysates were added to flag-affinity beads and eluted using flag peptide.  
The eluted protein was run on an SDS PAGE gel. Sections of the gel were cut and analysed using 
LC-MS/MS. The proteins were separated based on stable isotope labelling. The samples were 
performed in duplicate with reciprocal labelling with each replicate shown on one axis. The graph was 
plotted using Excel. (A) Components of the mt-LSU are marked with red markers (B) Components of 
the mt-SSU are marked with red markers 
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A recent publication identified that 16S rRNA modifiers interact with the 
mitoribosome. MRM2 interacts with the mtLSU and the assembled mitoribosome, 
while MRM3 only interacts with the mtLSU (Rorbach et al., 2014). However, the 
MRM1 homolog in yeast does not interact with the mitoribosome (Sirum-Connolly 
and Mason, 1993). It is possible that conditions used in the flag immunoprecipitation 
may not be idea for preserving MRM1-mitoribosome interactions. Therefore, sucrose 
gradient fractionation was used to investigate if MRM1 interacts with the 
mitoribosomes (Figure 3.2.4). This involved resolving the various mitoribosomal 
assemblies in the cell lysate using a 10-30% (v/v) isokinetic sucrose gradient. Sucrose 
gradient fractions were then resolved on a 4-12% Tris-glycine SDS-PAGE gel and 
analysed using western blotting. MRPL12 was used to probe for mt-LSU and 
MRPLS18b was used to probe for the mt-SSU. This analysis confirmed that MRM1 
did not co-localise wth the mt-LSU or the mt-SSU (Figure 3.2.4). 
 
 
Figure 3.2.4 Analysis of MRM1 interaction with the mitochondrial ribosome. 750 µg of isolated 
mitochondrial lysate from Hap1 parental cells were separated using 10-30% (v/v) isokinetic sucrose 
gradient fractionation. 100 µl fractions were then analysed using western blotting. Antibodies against 
MRPL12 and MRPS18b were used to identify the mt-LSU and mt-SSU, respectively. Antibodies 
against endogenous MRM1 were used to identify MRM1.  
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3.2.2 Analysis of the mitoribosomes upon MRM1 overexpression 
To analyse the function of MRM1 in the mitochondrial ribosome, overexpression was 
induced in HEK293T Flp-In cells using 50 ng/ml of doxycycline for 48 hours. Then, 
the cell lysates were loaded onto an isokinetic sucrose gradient and after 
ultracentrifugation, 100 µl fractions were resolved in a 4-12% Bis-Tris SDS-PAGE 
gel. Western blotting using antibodies against components of the mt-LSU (MRPL12) 
and mt-SSU (MRS18b) were used to analyse changes in ribosomal complexes. This 
showed no major change in large and small subunits upon MRM1 overexpression. 
However, a large amount of MRPL12 protein was found in the ‘free protein’ fractions 
(fractions 1-4, Figure 3.2.5) in MRM1 overexpression induced cells compared to other 
sucrose gradients performed before in HEK293T parental or MRM1 deficient cell 
lines (Section 3.2.5, Figure 3.2.16).  Potentially, this could be caused by high levels of 
MRM1 and suggests that leaky expression of MRM1 in the uninduced cell line may 
be sufficient to disrupt assembly of the ribosome (Figure 3.2.4).   
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Figure 3.2.5. Assembly of the mitoribosomes in MRM1-overexpressing cells. Total cell lysate from 
MRM1 overexpressing cells (uninduced and induced for 3 days at 50 ng/ml) were separated in a 0-
30% (v/v) isokinetic sucrose gradient and fractionated. The fractions obtained were analysed using 
western blotting using antibodies specific to mt-LSU (MRPL12) and mt-SSU (MRPS18b). The 
band intensities were calculated using Image J and the relative band intensity to the total was plotted 
using Prism 7. 
 
	94	
The disadvantage of using isokinetic sucrose gradients followed by western blot 
detection to investigate mitoribosomal integrity is that only a limited number of 
mitoribosomal components can be investigated and the comparison of various western 
blots is mostly qualitative. There, we used complexomic profiling to measure the 
presence of all the protein components of the mitoribosomes in their various stages of 
assembly. In this method, mitochondrial membranes from HEK293T control and 
MRM1 (-/-) cells were isolated, solubilised with detergent and the proteins were 
resolved on a native PAGE gel. Each lane was cut into 64 X 1 mm slices. The protein 
composition of each slice was analysed by LC-MS/MS. The intensity of peptide 
detection was used to generate a heatmap.  
As this method had not been previously used to investigate mitoribosomal integrity, 
various optimisation steps were required namely identifying the correct detergent 
concentration to solubilise the membrane and freezing the complexes for resolution 
on a PAGE gel, limiting degradation of the mitoribosomes. The membrane fraction 
was used because the mitoribosomes is tethered to the inner membrane through the 
large subunit (Brown et al., 2017; Liu and Spremulli, 2000). The resolved protein 
complexes were studied by staining the gels with Coomassie Brilliant Blue and western 
blotting. Inappropriate detergent concentrations caused smearing of the proteins and 
insufficient membrane solubilisation (as seen in 0.2% DDM, Figure 3.2.6). Above 
0.45%, the maximum solubilisation had already occurred, as the western blot bands 
did not increase in intensity when DDM concentration was increased. Western blot 
analysis was performed using antibodies against MRPS18b for the small subunit and 
MRPL3 and MRPL12 for the large subunit. This showed that the gel does not 
adequately resolve the free mtLSU and mtSSU from the assembled monosome.  In 
the western blot, this appeared as a thick band roughly 2 to 3 MDa in size. In the 
western blot probing for MRPL12, a smaller band was also observed at about 400 
kDa, which corresponds to the ribosomal subcomplex suggested by Wessel et al. 
(2013). Smaller complexes were observed in the soluble fractions (relative to the 
membrane fractions) indicating possible partially assembled or partially degraded 
ribosomal complexes (Figure 3.2.6). 
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Figure 3.2.6. Optimisation of membrane solubilisation. Isolated mitochondria from HEK293T cells 
were fractionated into soluble and membrane fractions. Increasing mass of soluble fraction and 2 X 25 
µg of membrane fraction solubilised with increasing DDM detergent were resolved on two 3-12% 
Novex Native PAGE gels. (A) One gel was stained with Coomassie Brilliant Blue to visualise bands 
corresponding to mitochondrial complexes. (B) Another gel was analysed using western blot using 
antibodies against mt-SSU component, MRPS18b, and (C) mt-LSU components, MRPL3 and 
MRPL12. 
 
To verify the results of the sucrose gradients, complexomic profiling was used to 
analyse cells expressing MRM1. To avoid issues with the side effects of MRM1 leaky 
expression, HEK293T parental cells were used as the control. Indeed, this showed a 
marked decrease in ribosomal integrity. Both the mtLSU (Figure 3.2.7) and the 
mtSSU (Figure 3.2.8) showed a shift in the highest intensity peak to a lower molecular 
weight (M.W.). This suggested that the highly abundant MRM1 protein in the 
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overexpression cell line might be interfering with mitoribosomal assembly. This may 
suggest a role of MRM1 dissociation from the mtLSU as a checkpoint in biogenesis 
since high abundance of the protein could hinder dissociation of the protein from the 
rRNA. Moreover, the mtLSU in the overexpression sample shows fewer complexes 
than the parental control, which shows two major peaks of roughly equal abundance. 
The mtSSU shows a matching profile to their respective mtLSU profiles, for both the 
control and the MRM1 overexpression cell line (Figure 3.2.8). Unfortunately, the 
method does not have sufficient resolution capacity to separate the large and the small 
subunit.  
The multiple peaks in the control sample could have been caused by slightly different 
treatment of the samples. Therefore, the integrity of Complex I was investigated in 
both samples (Figure 3.2.9). Complex I in the control sample did not show any 
notable difference in composition or degradation products. However, compared to the 
mitoribosomes, Complex I is a smaller complex. It may not be as sensitive to slight 
differences in treatment. This also showed that an error of approximately 1-2 slices 
should be considered when approximating the location of the peak. Taking all this 
into account, the intense peak produced in the overexpression cell line (slice 16) 
corresponds to the lighter peak of the control sample (slice 15).  In particular, the mt-
LSU components, MRPL12, MRPL14, MRPL16 and MRPL30 are more abundant 
in the heavier fraction 13 peak in the control sample than in the lower peak (fraction 
15).  In the control samples, a majority of the mt-SSU components co-localise with the 
heavier peak (fraction 13) and the even heavier but less abundant peak in fraction 11. 
In the overexpression sample, the higher peaks are absent and the mt-SSU co-
localised with the lighter fraction 15 mt-LSU peak (Figure 3.2.7 and 3.2.8).   
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Figure 3.2.7 Analysis of changes to assembly of the mitoribosomal large subunit upon MRM1 
overexpression. Mitochondria from parental HEK293T and MRM1-overexpressing cells (induced 
with 50 ng/ml doxycycline for 48 hours) were extracted. The membrane and soluble fractions were 
separated. The membrane proteins were solubilized in 0.45% DDM. The protein complexes were 
resolved on a blue native PAGE gel. The gel was cut into 64 slices and each slice was analysed using 
mass spectrometry. For each protein and for each slice, peptides common to both samples were found 
and using the highest abundance as ‘1’, a relative abundance of the peptide was calculated and a 
heatmap was visualised using Excel. Each column indicates a slice with the top of the gel being at the 
left of the heatmap. The first 33 slices are shown. The first and the thirty third slice are marked above 
the heat maps. 
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Figure 3.2.8 Analysis of changes to assembly of the mitoribosomal small subunit upon MRM1 
overexpression. Mitochondria from parental HEK293T and MRM1-overexpressing cells (induced 
with 50 ng/ml doxycycline for 48 hours) were extracted. The membrane and soluble fractions were 
separated. The membrane proteins were solubilized in 0.45% DDM. The protein complexes were 
resolved on a blue native PAGE gel. The gel was cut into 64 slices and each slice was analysed using 
mass spectrometry. For each protein and for each slice, peptides common to both samples were found 
and using the highest abundance as ‘1’, a relative abundance of the peptide was calculated and a 
heatmap was visualised using Excel. Each column indicates a slice with the top of the gel being at the 
left of the heatmap. Note that the order of the proteins is not the same as a different subset of total 
small subunit components was detected in each sample. The first 33 slices are shown. The first and 
the thirty third slice are marked above the heat maps. 
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Figure 3.2.9 Analysis of changes to mitoribosomal assembly upon MRM1 overexpression. The 
average protein abundance of each of the complexes was calculated and plotted using Prism 7. (A) 
mtLSU (B) mtSSU (C) Complex I control was also used as its abundance should not be affected. As 
SILAC was not used, this controls for differences in gel running and differences in gel slicing. 
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3.2.3 MRM1 knockout generation in HEK293T Flp-In cells 
Human MRM1 was previously shown to be a 2’-O-ribose methyltransferase that 
methylates G1145 in the mt-LSU 16S rRNA (Lee and Bogenhagen, 2014). However, 
the function and the reason for the strong conservation of this modification were not 
clear. Therefore, to decipher the function of the modification in the translation 
apparatus, a knockout cell line approach was pursued. At the time of creating this 
knockout, the CRISPR-Cas9 system was still in its infancy and had various issues with 
off-target cleavage and efficiency that had to be addressed. Various attempts using 
self-designed guide RNA sequences were made to generate knockout HEK293T Flp-
In T-Rex cell lines (not shown). However, this was not successful. Therefore, the well-
established method of zinc-finger nuclease (ZFN)-based gene targeting was used. This 
could be purchased as vectors encoding the two ZFNs that bind to the sense and anti-
sense DNA strand and could be easily transfected into the required cell line using 
lipofection. In addition, the Sigma CompoZr custom ZFN service provided a 
validated pair of ZFNs that guaranteed high efficiency of gene targeting. The 
HEK293T Flp-In cell line was used because it contains the Flp-In system, which can 
be used for a straightforward complementation of the knockout to show rescue of 
phenotype upon reintroduction of the protein-coding cDNA.   
The double strand break produced in the target gene by the ZFN can be repaired by 
the cell using non-homologous end joining (NHEJ) or homology directed repair 
(HDR). As a donor-targeting construct for HDR was not supplied to the cell in our 
experimental system, we relied upon NHEJ to introduce insertions or deletions. The 
ZFN was targeted to the first exon of the gene and any out-of-frame mutation 
introduced by NHEJ would produce a premature stop codon. 
Prior the ZFN targeting, the HEK293T cells were karyotyped to study the extent of 
genetic rearrangements in this model cell line. Out of seven clonal cells analysed, 
chromosomal analysis showed severe aneuploidy and multiple rearrangements 
between the seven clones. The cells showed between 46 and 58 chromosomes and 
structural rearrangements were observed in chromosomes 1, 3, 5, 11, 13, 14 and 16, 
with at least two unidentified marker chromosomes (Figure 3.2.10). The MRM1 gene 
locus is found on Chromosome 17, which showed three copies of the gene that needed 
to be targeted by ZFN. Nevertheless, HEK293T Flp-In cells were used to make use of 
the Flp-In system at a later date.  
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Figure 3.2.10 Karyotype for HEK293T cells. The cell lines are arrested in metaphase, stained and 
imaged. The chromosomes are identified based on banding pattern.  Karyotyping performed by Cell 
Guidance Systems Karyotyping service. 
 
Vectors encoding the two ZFNs were transfected into the parental HEK293T Flp-In 
cell line using nucleofection, and the cells were allowed to recover for 48 hours and 
diluted to obtain single-cell derived clones in eight 96-well plates at a concentration of 
0.2 cells per well. Cells were allowed to recover and single colonies were split in 
triplicate into three plates. The cells were allowed to reach 60-80% confluency (for 
two weeks) before being frozen or harvested for screening. To identify potential 
MRM1 knockout candidates, the cells were lysed using TG lysis buffer and subjected 
to western blotting using antibodies against endogenous MRM1. Loading was 
quantified by probing the blot against b-actin (Figure 3.2.11A). Clones identified via 
western blotting were analysed using PCR across the ZFN target site, TOPO cloning 
to separate the different alleles and Sanger sequencing (Figure 3.2.11B, C).  
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Of the 192 clones screened, two clones were identified for further study. Clone 7 
showed a complete lack of protein in the western blot analysis. Sequencing the three 
alleles showed 4 bp, and 7bp (2 alleles) deletions, producing premature stop codons 
leading to a 167 aa protein and a 120 aa protein, respectively. However, a western 
blotting analysis showed no detectable MRM1 in the clone 7 sample, suggesting a loss 
of stability of the produced proteins, efficient nonsense-mediated decay or that the 
epitope is not on the lost N-terminus (Figure 3.2.11A). Clone 7 will be henceforth 
referred to as MRM1 (-/-). Similarly, clone 71 was identified on initial western blot 
screening, which showed strongly depleted MRM1 levels. However, repeated western 
blotting with protein quantification showed low but detectable amounts of 
endogenous MRM1. Furthermore, sequencing across the ZFN target site showed that 
only two of of three alleles had been successfully targeted producing a 14 bp deletion 
(167 aa protein) and a 2 bp deletion (171 aa protein) (Figure 3.2.11C). Clone 71 will 
henceforth be referred to as MRM1 (+/-). 
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Figure 3.2.11 Screening for MRM1 knockout HEK293T cells. (A) Initial western blot analysis of 
cell lysate from single cell - derived clones using antibodies against endogenous MRM1, OxPhos 
complexes and b-actin. Initial screening is shown on the left showed a severe decrease in endogenous 
MRM1 and a weak non-specific band in its place. Further analysis using quantified protein is shown 
on the right. (B) PCR products containing the ZFN target site (marked in red) were TOPO cloned, 
transformed into E. coli, and bacterial colonies were submitted for Sanger sequencing. The sequences 
were aligned against the wild-type sequence. 
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MRM1 is responsible for 2’-O-ribose methylation of G1145 on the 16S rRNA of the 
mt-LSU. Therefore, the mitochondrial rRNA for the HEK293T cell lines was 
analysed for G1145 ribose methylation. This was analysed by reverse transcription 
primer extension, a method that utilises the inefficiency of reverse transcriptase in 
reverse transcribing across a modified nucleotide. The knockout cells were also 
complemented with doxycycline-inducible Flag-tagged MRM1 using the Flp-In 
recombination system. Confirmation of successful reintroduction of MRM1 was 
shown using western blotting (Figure 3.2.12). The reintroduction of the modification 
in these cells would confirm that MRM1 is indeed required for the modification, and 
that the loss of the modification is caused by the loss of the protein.  
 
 
Figure 3.2.12 Complementation of MRM1 (-/-) with MRM1-Flag. Mitochondria were isolated 
from the HEK293T parental cells, the MRM1-deficient MRM1 (+/-) and MRM1 (-/-) cells 
and the MRM1-complemented knockout cells (induced for 24 hours with 50 ng/ml doxycycline). 
Western blotting was performed. Antibodies against endogenous MRM1 were used to show 
complementation. Antibodies against TOM22 were used as a loading control.  
 
Reverse transcription primer extension involved extracting mitochondrial RNA from 
the parental HEK293T cells, the MRM1 deficient MRM1 (+/-) and MRM1 (-/-) 
cells, and the rescued MRM1 (-/-) cells. Two primers were chosen which anneal 
downstream of the site of the modification. To control for loading internally, dATP 
was not added to the reverse transcription reaction, therefore, in addition to the 
pausing at the modified nucleotide, the lack of dATP would cause all reverse 
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transcription to stall when it encountered a ‘U’ (a schematic representation is provided 
for both primers in Figure 3.2.13 and 3.2.14). Therefore, a ratio of primers paused at 
the modification and those that are stalled due to a lack of dATP could be calculated 
(Figure 3.2.13A and 3.2.14A). This removed the errors caused by differences in RNA 
loading. As a further negative control, an in vitro transcribed 1059 nucleotide RNA 
substrate, containing the 16S rRNA position G1145, was used as a negative control to 
indicate the levels of false positive pausing signals that may be observed. The primers 
were end-labelled with [32P]-ATP and polynucleotide kinase (PNK) so that reverse 
transcription products could be visualised using autoradiography (Figure 3.2.13B and 
3.2.14B).  
For both primers, a substantial decrease is observed in the pausing caused by the 
Gm1145 modification in MRM1 depleted cells. Moreover, in the knockout cells 
where MRM1 was reintroduced, a substantial amount of modification-mediated 
pausing was observed, higher than in control cells. This could be attributed to 
methylation of immature 16S molecules that would not normally be modified by 
endogenous MRM1 (Figure 3.2.13C and 3.2.14C).  
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Figure 3.2.13 Identifying G1145 methylation status following MRM1 knockout. [32P]-end-labelled 
primer complimentary to a sequence downstream to the site of the modification is annealed to the mt-
RNA from HEK293T parental, MRM1 (-/-), MRM1 (+/-) and MRM1 (-/-) rescue cells, and 
1059 nt RNA substrate, and reverse transcription is carried out. (A) Schematic representation. In the 
presence of the modification, primer extension by the reverse transcriptase is paused by the modification. 
Lack of dATP causes complete stalling of the primer extension reaction. (B) The primer (21 nt) 
produces a 23 nt product when reverse transcription paused by Gm1145 and a 25 nt product when 
stalled due to lack of dATP. (C) Ratio of band intensities of primer stalling to Gm1145 pausing are 
calculated using Image J.  
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Figure 3.2.14 Identifying G1145 methylation status following MRM1 knockout. [32P]-end-labelled 
primer complimentary to a sequence downstream to the site of the modification is annealed to the mt-
RNA from HEK293T parental, MRM1 (-/-), MRM1 (+/-) and MRM1 (-/-) rescue cells, and 
1059 nt RNA substrate, and reverse transcription is carried out. (A) Schematic representation. In the 
presence of the modification, primer extension by the reverse transcriptase is paused by the modification. 
Lack of dATP causes complete stalling of the primer extension reaction. (B) The primer (21 nt) 
produces a 24 nt product when reverse transcription paused by Gm1145 and a 26 nt product when 
stalled due to lack of dATP. (C) Ratio of band intensities of primer stalling to Gm1145 pausing are 
calculated using Image J. 
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3.2.4 Characterisation of growth rate, OxPhos function and mitochondrial translation 
MRM1 knockout cell lines 
 
Next, the newly generated MRM1 deficient cell lines were characterised to identify 
the effect of MRM1 ablation on mitochondrial function. Firstly, growth rate of the 
HEK293T, MRM1 (+/-) and MRM1 (-/-) cell lines was measured in glucose and 
galactose media. The galactose media forces the cell to rely on mitochondrial 
respiration for ATP production. This is because galactose metabolism is linked to 
pyrimidine biosynthesis. The breakdown of galactose requires mitochondrially-
produced UTP, which in turn requires dihydroorotate dehydrogenase (DHODH). 
However, DHODH also functions as an accessory enzyme of OxPhos. Therefore, 
disruption of OxPhos causes disruption of pyrimidine synthesis and thus, galactose 
cannot be metabolised by the cell (Gattermann et al., 2004). This stress causes cells 
with defective mitochondria to suffer and thus reduces cell viability. No significant 
difference in cell viability was observed in the MRM1 depleted cells (Figure 3.2.15A).  
Subsequently, OxPhos function was assessed using microscale oxygraphy using an 
Extracellular Flux Analyzer to measure oxygen consumption rate of plated cells upon 
sequential injection of ATP synthase inhibitor, Oligomycin, mitochondrial uncoupler, 
Bam15, and Complex I and III inhibitors, Rotenone and Antimycin A. No significant 
difference in oxygen consumption rate was observed between the HEK293T parental, 
MRM1 (+/-) and MRM1 (-/-) cell lines (Figure 3.2.15B). 
Since, the modification is strongly conserved in 16S ribosomal RNA, the effect of the 
lack of MRM1 on mitochondrial translation was assessed using the incorporation of 
[35S]-methionine into newly synthesised mitochondrially encoded proteins. To do this, 
the cells were incubated with cytoplasmic translation inhibitor, emetine. Then, [35S]-
methionine was introduced to the cells and incubated for 30 minutes. The cell lysate 
was run on a SDS-PAGE gel, dried and visualised using autoradiography. This 
showed no significant difference between the control HEK293T cells and the MRM1 
deficient cell lines (Figure 3.2.15C).  
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Figure 3.2.15 Characterisation of MRM1 knockout cell lines (A) Growth curve. 10,000 cells of the 
HEK293T parental, MRM1  (+/-) and MRM1 (-/-) cell lines were plated in triplicates in 4.5 
g/L glucose or 4.5 g/L  galactose and confluence was measured using Incucyte HD. Error bars =1 
SEM; n=3.  (B) Microscale oxygraphy.  15,000 cells of the three cell lines were plated in a XF96 
cell culture microplate 24 hours before the media was replaced with low-buffered DMEM. Using the 
XF96 Extracellular Flux Analyzer, wells were sequentially injected with Oligomycin (2 µM), 
Bam15 (2µM) and Antimycin A and Rotenone (1 µM). Oxygen consumption rate was measured 
before and after the introduction of the inhibitors. Error bars indicate standard error. The experimental 
protocol was provided by and optimisation of the protocol for HEK293T cells was performed in 
collaboration with Dr Hannah Bridges. (C) [35S]-methionine labelling of newly synthesised 
mitochondrial translation products. The three cell lines were incubated in cytoplasmic inhibitor, 
emetine, for 30 minutes before the addition of the [35S]-methionine. After 30 minutes, the cells were 
lysed with 0.1 % DDM and 0.1 % SDS and 30 µg of protein were resolved on a 10-20% Tris-
glycine SDS-PAGE gel. Coomassie Brilliant Blue staining was used as a loading control. The gel 
was dried, exposed to a storage phosphor screen and scanned using a Typhoon imager. Band intensity 
was quantified using Image J and plotted using Prism 7. 
 
3.2.5 The effect of MRM1 depletion on mitoribosomal integrity 
 
To assess if MRM1 depletion has any detrimental effects on the biogenesis of the 
mitoribosome, we next performed sucrose gradient fractionation and western blotting. 
This involved resolving the various mitoribosomal assemblies in the cell lysate using a 
10-30% (v/v) isokinetic sucrose gradient. Sucrose gradient fractions were then 
resolved on a 4-12% Tris-glycine SDS-PAGE gel and analysed using western blotting. 
MRPL3 was used to probe for mt-LSU and MRPLS18b was used to probe for the 
mt-SSU. No MRM1-specific deficiency in mitoribosomal integrity was observed in 
MRM1-deficient cells (Figure 3.2.16).  
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Figure 3.2.16 Analysis of mitochondrial ribosome upon MRM1 knockout. 750 µg of cell lysate were 
separated using 10-30% (v/v) isokinetic sucrose gradient fractionation. 100 µl fractions were then 
analysed using western blotting. Antibodies against MRPL3 were used to identify the mt-LSU. 
Antibodies against MRPS18b were used to identify the mt-SSU. Bands were quantified using Image 
J and plotted as a proportion of total protein using Prism 7.  
 
Small difference between the samples may not be detected due to the low sensitivity of 
the isokinetic sucrose gradient fractionation method. Therefore, we pursued the use of 
SILAC and complexomic profiling as described by Vidoni et al. (2017) to analyse the 
mitochondrial ribosomes. Stable isotope labelling by amino acids in cell culture 
(SILAC) was used to quantitatively compare the composition of the mitoribosomes 
and any subassemblies identified in the analysis. There are advantages and 
disadvantages to using SILAC in complexomic profiling. When using SILAC, 
peptides detected in only one of the two samples are omitted from the data analysis. A 
comparison of the presence of the protein cannot be made as a lack of detection of the 
protein does not indicate an absence of the protein. However, the disadvantage of a 
SILAC-free method is the human error introduced in unequal slicing of the gel 
between the two samples. The use of SILAC also allows internal normalisation 
between samples and a direct relative quantification to be made between the samples. 
Moreover, since the samples from the control and MRM1 knockout cells are mixed 
before being resolved on a gel, difference in gel slicing and the resulting errors in 
interpretation of the data are minimised.  
For SILAC-complexomics, the HEK293T parental cells and the MRM1 knockout 
cells were grown in heavy and light SILAC media. They were mixed in equal 
proportion and the mitochondria were isolated. The rest of the complexomic analysis 
was carried out as described earlier. The SILAC labelling was used to identify and 
separate proteins from both samples. For each protein, only peptides common to both 
samples are used to quantify abundance. An abundance profile is created for each 
protein using the maximum value from both sets being assigned the value of 1 and the 
remaining intensities are proportionally scaled. The black to red colour scheme in the 
heatmap implies an abundance of 0 to 1. Comparison of the complexomic profiles of 
mt-LSU suggests no major differences in intensity profiles. The smaller subassembly 
observed in optimisation western blot for MRPL12 was not detected in the mass 
spectrometry data. Due to the large size of the mt-LSU and mt-SSU, it is not 
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sufficiently resolved from the monosome (Figure 3.2.17 and 3.2.18). Comparison of 
the heatmap and profiles of the mtSSU showed that the assembled small subunit does 
not show accumulation of an assembly intermediate. In addition, a smaller 
subassembly of the mtSSU is also observed. However, this is also not different 
between the MRM1 knockout cells and the control cells (Figure 3.2.18). Any 
differences in presence of a protein could be attributed to variation in peptide 
detection. This is most noticeable in the profile of the average abundance of all the 
protein components in the mtLSU and mtSSU  (Figure 3.2.19). Taken together, this 
suggests that neither MRM1 nor the G1145 modification is crucial for mitochondrial 
assembly and integrity. 
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Figure 3.2.17 Analysis of composition of the mitoribosomal large subunit using SILAC-complexomic 
profiling. (A) Mitochondrial membranes of HEK293T parental cells grown in heavy or light SILAC 
media and MRM1 (-/-) cells were grown in the other medium (This experiment was repeated with 
reciprocal labelling) and mixed in equal proportion, were isolated using homogenisation, sonication and 
ultracentrifugation. 25 µg of membrane proteins were solubilised using 0.45% DDM and run on 3-
12% Novex Native PAGE gel for 1 hour at 80 V and for 1 hour at 200 V. Each lane was cut into 
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64 equal slices and analysed using LC-MS/MS. Heatmap was generated using Excel, using peptides 
common to both samples such that the maximum abundance of a peptide in both samples was given an 
abundance of 1 and the remaining slices from both samples were scaled proportionally. Each slice is a 
column in the heatmap with the highest molecular weight slice from the top of the gel positioned at the 
left of the heatmap. The rows indicate the protein components of the mitochondrial large subunit 
detected in both samples. The first 27 slices are shown. Sliec numbers are indicated above the 
heatmaps. This experiment was performed in collaboration with Dr Michael Harbour.  
 
 
Figure 3.2.18 Analysis of composition of the mitoribosomal small subunit using SILAC-complexomic 
profiling. (A) Mitochondrial membranes of HEK293T parental cells grown in heavy or light SILAC 
media and MRM1 (-/-) cells were grown in the other medium (This experiment was repeated with 
reciprocal labelling) and mixed in equal proportion, were isolated using homogenisation, sonication and 
ultracentrifugation. 25 µg of membrane proteins was solubilised using 0.45% DDM and run on 3-
12% Novex Native PAGE gel for 1 hour at 80 V and for 1 hour at 200 V. Each lane was cut into 
64 equal slices and analysed using LC-MS/MS. Heatmap was generated using Excel, using peptides 
common to both samples such that the maximum abundance of a peptide in both samples was given an 
abundance of 1 and the remaining slices from both samples were scaled proportionally. Each slice is a 
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column in the heatmap with the highest molecular weight slice from the top of the gel positioned at the 
left of the heatmap. The rows indicate the protein components of the mitochondrial small subunit 
detected in both samples. The first 33 slices are shown. Sliec numbers are indicated above the 
heatmaps. This experiment was performed in collaboration with Dr Michael Harbour.  
 
 
 
 
Figure 3.2.19 Analysis of composition of the mitoribosomal subunits using SILAC-complexomic 
profiling. The average abundance of all the components of the (A) large subunit and (B) small subunit 
was calculated and plotted using Excel. Only 26 slices are shown for the mt-LSU and 33 slices are 
shown for the mt-SSU.  
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3.3 MRM1 - Discussion 
In mammalian mitochondria, the ribosomal RNA undergoes ten highly conserved 
modifications found in close proximity to the catalytic centre of the mitoribosome, 
including base methylations, 2’-O-ribose methylations and pseudouridylation. This 
works aims to characterise in particular the highly conserved G1145 2’-O-ribose 
methylation and its role in mitoribosomal biogenesis. While this work was in progress, 
Lee and Bogenhagen (2014) demonstrated that MRM1 catalyses the formation of 
Gm1145 on the P-loop of the 16S rRNA of the mitochondrial large ribosomal 
subunit. The importance of this modification varies depending on species. In bacteria, 
lack of this modification does not seem to affect ribosomal assembly and function 
(Lovgren and Wikstrom, 2001). However, it is indispensable in yeast (Connolly et al., 
1995). Therefore, knockout cells were generated to identify the function of MRM1 
and purpose of this modification. We showed that despite being highly conserved, 
knockout of the methyltransferase does not affect OxPhos function, mitochondrial 
translation and mitoribosomal biogenesis. 
 
3.3.1 MRM1 is required for G1145 methylation 
In the MRM1 knockout cells, a small amount of pausing of reverse transcription at 
the site of modification is still observed in the knockout cells. However, this pausing is 
also seen in in vitro transcribed substrates suggesting that this observed pausing is not 
specific to the modification and may be due to the specific sequence. A substantial 
increase in pausing of reverse transcriptase at the site of modification upon expression 
of MRM1 in knockout cells suggests that there is a pool of 16S rRNA that is 
unmodified and that MRM1 concentration is the rate-limiting step. Alternatively, it is 
more likely that these unmodified RNA molecules are earlier in the stages of 
maturation and the excess of MRM1 causes a deregulation in the hierarchy of 16S 
rRNA maturation. This would suggest that MRM1 modification does not happen co-
transcriptionally.  
Other methods have also been used previously to identify the presence of a 
modification such as mass spectrometric analysis of 16S rRNA extracted from sucrose 
gradient fractionated samples (Su et al., 2014), or a direct comparison of parental and 
knockout cell 16S rRNA using Nanopore techniques (Marchand et al., 2016).  
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3.3.2 MRM1 depletion does not affect cell viability and mitochondrial gene 
expression 
The modification of the guanine in the peptidyl transferase loop of domain V of 16S 
rRNA is highly conserved (Baer & Dubin, 1981). However, the effect of loss of the 
MRM1-induced modification is variable across various species. In E. coli, loss of 
RlmB, homolog of MRM1, does not cause any changes to cell viability (Lovgren and 
Wikstrom, 2001). In S. cerevisiae mitochondria, loss of the homolog, Pet56p, led to a 
strong respiratory defect and a reduction in growth in media containing non-
fermentable carbon source (Connolly et al., 1995). In S. cerevisiae cytoplasmic 
ribosomes, knockout of snoRNA snR67 required for the methylation of the equivalent 
site (G2619) causes a mild defect in growth in basal medium. However, loss of the 
modification does not affect sensitivity to ribosomal inhibitors and extraribosomal 
stresses (Esguerra et al., 2008). In our HEK293T knockout cells, the absence of 
MRM1 does not lead to a reduction in cell viability in glucose or galactose medium. 
Further analysis also showed that MRM1 and the G1145 methylation is not required 
for the synthesis of mitochondrially-encoded components of the respiratory chain. 
Any inefficiencies introduced by the lack of modification to the effective decoding of 
the mRNA did not lead to any measurable deficiencies in OxPhos function.  
A similar lack of phenotype has been observed in other cells where conserved tRNA 
modifiers have been lost. However, upon further knockdown of one or more other 
modifiers, a deficiency in translation was observed. For example, in yeast, 
independent deletion of TRM140 and TRM1 modifiers of the tRNA anti-codon loop 
do not have any effect on translation or cell viability. However, deletion strains 
lacking both proteins show a modest growth phenotype, but only in the presence of a 
translation inhibitor, cyclohexamide (D’Silva et al., 2011). In the case of MRM1, a 
similar model with multiple deletions may be required to elicit a translation defect.   
 
3.3.3 The role of MRM1 in mitoribosome biogenesis 
The biogenesis of the mitoribosome involves the methylation of multiple sites by 
different conserved methyltransferases. The loss of Um1369 and Gm1370 by 
methyltransferases related to MRM1 (MRM2 and MRM3), causes a defect in mt-
LSU assembly, which subsequently leads to a respiratory deficiency (Lee and 
Bogenhagen, 2014; Rorbach et al., 2014). It then stands to reason that MRM1, being 
a highly conserved protein involved in a highly prevalent modification should be also 
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important for mitoribosome biogenesis. Analysis of different species lacking this 
methyltransferase activity seems to give mixed results. In bacteria, loss of the MRM1 
homolog does not lead to changes in ribosome assembly (Lovgren & Wikstrom, 2001). 
However, in yeast mitochondria, depletion of the MRM1 homolog leads to a defect in 
mt-LSU assembly with an associated accumulation of lower sedimenting particles 
lacking Mrp7p (homolog of bL27 and MRPL27) (Sirum-Connolly & Mason., 1993; 
Sirum-Connolly et al., 1995). However, knockout of MRM1 in HEK293T cells did 
not show any detectable differences in mitoribosome subunit assembly and 
composition.  
This lack of a phenotype in MRM1 knockout cells implies that its function is either 
very subtle and cannot be identified by the experiments performed, or that the effects 
of the modification may only come into play under certain contexts, such as under 
certain environmental stresses, in specific cell types or at certain stages of 
development. It is also possible that under standard conditions testing in this work, the 
lack of this modification does not hinder translation. As previously described, a double 
or triple knockout of multiple modifications or a suitable environmental stress may be 
required to bring about significant differences in translation (D’Silva et al., 2011).  
Recent structural work on a ribosome with a tRNA in the P-site showed that G1145 
(target of MRM1) and G1146 base pairs with C75 and C74 of the universally 
conserved aminoacylated CCA sequence at the 3’ of the tRNAs (figure 3.3.1) (Greber 
et al., 2015). In this context, the 2’-O-ribose methylation of rRNA could have another 
structural function. The methylation of the hydroxyl group, often prevents it from 
hydrogen binding and stabilises the structure (Motorin and Helm, 2010). Esguerra et 
al. (2008) also suggest that strategically placed modifications may also serve a function 
analogous to ‘ball bearings’ which facilitate the repetitive ratchet-like mechanism of 
ribosome and tRNA movement during translation. For example, in the bacterial 
ribosome, when the P-site substrate is bound, U2585 points towards the A-site until 
the A-site substrate enters. This causes a shift in conformation such that it faces away 
from the tRNA-amino acid ester group. This change in conformation positions the 
amino and carbonyl groups such that nucleophilic attach can occur and leading to the 
formation of the peptide bond (Steitz, 2008). In bacteria, this is the region where 
RrmJ (MRM2 homolog) methylates U2552 and this modification may function as the 
‘ball bearing’ facilitating conformational change.  
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Figure 3.3.1 G1145 in the P-site. Orange, MRPLs; dark grey, rRNA; light orange, MRPSs; red, 
P-site tRNA. The 3’ CCA and G1145-1146 are depicted as cartoons by element showing that they 
are roughly hydrogen bonding distance away from each other. The structure does not contain 
information about the tRNA sequence and hence Watson-Crick bonding could not be shown.  
(Modelled using Pymol molecular visualisation system, PDB 3J9M) 
 
Complexomic profiling using proteins labelled with stable isotopes is a novel method 
with a potential for the analysis of the large complexes, including mitoribosome. 
However, there are some issues that still need to be addressed with this method. The 
enormity of the mitoribosome and its subunits prevent them from being sufficiently 
resolved by the blue native PAGE gel. There is a strong overlap between the peaks of 
the large and small subunits. However, to a certain extent, SILAC labelling 
compensates for this and allows for a direct comparison between the parental and 
knockout samples.  
Our results did not show any substantial differences between the HEK293T parental 
cells and the MRM1 knockout cells. However, this method also revealed certain 
previously unidentified characteristics of the mitoribosome. The complexomic profile 
of the mt-LSU is much less diffused than that of the mt-SSU. In addition, the mt-LSU 
has fewer major peaks. This may suggest that as in bacterial ribosomal assembly, the 
large subunit also has fewer assembly intermediates, and thus assembly pathways than 
the small subunit. Variations in sample handling between experiments can also affect 
the integrity of the protein complex. For example, the mt-SSU subassembly detected 
in the different HEK293T cell lines reproducibly contains the subunits MRPS26, 
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MRPS17, MRPS34, MRPS27, MRPS18b, MRPS5, MRPS6 and MRPS22 and may 
represent an assembly intermiadiate. When visualised on the 3D structure, these 
subunits seemed to cluster together. However, the detection and the composition of 
this subassembly may vary depending on these variations (Figure 3.3.2).  
 
 
 
Figure 3.3.2 Subassembly of the small subunit observed in various SILAC-complexomics results. The 
darkness of the orange signifies how repeatable the presence of the protein is. Light grey, MRPSs, Dark 
grey, 12S rRNA (PDB:3J9M) 
In cells overexpressing MRM1, both sucrose gradient fractionation and complexomic profiling 
identified a block in the assembly of mt-LSU and the mt-SSU. This is clearly visible in the average 
protein abundance of each slice of the complexomic profiles (Figure 3.2.8). In particular, the stalled 
subassembly of the mt-LSU lacked subunits lack subunits MRPL16, MRPL14, MRPL28 and 
MRPL41 (Figure 3.3.3). However, the composition of the stalled mt-SSU was the same as the 
control sample. The reason for the lower molecular weight cannot be attributed to the absence of 
specific protein components. This could be a non-specific side effect of the overexpression of an RNA-
binding protein. Alternatively, this could be explained by the abundant MRM1 preventing the 
dissociation of the protein from 16S rRNA, which in turn prevents the association of MRPs and the 
progression of assembly. Many of the mitoribosome biogenesis factors, namely GTPases, rely of the 
hydrolysis of GTP to induce dissociation, which in turn causes assembly to progress (See section 
1.7.4.1). In the case of MRM1, one assumes that the affinity of MRM1 to its substrate decreases 
after 2’-O-ribose methylation, which leads to dissociation. However, the high abundance of the protein 
in overexpression cell lines may compensate for this lower affinity and may cause the rRNA site to be 
constantly occupied by MRM1. 
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Figure 3.3.3 Subassembly of the large subunit observed in complexomic profiling of MRM1 
overexpression cells. The orange signifies proteins found in the subassembly of the mt-LSU found in 
slice 16 of the complexomic profile shown in Figure 3.2.6 (where abundance of the protein is highest, 
red) (PDB:3J9M) 
 
3.3.3.1 MRM1 does not interact with mitoribosomal proteins or other known 
biogenesis factors 
Previously identified 16S rRNA methyltransferases strongly interact with the 
mitoribosome. MRM2 interacts with the mt-LSU and the assembled mitoribosome, 
while MRM3 only interacts with the mt-LSU (Rorbach et al., 2014). Therefore, it was 
assumed that MRM1 would also show similar interactions. Western blotting and 
complexomic profiling did not identify MRM1 co-localising with the mitoribosome. 
Proteins immunopurified after treatment with benzonase, to identify interactions 
independent of RNA interaction, identified direct interactions between the proteins 
independent of RNA intermediaries. However, even though MRM1 binds and 
modifies 16S rRNA, it failed to pull down known 16S rRNA-associated MRPs or 
biogenesis factors. Instead, mt-SSU biogenesis factor, ERAL1, was pulled down as a 
weak interactor. In addition, LYRM7, a late stage assembly factor of Complex III was 
also immunopurified. However, a role in co-translational assembly of the complex is 
discounted by the fact that OxPhos function and steady state level of complex III 
subunit was not changed by the absence of MRM1. Interestingly, NT5DC2, a 
predicted mitochondrial nucleotidase is also common to both immunopurifications 
with and without benzonase treatment. As a nucleotidase, it is capable of binding 
RNA, and thus may play a role in ribosome biogenesis. However, the protein remains 
uncharacterised and could be an interesting subject for further studies. The failure of 
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MRM1 to bind to mitoribosome-associated proteins suggests that MRM1 may act on 
16S rRNA at an early stage of biogenesis. A summary of the proteins pulled down by 
MRM1, their cellular localisation and previously characterised roles in the cell are 
detailed in tables 3.3.1 and 3.3.2. 
 
Interactors Localisation Function References 
DIS3L Found 
predominantly 
in the 
cytoplasm. 
3’-5’ exoribonuclease activity. 
Possible RNA-binding 
contaminant as it is removed by 
benzonase treatment. 
Tomecki et al. 
(2010) 
HSPA9 Mitochondria Heat shock protein possibly 
produced as a result of 
overexpression of the MRM1 
bait protein. 
Wadhwa et al. 
(2002) 
EPPK1 Cytoplasm Cytoskeleton maintenance Jang et al. (2005) 
ERAL1 Mitochondria mt-SSU biogenesis factor (see 
section 1.7.4) 
Dennerlein et al. 
(2010) 
LYRM7 Mitochondrial 
inner 
membrane 
Complex III assembly factor Sanchez et al. 
(2013) 
PRDX3 Mitochondria Antioxidant protein Watabe et al., 
1997 
NT5DC2 Predicted 
mitochondrial 
Not characterised. Contains 
domains for hydrolase and 5’-
nucleotidase activity.  
- 
Table 3.3.1 Function of MRM1 immunoaffinity proteins in the absence of benzonase 
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Interactors Localisation Function References 
PPM1B Nucleus Mg2+/Mn2+ dependent protein 
phosphatase 
Tasdelen et al. 
(2013) 
SELO Mitochondria Antioxidant protein Han et al. (2014) 
FAHD1 Mitochondria Fumarylacetoacetate hydrolase 
activity in tyrosine catabolism 
pathway 
Pircher at al. 
(2011) 
HSPA9  See Table 3.3.1  
ERAL1  See Table 3.3.1  
NT5DC2  See Table 3.3.1  
MCCC1 Mitochondria 3-methylcrotonyl-coA carboxylase 
activity in leucine catabolism 
pathway 
Obata et al. 
(2001) 
PRDX3  See Table 3.3.1  
LYRM7  See table 3.3.1  
Table 3.3.2 Function of MRM1 immunoaffinity proteins in the presence of benzonase 
 
Only 7 of these proteins were identified in three independent complexomic profiling 
data sets of HEK293T control cells (Figure 3.3.4). Of these, PRDX3 and HSPA9 
were found evenly spread in all the lanes indicating that the proteins indiscriminately 
bind to proteins in the mitochondria. ERAL1, a known late-stage assembly factor of 
the mt-SSU seems to co-migrate with the assembled mt-LSU/mt-SSU (complex A) 
(Figure 3.3.3 assembly labelled ‘A’). Since the assembled mt-LSU and mt-SSU are not 
adequately resolved on the blue native gel, it is difficult to conclude which complex 
the protein is bound to. However, in the third of the three experiments shown, 
ERAL1 does not seem to co-migrate with the complex A indicating variability in the 
results and that a lack of an observed interaction does not indicate an absence of an 
interaction. Similarly, NT5DC2 is seen co-migrating with both the assembled 
mitoribosomal complexes and the mt-SSU subassembly described earlier (Figure 
3.3.4). FAHD1 co-migrates with complex A in one of the three experiments. LYRM7 
and MCCC1 are both detected in the same fraction as the mt-SSU subassembly 
(complex B). However, if this is a true co-migration, why mt-SSU-interacting proteins 
would be pulled down with MRM1 is unclear.  
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Figure 3.3.4 Immunoaffinity purified MRM1 interactors in complexomic profiles of HEK293T 
cells. The membrane fraction of mitochondria extracted from parental HEK293T cells was resolved 
on a blue native PAGE gel. The lane was cut into 64 slices and each slice was analysed via mass 
spectrometry. The colour of the heatmap indicates the intensity of detection of the protein in that 
fraction where red indicates the maximum intensity and black indicates the minimum. Green box A – 
mt-LSU/mt-SSU assembled complexes, Green Box B – mt-SSU subassembly 
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4 YbeY – A novel mitochondrially-targeted endonuclease 
required for mitoribosomal biogenesis 
 
4.1 YbeY – A novel mitochondrially-targeted endoribonuclease 
Human YbeY protein encoded by the C21orf57 gene is an uncharacterised protein 
predicted to be a mitochondrially-localised by mitochondrial localisation database 
MitoCarta 2.0 and MitoMiner 4.0 (Calvo et al., 2016, Smith and Robinson, 2016).  
YbeY is conserved in prokaryotes, some protists, a few plant species and higher 
metazoans. However, it has been lost in a majority of protists, plants, fungi and lower 
metazoans (Figure 4.1.1). The E. coli homolog, eYbeY (UPF0054 protein family), was 
identified as one of 206 genes that are vital for viability and comprise the ‘minimal 
bacterial genome’ set (Gil et al., 2004). Deletion of the protein in E. coli leads to a 
severe sensitivity to temperature, detergents, oxidative stress, β-lactam antibiotics and 
aminoglycoside antibiotics (Davies et al, 2010). Furthermore, YbeY is essential for 
pathogenesis in bacteria. Without the protein, Vibrio cholerae are incapable of correctly 
expressing small RNAs required for virulence, causing an inability to colonise mice or 
to produce biofilm. Similarly, YbeY is required by Yersinia enterocolitica for the 
expression of virulence factors required for adhesion and infection of eukaryotic cells 
(Leskinen et al., 2015). This necessity of YbeY also extends to symbiosis. In 
Sinorhizobium meliloti, the lack of YbeY prevents the nitrogen-fixing bacteria from 
effectively forming a symbiotic relationship with their legume hosts (Davies and 
Walker, 2008). 
This is in contrast with in fungi, which have lost the YbeY-coding gene, and 
expression of the human YbeY in Saccharomyces cerevisiae causes a strong growth 
phenotype and extreme toxicity (Ghosal et al., 2017).  
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Figure 4.1.1 Conservation and phylogeny of YbeY. Evolutionary conservation of YbeY was calculated 
using CLIME portal online web service (gene-clime.org). The bottom bar indicates the presence of the 
protein in the species indicated above on the evolutionary tree. Grey indicates absence of the protein 
while blue indicates presence of the protein. The length of the branches in the phylogenetic tree indicate 
divergence of the protein since a common ancestor. 
 
Bacterial YbeY is a single strand-specific endoribonuclease, which contains a highly 
conserved Arg59 residue for RNA binding and a zinc ion-coordinating histidine triad 
(H3XH5XH) domain for endonucleolytic cleavage (Davies et al., 2010; Jacob et al., 
2013). Human YbeY shares 23% sequence identity with its bacterial homolog. 3D 
homology modelling of human YbeY using the E. coli protein as a template (PDB 
1XM5) shows that the catalytically important residues are conserved in humans (see 
Figure 4.2.1). Therefore, it is predicted that RNA binding and endonuclease function 
is retained in the human version of the protein. 
In E. coli, eYbeY has been assigned various rRNA maturation functions. It is 
responsible for the 3’ end processing of the SSU rRNA (16S in E. coli) and depletion 
of eYbeY leads to a loss of translation caused by the depletion of the 30S SSU 
(Rasouly et al., 2009; Rasouly et al., 2010). 
Furthermore, it has been shown to play a role in the maturation of the 23S LSU 
rRNA and 5S RNA molecule (Jacob et al.,2013). Early studies with eYbeY showed 
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that it interacts with exonuclease, RNase R, rRNA maturation factor, RNase III and 
exoribonuclease, PNPase. In association with exonuclease RNase R, eYbeY was 
shown to specifically degrade rRNA from late stage 70S ribosomes with defective 30S 
SSUs, without degrading rRNA from unassembled LSU and SSU (Jacob et al., 2013) 
and as such plays a role in ribosomal quality control (Davies et al., 2010).  
Recent bacterial 2-hybrid analysis with eYbeY showed that it interacts with ribosomal 
protein, S11, GTPase Era, a protein that acts as a checkpoint in 30S ribosomal 
subunit maturation and GTPase Der which is a 50S ribosomal subunit maturation 
switch (Vercruysse et al., 2016), stress regulator SpoT and YbeZ. The interaction with 
S11 occurs through a conserved four-stranded β-sheet distinct from the catalytic site. 
The residues involved in this interaction are conserved in human YbeY (Figure 
4.2.29). A disruption of the eYbeY-S11 interaction led to an increase in the 16S rRNA 
precursor and a subsequent increase in sensitivity to stress (Vercruysse et al., 2016).  
YbeY has also been investigated in eukaryotic models. In Arabadopsis thaliana, YbeY 
has been shown to co-localise to the chloroplast where it is involved with maturation 
of the 23S, 16S and the 4.5S rRNA components. Consequently, mutations in YbeY 
lead to deficiencies in ribosomal biogenesis and translation in the chloroplast. YbeY 
null mutants showed seedling lethality and YbeY knockdown showed slow growth and 
impaired photosynthesis (Liu et al. 2015).    
Recent work on human YbeY identified non-specific ribonucleolytic activity of the 
protein, in in vitro assays. Notably, the expression of human YbeY in bacterial cell lines 
lacking the protein, partially rescued the phenotype of the cells investigated by 
measuring changes in sensitivity of the cells to various stresses. However, a completion 
of 16S processing was not observed in these cells. This partial rescue was not observed 
with catalytically inactive human YbeY (Ghosal et al., 2017). This suggests that the 
divergence of the human YbeY sequence coincides with a divergence of function. In 
the mitochondria, the function of YbeY is unclear. The mammalian mitochondrial 
rRNA is assembled into the ribosomes without the need for end-processing as 
observed in bacteria. Both the 12S mtSSU and 16S mtSSU mt-rRNAs are flanked by 
tRNAs and excision of these tRNAs by RNase P and ELAC2 is sufficient to liberate 
mt-rRNA ready for assembly into the mitochondrial ribosome (Dubin et al., 1982; 
Mercer et al., 2011). Therefore, the human orthologue of YbeY is likely to have a 
different function in the mitochondria, yet the exact role of YbeY in mammalian 
mitochondria is still unknown. In this section, we aim to show mitochondrial 
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localisation of the protein and elucidate the function of the protein through 
characterisation of YbeY-deficient cell lines and immunoaffinity-based protein-protein 
interaction assays. 
 
4.2 Identification of the role of YbeY in mitochondria using YbeY-deficient and 
YbeY-overexpressing cell lines 
 
4.2.1 Structural analysis of YbeY 
YbeY is not conserved in many clades of the evolutionary tree. However, it’s 
endonucleolytic function is vital in bacteria. To identify if this function is preserved in 
human YbeY, the sequence conservation of YbeY was investigated by aligning the 
amino acid sequence of the protein to that of various species using the Clustal omega 
online tool (figure 4.2.1). Previously arg59 (bacterial numbering) and a histidine triad 
(H3XH5XH) have been identified as vital for endonucleolytic activity of the bacterial 
enzyme. The sequence comparison showed that these catalytically important residues 
are conserved in humans. Then, homology modelling of human YbeY was performed 
to predict the 3D structure using the bacterial structure as a template (Figure 4.2.2A). 
The SwissDock ligand docking software was used to dock ADP into YbeY, to identify 
whether it is still capable of binding RNA, and whether the predicted site of docking 
corresponds to the catalytic site. The software output also provides an electrostatic 
surface, which showed that the catalytic cavity, where the conserved residues reside, 
has an electropositive surface (Figure 4.2.2B, blue), suitable for binding the negatively 
charged nucleic acid backbone. The software provides a large number of candidate 
sites where the ligand may bind the protein surface. The first 50 probable docking 
configurations were modelled on the protein surface (Figure 4.2.2C). The top 49 
docking configurations of ADP were found to be within the catalytic site. This 
indicated the human YbeY contains a conserved RNA binding pocket similar to the 
bacterial protein.  
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Figure 4.2.1 Sequence alignment of YbeY. 
The YbeY amino acid sequences for various species were aligned using the Clustal 
Omega online tool (www.ebi.ac.uk/Tools/msa/clustalo). The catalytically-important 
RNA-binding arginine and the zinc ion binding H3XH5XH motif are highly 
conserved and indicated with a red box and an asterisk.  
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Figure 4.2.2 Structural analysis of Human YbeY (A) Homology modelling of YbeY using E. coli 
YbeY as a template (PDB: 1XM5). Blue, human YbeY; grey, bacterial YbeY; red, catalytically 
important residues; green, zinc ion. Homology modelling was performed using Swiss-Model homology 
modelling server and visualised using PyMol. (B) Most probable ADP docking site in homology 
modelled human YbeY with catalytically important residues identified. The protein is colour based on 
electrostatic surface charge. Blue, electropositive; red, electronegative; dark grey, neutral. Docking 
analysis and electrostatic surface charge analysis was performed using the SwissDock web service (C) 
50 most probable ADP docking sites on the YbeY surface as calculated by the SwissDock web service. 
The docking models were visualised using Chimera.  
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4.2.2 Localisation of YbeY in the cell   
Mitochondrial localisation prediction compendia such as MitoCarta2.0 and 
MitoMiner 4.0, had already predicted the localisation of YbeY in the mitochondria 
(Calvo et al., 2016, Smith and Robinson, 2016). Additionally, in silico analysis of the 
N-terminus of the protein was used to assess subcellular localisation of a protein to the 
mitochondria. This method looks for a consensus sequence, also called the 
mitochondrial targeting sequence, which composes of amphipathic a-helices and 
targets the protein for mitochondrial import. There are two variants of YbeY 
produced by alternative transcription start sites (Genbank Accession number: 
BC022828). However, only transcript 1 produces a protein with the catalytic site (see 
Section 4.2.1). Bioinformatic analysis of the N-terminal sequence of the YbeY protein 
produced from transcript 1 showed a high probability of mitochondrial localisation 
(Table 4.1).  
 
 Probability of mitochondrial localisation 
Predotar 87% 
TargetP 86.2% 
Mitoprot II 95.8% 
 
Table 4.2.1 In silico analysis of mitochondrial localisation of YbeY. Analysis of the probability of 
mitochondrial localisation was performed using Predotar (Small et al, 2004), TargetP (Emanuelsson 
et al., 2000) and Mitoprot (Claros and Vincens, 1996), by analysing the composition of the N-
terminus of the protein. 
 
To analyse this prediction experimentally, YbeY cDNA was cloned into a 
pcDNA5/FRT/TO flag/strep2 plasmid, transiently transfected into HeLa cells. 
Upon fixing, cells were subjected to ICC, using antibodies against the flag epitope to 
detect YbeY (anti-mouse secondary, green). Antibodies against mitochondrial outer 
membrane translocase, TOM20 were used to label mitochondrial membranes (red). 
Overlap of the red and green signal is visualised as yellow. This shows co-localisation 
of the YbeY signal in the mitochondria (Figure 4.2.3A).  
Then, to assess if the protein co-localises within mitochondrial RNA granules (MRGs) 
within the mitochondria, immunocytochemistry was performed using antibodies 
against GRSF1 to label MRGs (Antonicka et al., 2013). MRGs appear as distinct 
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puncta whereas YbeY seems to be distributed throughout the mitochondria (Figure 
4.3B). This showed that YbeY is exclusively localised in the mitochondria and not 
found in MRGs. 
 
Figure 4.2.3 Immunocytochemistry of YbeY. Flag-tagged YbeY was transiently expressed in Hela cells 
and visualised using anti-flag antibodies (goat anti-mouse IgG, Alexa fluor 488, green, left). (A) The 
mitochondrial network was stained using antibodies against mitochondrial outer membrane translocase, 
TOM20 (goat anti-rabbit, Alexa fluor 594, red, middle). Co-localisation of YbeY and TOM20 is 
shown in yellow (right). (B) RNA granules were stained using antibodies against GRSF1 (red, 
middle). The digitally merged image does not show distinct yellow puncta that would indicate co-
localisation of GRSF1 and YbeY in RNA granules (yellow, right). White scale bar at the bottom 
right indicates 10 µm. Immunocytochemistry and microscopy was performed by Pedro Guiomar.  
 
The subcellular localisation of endogenous YbeY antibody was also analysed using 
western blotting of subcellular fractions of HEK293T cells. Homogenisation and 
centrifugation was used to isolate nuclear, cell debris, cytosolic and mitochondrial 
fractions. An additional Proteinase-K treatment was used to degrade proteins bound 
to the exterior of the mitochondria. Proteins in the mitochondrial fraction, that are 
resistant to Proteinase-K treatment, can be inferred to be in the mitochondrial matrix. 
Antibodies were used against cytosolic GAPDH, outer membrane translocase 
	136	
TOM22, inner mitochondrial complex I component, NDUFS1, and endogenous 
YbeY. TOM22, NDUFS1 and YbeY, but not GAPDH, were enriched in the 
mitochondrial fractions. Both NDUFS1 and YbeY show resistance to Proteinase K 
treatment indicating that the proteins are localised within the mitochondrial matrix 
(Figure 4.2.4). 
 
 
Figure 4.2.4 Localisation of YbeY in Subcellular fractions. Subcellular fractions of HEK293T cells 
were isolated and assessed using western blot. Antibodies were used to against endogenous YbeY and 
various protein markers for the subcellular fractions, namely, GAPDH (cytosol), TOM22 (outer 
membrane), NDUFS1 (mitochondrial matrix). T, total cell lysate; D, cell debris; C, cytoplasm; M, 
mitochondria  
 
4.2.3 Role of YbeY in Cleavage of the ATP8/6-CO3 junction in mitochondrial RNA 
precursor  
Structural analysis of YbeY showed that the catalytically important residues required 
for RNA binding (R59 in E. coli) and endonucleolytic activity (H3XH5XH motif) are 
strongly conserved in the human enzyme (Davies et al., 2010) (Figure 4.2.2A). This led 
us to postulate a role of YbeY in the processing of the non-canonical cleavage sites 
that are not catered for by the Punctuation model. There are a few of these sites in the 
polycistronic precursor, namely the ATP8/6-CO3 junction, the ND5-Cytb junction, 
the 3’ end of ND6 and the 5’ end of CO1 (Figure 4.2.5).  
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Figure 4.2.5 Non-canonical cleavage sites. RNase P and ELAC2 cleave the 5’ and 3’ ends of tRNAs 
in the polycistronic precursor molecules transcribed from the HSP and LSP. Light grey regions depict 
mRNAs and rRNAs. Dark grey regions depict tRNAs. Green regions depict immature molecules 
produced by RNase P and ELAC2 that require further maturation through non-canonical cleavage. 
Non-canonical cleavage sites are indicated with purple triangles. Regions contained within a dotted 
line are non-coding regions.  
 
To investigate if YbeY is involved in the cleavage of non-canonical mtRNA sites, 
YbeY was knocked down using siRNA and transcripts were analysed using northern 
blotting and qPCR. In preliminary experiments, an accumulation of the ATP8/6-
CO3 precursor was observed in cells transfected with siRNA and stressed with 
galactose media as the only carbon source where the cells were forced to be 
dependent on mitochondrial ATP production (Figure 4.2.6C and 4.2.6E). We 
hypothesised that growing cells in galactose media would lead to up-regulation of 
mitochondrial transcription, which would lead to an accumulation of unprocessed 
precursor transcripts due to a reduction in YbeY. No change was observed in control 
mtRNAs (16S rRNA, 12S rRNA, ND5 rRNA) (Figure 4.2.6B). However, this 
observation did not lead to defects in translation of the ATP8/6 or CO3 mRNA nor 
to changes in steady state levels of OxPhos complexes IV and V when analysed using 
western blot analysis (Figure 4.2.6D). This lack of a translational defect was attributed 
to there being sufficient YbeY in the knockdown cells to produce the required 
transcripts for mitochondrial translation. However, our preliminary hypothesis was 
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that, in mammalian mitochondria, YbeY had evolved to process the non-canonical 
cleavage sites, namely the ATP8/6-CO3 precursor transcript (Figure 4.2.8).     
 
 
Figure 4.2.6 Western blot and northern blot analysis of HeLa cells transfect with siRNA and grown 
in galactose media. (A) Western blot analyses of HeLa cells transfected with control siRNA (against 
GFP) and three different siRNAs against YbeY, probed with anti-YbeY antibody. (B) Northern blot 
probing for 16S rRNA, 12S rRNA and ND5 mRNA. (C) Northern blot analysis probing for CO3 
which also binds to the ATP8/6-CO3 precursor transcript (Northern blot analysis performed by Dr 
Joanna Rorbach). (D) Western blot analysis of the siRNA knockdown cells after 1 transfection (3 
days) and 4 transfections (12 days) with antibodies against the mitochondrial complexes. (E) qPCR 
analysis was performed on the RNA extracted from HeLa cells treated with YbeY siRNAs. Student’s 
t-test was used to determine statistical significance (n.s., not significant; ** p<0.01). qPCR reaction 
was performed by Dr Christopher Jackson  
 
YbeY endonucleolytic cleavage of RNA in bacteria leads to the formation of a 5’ 
hydroxyl and 3’ phosphate group. We speculated that this biochemical feature is 
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conserved in the human enzyme. To analyse the nature of cleavage of the ATP8/6-
CO3 precursor, we used the Terminator exonuclease that allows the phosphorylation 
state of the 5’ end of the CO3 mature transcript to be assessed. Terminator 
exonuclease degrades RNA that has a 5’-monophosphate. It is incapable of degrading 
RNA with a 5’ di/triphosphate, cap or hydroxyl group. In addition, the terminator 
assay was repeated after phosphatase treatment which would remove the 5’-
phosphates in a di/triphosphate, leaving behind a monophosphate which is 
susceptible to Terminator-mediated degradation. Dephosphorylation of the 
di/triphosphate 5’ end would then make the RNA susceptible to Terminator 
exonuclease. The RNA products were then analysed using northern blotting. A probe 
against CO1 was used as a control as it is known that it contains the 5’-
monophosphate and would be susceptible to degradation (Mercer et al., 2011).  
The CO1 mRNA and the ATP8/6-CO3 precursor transcript was degraded by the 
Terminator exonuclease confirming the presence of a 5’-monophosphate. On the 
other hand, the CO3 mRNA was not degraded by the exonuclease. In addition, 
phosphatase treatment caused some of the CO3 to be degraded by the exonuclease. 
This analysis showed that CO3 does not have a 5’-monophosphate, suggesting the 
presence of a 5’ di/triphosphate, cap and/or hydroxyl group. It seems that at least a 
small population of molecules are phosphorylated after cleavage. The 5’ end of 
ATP8/6 contains a 5’ monophosphate which is produced by ELAC2 upon excision of 
tRNA-lysine (Figure 4.2.7).  Differences observed in the degradation of CO1 and 
CO3 could also be attributed in part to secondary structure of the RNA and 
availability of the RNA to the Terminator nuclease.  
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Figure 4.2.7 Terminator assay. RNA extracted from HEK293T cells was treated with Terminator 
nuclease or with Phosphatase and Terminator nuclease. The control sample was untreated. The RNA 
was then analysed using northern blotting, probing for CO1, and CO3. Bands were quantified using 
Image J and plotted using Prism 7. Experiments performed in collaboration with Dr Christopher 
Powell. 
 
 
Figure 4.2.8 Primary hypothesis of the function of YbeY. The model shows canonical cleavage at the 
5’ and 3’ ends of tRNAs by RNaseP and ELAC2 to produce the majority of mRNAs, tRNAs and 
rRNAs in the mitochondria. YbeY may be responsible for the cleavage of the ATP8/6-CO3 precursor 
transcript, which is not punctuated by tRNAs. 
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In order to directly investigate the cleavage activity of YbeY, HEK293/FRT/TO 
Flp-In cell lines were generated in which the expression of wild-type and catalytically 
inactive (R55A) YbeY could be induced using doxycycline. Arg55 (equivalent to E.coli 
Arg59) is important for RNA binding and indispensable for endonucleolytic cleavage 
in bacteria. The recombinant YbeY contained a C-terminal flag/strep2-tag that could 
then be purified from isolated mitochondria using streptavidin beads. Elution was 
confirmed using antibodies against the flag epitope and CBB staining (Figure 4.2.9A).  
Using this purified wild-type and mutant protein, in vitro cleavage assays were 
performed using in vitro transcribed a[32P]-UTP-labelled RNA substrates. A 60 
nucleotide control sequence encoding a sequence downstream in the ATP8/6-CO3 
junction and a 70 nucleotide sequence spanning the ATP8/6-CO3 junction were 
used as substrates. This would indicate if YbeY has site-specific endonucleolytic 
activity. Furthermore, the concentration of the protein in the assay was varied from 0 
to 20 pmol to show a concentration-dependant increase in cleavage. Cleavage activity 
would have been indicated with concentration-dependant increase in smaller cleavage 
products. No junction-specific cleavage or non-specific cleavage activity of the 
endonuclease was observed (Figure 4.2.9B). YbeY is a zinc-ion dependant 
endonuclease with a conserved zinc-ion binding H3XH5XH motif required for 
catalysis. Work in Sinorhizobium meliloti showed that the catalytic activity of the 
bacterial protein was also supported by other divalent metal ions such as Mg2+, 
Mn2+, and Ca2+ (Samarago et al., 2016). Therefore, the metal ion composition of the 
reactions was changed to elucidate if this would have an effect on cleavage activity. 
However, no metal ion-specific effect on cleavage of the RNA substrates was observed 
(Figure 4.9C).  
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Figure 4.2.9 Affinity-purification of YbeY and In vitro cleavage assay. (A) HEK293T Flp-In cells 
containing wild-type (left) and catalytic mutant (R55A, right) were induced using 50 ng/ml 
doxycycline. Mitochondria were isolated and recombinant flag/strep2 – tagged protein was affinity 
purified using a streptactin column. Antibody against the flag epitope was used to detect YbeY. The 
SDS-PAGE gels were stained using coomassie Brilliant Blue stain. The prominent band in the elution 
fraction corresponds to purified YbeY-flag/strep2 protein. M - Mitochondrial fraction, B – Beads (B) 
Different concentrations (0-20 pmols) of purified recombinant protein were incubated with ~400 ng 
of radiolabelled in vitro transcribed RNA of length 60 (control, mtDNA  positions 9371-9421) and 
70 (ATP8/6-CO3 junction, mtDNA  positions 9183-9251) nucleotides. (C) The cleavage assays 
were repeated with the 70 nt RNA substrate (~400ng)  and wild-type YbeY (20 pmol) with different 
metal ions (10 mM) in the reaction. These experiments were performed in collaboration with Dr 
Thomas Nicholls. 
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4.2.4 YbeY Knockout and Complementation cell lines 
 
4.2.4.1 Knockout generation in HEK293T cells  
The results obtained from the siRNA experiments and the lack of confirmation of the 
preliminary hypothesis from in vitro experiments led us to pursue the creation of a 
knockout cell line. This would enable direct study of effects of lack of YbeY on the 
mitochondrial transcriptome, especially the non-canonical cleavage sites. Initially, 
when this was being attempted, the CRISPR-Cas9 technology was still in its infancy 
and the efficiency and specificity of the targeted DNA cleavage was still low. 
Karyotyping of the HEK293T cell line showed major rearrangements of the genome 
(see section 3.2.1). However, YbeY is positioned on chromosome 21, which showed 
no rearrangements and two or three copies of the chromosomes that needed to be 
targeted.  
Zinc-finger nucleases (ZFN) were used to target the YbeY gene. The Sigma CompoZr 
custom ZFN service provides custom designed and validated ZFN pairs for the 
required gene target. Through this, we purchased two constructs targeting the first 
exon of YbeY. The double strand breaks created by the ZFNs would induce DNA 
repair through non-homologous end joining (NHEJ) or homology directed repair 
(HDR). HDR could be used to specifically direct gene editing using a donor targeting 
construct. However, in our system, NHEJ was harnessed to introduce insertions or 
deletions (indels), which would lead to a frameshift mutation and the generation of a 
premature stop codon.  
HEK293T Flp-In cells were transfected with the ZFN vectors using lipofectamine and 
single colonies were split for freezing and screening. The protocol was the same as 
that used to produce MRM1 knockout clones in section 3.2.1. Initially candidates 
were identified using western blotting against endogenous YbeY and b-actin for 
loading. According to our preliminary hypothesis, we believe YbeY is required for 
effective production of mature transcripts. Therefore, antibodies against OxPhos 
complexes were also used to identify any other characteristics that might identify a 
potential YbeY knockout (Figure 4.2.10A).  
Of the 192 clones screened, nine clones showing a lower level or complete lack of 
YbeY were selected from this initial screen. These candidates were analysed with 
PCR which would give a product spanning the ZFN target site, and thus, the site most 
likely to contain the NHEJ-mediated mutation. The PCR reaction mix was sent for 
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Sanger sequencing. Aligning the sequence against the wild-type sequence showed 
lower consensus after the ZFN cut site in cases where indels had caused a frameshift. 
The PCR products from candidates identified in this step were cloned into a pCR4 
vector using the Zero Blunt TOPO cloning kit and multiple bacterial colonies for 
each clone were sent for Sanger sequencing. This is required because the indels 
produced by NHEJ could be different in each copy of the gene. In the case of YbeY, 
we expected to find 2-3 copies of YbeY per cell and therefore, we expected to see up 
to three different indels per clone. However, of the many clones screened, no 
complete knockout was identified with all alleles containing out-of-frame indels. 
Figure 4.2.10 shows two clones that were used for subsequent experiments.  
In clone 4, four alleles of YbeY were identified with a 4 bp insertion (allele 1), a 
deletion of 13 bp and an insertion of 1 bp (allele 2), a deletion of 8 bp (allele 3) and a 
deletion of 67 bp (allele 4). In the first two alleles, a frameshift mutation led to a 
premature stop codon. In the third allele, the indel led to an inframe frameshift 
leading to a change in 12 amino acids in the protein. In the fourth allele, a large 
deletion led to the removal of the start codon. This hemizygous clone will 
subsequently be referred to as YbeY (-/m) (Figure 4.2.10B). In this clone, preliminary 
western blotting against the respiratory complexes showed a depletion in Complexes I 
and IV. 
In clone 7, five copies of YbeY were identified. Three of these alleles (alleles 1, 2 and 
4) contained indels which led to premature stop codons which would lead to early 
termination of translation. Allele 3 contained an in frame frameshift leading to the loss 
of two amino acids from the protein. The fifth allele was not affected (Figure 4.2.10C). 
The heterozygous clone will subsequently be referred to as YbeY (+/-). The two cell 
lines were thawed and screened further using western blotting and sequencing.  
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Figure 4.2.10 Screening for YbeY knockout HEK293T cells. (A) Western blot analysis of cell lysate 
from single cell-derived clones using antibodies against endogenous YbeY, OxPhos complexes and b-
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actin. (B) PCR products containing the ZFN target site (marked in red) were TOPO cloned and 
bacterial colonies were submitted for Sanger sequencing. The sequences were aligned against the wild-
type sequence.  
 
4.2.4.2 Hap1 knockout cells  
At the same time, a YbeY knockout Hap1 cell line (Product ID: HZGHC002765c022) 
became available with a 13 bp insertion which produced a premature stop codon 
leading to an 80 amino acid truncated protein instead of the wild-type 168 amino acid 
wild-type protein. The resultant protein, if stable, would contain the catalytically 
important R55 (equivalent to R59 in the bacterial homolog), but would lack the 
H3XH5XH motif that chelates the zinc ion necessary for endonucleolytic activity.    
 
4.3.4.3 Characterisation of growth rate, OxPhos function and mitochondrial 
translation in YbeY-deficient cell lines 
Initial culturing of cells showed slower growth of the YbeY deficient HEK293T cells. 
Furthermore, the YbeY knockout Hap1 cells (YbeY (-/-)) showed rapid acidification 
of the media and higher sensitivity to media acidification than Hap1 parental cells, 
identified by the change in colour of phenol red pH indicator in the DMEM culture 
media. This indicates a strong reliance on glycolysis for ATP production and a 
resultant production of acidic lactate. The YbeY (-/-) had an extreme growth defect 
and required supplementation with 20% foetal calf serum and regular media changes. 
To determine that these defects are caused by a deficiency of YbeY, the knockout cell 
line was complemented with wild-type and H117A mutant (equivalent to H114 in the 
bacterial homolog) cDNA using lentiviral infection. The cDNA of wild-type YbeY 
and predicted catalytic H117A mutant were cloned into the pBMN vector which were 
packaged into lentivirus by Phoenix-AMPHO cells. Media from these cells were then 
filtered to remove any packaging cells and the viruses were added to the YbeY (-/-) 
cells. Hygromycin section was used to select for select for cells that successfully 
incorporated the cDNA. Interestingly, the mitochondrial translation phenotype was 
rescued by both wild-type YbeY and YbeY lacking the His117 residue predicted to be 
required for zinc sequestration and endonucleolytic activity.   
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To investigate the deficiency in oxidative phosphorylation in these cell lines, growth 
rate was measured and western blot analysis were carried out, probing for 
components of the five respiratory complexes.  
The western blot analysis of the HEK293T cell lines showed that, in the YbeY (-/m) 
cells, there was a strong reduction in steady-state levels of Complex I and IV 
compared to wild-type parental cells. This was not seen in heterozygous YbeY (+/-) 
HEK293T cells which had comparable protein levels to wild-type. On the other 
hand, Complex V and Complex II levels were not affected by reduction of YbeY 
(Figure 4.2.11A). Complex II was entirely encoded in the nucleus and its components 
were imported into the mitochondria, and can be used as a loading control. 
Therefore, this indicates that the depletion is a product of a mitochondrial translation 
defect. To investigate how reduced translation affects growth rate in these cells, rate of 
proliferation was calculated by growing 10,000 cells in a 6-well plate in high glucose 
medium (4.5 g/L DMEM) which allows ATP production using glycolysis, or 
galactose-containing medium (4.5 g/L DMEM) which forces the cell to rely on 
OxPhos for their ATP production. The parental HEK293T, YbeY (+/-) and YbeY (-
/m) cell lines showed a marked decrease in growth rate in galactose media and 
furthermore, the change in growth rates depending on presence of YbeY was similar 
in both media types. Growth rate in the YbeY (+/-) cells was partially reduced with 
reduction of YbeY, while growth in the YbeY (-/m) cells was the most inhibited 
(Figure 4.2.11B).  
Similarly, western blot analysis of components of the mitochondrial respiratory 
complexes was performed on the Hap1 cell lines. This showed a corresponding loss of 
mitochondrially-encoded OxPhos complexes I, III and IV, and a mild decrease in the 
band size for complex V. No significant change was observed in nuclear encoded 
Complex II. An antibody against mitochondrial translocase, TOM22 was used as a 
loading control. However, upon complementation of the knockout cell line with 
constitutively expressed wild-type and H117A mutant transgene, the phenotype is 
rescued. Surprisingly, the introduction of YbeY with a mutation that is predicted to 
inhibit catalytic activity does not prevent rescue of translation in the mitochondria. 
This indicates that its endonucleolytic cleavage is not its primary function and is not 
necessary to rescue mitochondrial translation. Anti-YbeY antibody was used to probe 
for YbeY. Furthermore, despite having been completely rescued, the YbeY antibody 
could not bind as effectively to the mutant YbeY as the wild-type, suggesting a 
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possible change to protein structure and the antibody’s epitope, or a difference in 
expression levels upon transfection (Figure 4.2.11C).  
In addition to this, proliferation in the knockout cells was assessed using the Incucyte 
system that measures changes in cell confluence. The cells were plated at 10% 
confluence in wells of a 6-well plate, in high glucose and glutamine IMDM media 
with 20% fetal calf serum. In this medium, the knockout cells displayed extremely 
limited growth (Figure 4.2.11D). To further investigate the reliance of the knockout 
cells on glycolysis, the cells were also grown in varying concentration of glucose and 
galactose containing DMEM media with 20% fetal calf serum. However, the parental 
Hap1 cells showed a strong reduction in growth rate in the DMEM media 
independent of the glucose concentration, and the YbeY (-/-) cells showed a loss of 
viability in this growth media (Figure 4.2.11E). It seems that DMEM media is not 
conducive to the growth of Hap1 cells. A repetition of the experiment with galactose-
containing IMDM media was not financially justifiable as the effect in high glucose 
media was very strong.  
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Figure 4.2.11 Characterisation of the HEK293T and Hap1 cells with depleted YbeY. (A) Total cell 
lysate of the HEK293T parental cells, heterozygous (+/-) and hemizygous (-/m) cell lines were 
analysed with western blotting. The membrane was probed with anti-OxPhos and anti-YbeY 
antibody. Complex II antibody functions as a loading control in this blot. (B) 10,000 cells of the 
various HEK293T cell lines were plates in wells of a 6 well plate in high glucose (Glc) and galactose 
(Gal) medium. Growth rate, indicated by change in confluence, was measured using the Incucyte HD 
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and graphs were plotted using Prism 7.  (C) Total cell lysate of the Hap1 parental, knockout (-/-), 
wild-type-complemented knockout and mutant-complement knockout cell line were analysed via western 
blotting. The membrane was probed with anti-OxPhos and anti-YbeY antibody. Anti-TOM22 was 
used as a loading control. A faint band is also observed in the YbeY(-/-) cell line which we believe to 
be a non-specific band.  (D) 10,000 cells of the Hap1 parental and knockout cell lines were plated in 
wells of a 6 well plate in high glucose and glutamine IMDM media containing 20% FBS. As above, 
confluence was measured using Incucyte HD and plotted using Prism 7. (E) Hap1 cells were plated 
and measured as in (D). However, the cells were plated in DMEM media with 20% FBS with 
galactose media or increasing concentrations of glucose (0.15, 0.75, 1.5, 3 and 4 g/L) 
 
4.2.4.4 Measuring cellular respiration of cells with perturbed YbeY expression 
Due to the strong effect of YbeY depletion on translation and growth of Hap1 cells, 
OxPhos function was directly assessed using microscale oxygraphy. Oxygen 
consumption rate (OCR) was measured using an Extracellular Flux Analyzer upon 
sequential injection of ATP synthase inhibitor, Oligomycin, mitochondrial uncoupler, 
Bam15, and Complex I and III inhibitors, Rotenone and Antimycin A. In YbeY (-/-) 
cells, baseline oxygen consumption was incredibly low, suggesting a near complete 
lack of mitochondrial oxidative phosphorylation to generate ATP (Figure 4.2.12B).  
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Figure 4.2.12 Oxygen consumption rate in Hap1 YbeY (-/-) cells. 60,000 cells of control and 
knockout cells were plated onto XF96 cell culture microplates in 20% FCS containing IMDM 
media, 4 hours before the media was replaced with low buffered DMEM so that the cells could adhere 
to the plate. Using the XF96 Extracellular Flux Analyzer, wells were sequentially injected with 
Oligomycin (2 µM), Bam15 (2µM) and Antimycin A and Rotenone (1 µM). Oxygen consumption 
rate was measured before and after the introduction of the inhibitors. Error bars = SEM, n=46. 
Experiments were performed in collaboration with Dr Hannah Bridges.  
 
4.2.4.5 Assessing effects of YbeY depletion on mitochondrial translation using 35S 
labelling  
The effect of YbeY knockout on mitochondrial translation was further assessed using 
in vivo incorporation of [35S]-methionine into newly synthesised mitochondrially 
encoded proteins. After incubating the cells in media lacking methionine and 
containing non-competitive cytoplasmic translation inhibitor, emetine, for 30 minutes, 
radiolabelled methionine was added to the media. In this manner, any nascent 
peptide would contain would be radiolabelled. The cells were then lysed, the 
membrane solubilized with detergent and the protein was run on a SDS-PAGE gel. 
Coomassie Brilliant Blue staining was used as a loading control. The gel was dried 
and the proteins were then visualised using autoradiography. The assay demonstrated 
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a global mitochondrial translation defect with no visible translation product after 30 
minutes of incubation with radiolabelled methionine (Figure 4.2.13A). When the 
experiment was performed with the HEK293T parental, YbeY (+/-) and YbeY (-/m) 
cell lines, an intermediate translation defect was observed in the hemizygous clone, 
suggesting a dose-dependent effect of YbeY depletion (Figure 4.2.13B).  
To confirm that the loss of translation is mitochondria-specific, the experiment was 
repeated without any inhibitor or with chloramphenicol (CAP), a competitive 
inhibitor of mitochondrial translation. The latter required that the cells be incubated 
in CAP for 22 hours before [35S]-methionine could be introduced, with the rest of the 
protocol being the same as above. This experiment showed that without any 
inhibitors, the profile of labelled proteins is the same in the control and the knockout 
cells. This indicated that 35S-methioinine import into the cell and incorporation into 
cytoplasmic translation products is not impaired. However, in the cells in which only 
mitochondrial translation was inhibited with CAP, the control cells showed a much 
higher incorporation rate. This can be attributed to the detrimental effects of 
inhibiting mitochondrial translation over a long period of time in already defective 
YbeY (-/-) cells. Predictably, inhibiting both cytoplasmic and mitochondrial 
translation led to a complete lack of newly synthesised proteins being produced, 
confirming efficiency of inhibition (Figure 4.2.13C). 
Western blot analysis suggested that mitochondrial translation is not completely 
ablated in YbeY knockout cells (Figure 4.2.11B). Therefore, to assess the rate of 
translation in the knockout cells further, a time course experiment was carried out 
where the cells were incubated in [35S]-methionine for longer periods of time. This 
was carried out to a maximum of two hours. In this time, the intensity of the protein 
profile did not reach the levels in the control Hap1 cells suggesting that either the 
turnover of the proteins is higher in the knockout cells or that production of the 
proteins is strongly reduced (Figure 4.2.13D). Overall, this global effect on 
mitochondrial translation also contradicts the initial hypothesis of ATP8/6-CO3 
RNA cleavage by YbeY.   
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Figure 4.2.13 [35S]-methionine labelling of newly synthesised mitochondrial translation products in 
YbeY deficient cells. (A, B) The Hap1, YbeY (-/-), HEK293, YbeY (+/-) and YbeY (-/m) cells 
were incubated in cytoplasmic inhibitor, emetine, for 30 minutes before the addition of the 
radiolabelled methionine. After 30 minutes, the cells were lysed with 0.1 % DDM and 0.1 % SDS 
and 30 µg of protein were resolved on a 10-20% Tris-glycine SDS-PAGE gel. Coomassie Brilliant 
Blue staining was used as a loading control. The gel was dried, exposed to a storage phosphor screen 
and scanned using a Typhoon imager. (C) The experimental methodology was the same as in (A, B) 
but in the case of the chloramphenicol (CAP) treatment, the cells were incubated with CAP for 22 
hours prior to the introduction of [35S]-methionine. (D) The experimental methodology is the same as 
in (A, B) but the time of incubation with the radiolabelled methionine is increased in the difference 
samples in 30 min intervals for up to 3 h. Coomassie Brilliant Blue staining was used as a loading 
control. 
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4.2.5 Effect of YbeY knockout of the mitochondrial transcriptome 
 
4.2.5.1 Assessing cleavage products of ATP8/6-CO3 non-canonical cleavage in 
YbeY-deficient cells 
Cells lacking YbeY showed a strong translation phenotype. Therefore, to identify the 
cause of the severe defect, we analysed the mitochondrial transcriptome to see if the 
translational defect is caused by a deficiency in the maturation of the transcriptome. 
Initially, we looked to investigate the preliminary hypothesis of YbeY’s role in the 
endonucleolytic cleavage of the ATP8/6-CO3 non-canonical junction. In both the 
HEK293T cell lines (Figure 4.2.14A) and the Hap1 cell lines (Figure 4.2.14B), 
northern blot analysis showed no increase in the ratio of the precursor to the mature 
transcript. Indeed, in the Hap1 YbeY (-/-) cell lines a decrease in precursor molecule 
was observed. This was analysed using probes for both CO3 and ATP8/6. 
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Figure 4.2.14 Northern blot analysis (top) and quantification (bottom) of the ATP8/6-CO3 
precursor transcript in YbeY deficient cells. 4 µg of RNA extracted from control, YbeY (+/-) and 
YbeY (-/m) HEK293T cells (A), and control and YbeY (-/-) Hap1 cells (B) were run on a 1.2% 
agarose gel containing 1x MOPS and 3% formaldehyde. α[32P]-labelled probes complementary to the 
ATP8/6 or CO3 mRNAs were used for northern blotting. Quantification was performed using image 
J and graph were plotted using Prism 7.  
 
Next, we analysed mitochondrial rRNAs and mRNAs using northern blotting to 
identify potential changes in steady-state levels on the mature transcripts. A mild 
decrease in 12S SSU rRNA and no substantial change in 16S LSU rRNA was 
observed. In the coding regions, mRNAs for ATP8/6, CO2 and CO3 showed no 
substantial change. The ND3 mRNA, ND5 mRNA, the ATP8/6-CO3 precursor 
(RNA14) and the 16S+Leu(UUR)+ND1 precursor (RNA19) showed a decrease in 
abundance. An increase was only observed in ND1, ND2 and CytB mRNAs. This has 
been previously observed in cells with deficient RNA metabolism (Metodiev et al., 
2009; Pearce et al., 2017) and is thought to be a mitochondrial compensatory 
mechanism. 5S RNA was used a loading control (Figure 4.2.15). Despite these 
observed changes in mitochondrial RNA levels, the changes are not large enough to 
justify the severe and global reduction in mitochondrial translation. 
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Figure 4.2.15 Northern blot analysis of mitochondrial mRNAs in the absence of YbeY. 4 µg of RNA 
extracted from parental and YbeY (-/-) Hap1 cells were run on a 1.2% agarose gel containing 1 x 
MOPS and 3% formaldehyde. α[32P]-labelled probes complementary to mitochondrial rRNAs and 
mRNAs were used for northern blotting. Probes against 5S cytoplasmic rRNA were used as a loading 
control. Quantification was performed using image J and graph were plotted using Prism 7. Error 
bars (SEM) are plotted for experiments where n>=2. 
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4.2.5.2 Northern blot analysis of mitochondrial tRNAs in YbeY (-/-) cells 
Next, potential changes in abundance of mitochondrial tRNAs were analysed using 
northern blotting. All the tRNAs tested, except for mt-tRNASer(AGY) showed no change 
in steady state levels. In the northern blot, mt-tRNASer(AGY) is observed as two peaks. 
The lower band showed no change in intensity. However, the higher band is 
substantially reduced in the YbeY (-/-) cells (Figure 4.2.16).  
 
 
Figure 4.2.16 Northern blot analysis of mitochondrial tRNAs. 1 µg of RNA extracted from isolated 
mitochondria from parental Hap1 and YbeY (-/-) Hap1 cells were run on a high-resolution 
polyacrylamide gel. α[32P]-labelled probes complementary to the tRNAs were used for northern 
blotting.  
 
4.2.5.3 Determining the status of RNA processing in YbeY knockout cells 
The bacterial homolog of YbeY is responsible for the processing of the 5’ and 3’ 
termini of the SSU rRNA (16S in bacteria) and the maturation of the 5’ end of 
bacterial 23S LSU rRNA and 5S rRNA molecules (Davies et al., 2010). However, 
these functions are not required in mammalian mitochondria as transcribed spacers 
do not need to be processed from mitochondrial rRNA. Moreover, due to the strong 
conservation of the RNA binding and endonucleolytic activity amino acids, we 
employed circularisation RT-PCR to determine if YbeY is associated with correct 
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processing or maturation of mtRNAs. Northern blotting showed minor effects of the 
absence of YbeY on the steady state levels of the two mitochondrial rRNAs (Figure 
4.2.15). In circularisation RT-PCR, RNA from isolated mitochondria were purified, 
circularized and reverse transcribed across the junction formed by the ligated 3’ and 
5’ ends. PCR was used to amplify the junction, which was then cloned into a pCR 
4Blunt TOPO vector and analysed by Sanger sequencing. It must be noted that the 
data is limited by the size of the primer and any misprocessed tRNA that was smaller 
that the size of the two primers would not be detected. Moreover, since the ligation 
step is performed at 37oC, ligation would be biased towards incorrectly processed 
RNAs with weaker secondary structure that are more susceptible to melting than the 
correctly processed tRNAs and rRNAs with stronger secondary structures (Zhuang et 
al., 2012). The size and composition of the mt-tRNAs also skews the efficiency of the 
PCR reactions. Hence, the number of clones analysed for each mt-tRNA varied 
substantially. In this experiment, no significant difference between parental Hap1 and 
YbeY (-/-) cells was observed in the lengths of the tRNAs Ile, Gln and Leu(UUR) 
(Figure 4.2.17A). However, only 0.71% (2 out of 192) of the Ser(AGY) tRNAs were 
correctly cleaved from the primary transcript along with the correct addition of the 3’ 
CCA in YbeY (-/-) cells, compared to 85% in the control (Figure 4.2.18B). Alignment 
of the 5’ ends showed a preference for cleavage at the 12th and 14th nucleotide from 
the 5’ end with only 20.4% correctly processed, and alignment of the 3’ end showed a 
lower number of the tRNASer(AGY) molecules (63.7%) with correctly processed ends 
compared to the parental Hap1 control cells (Figure 4.2.18A).  
No significant changes in the lengths of the 12S (expected size of 955 nucleotides) and 
16S (expected size of 1559 nucleotides) mitochondrial rRNA was observed (Figure 
4.2.17 A, B). Interestingly, a large number of 16S rRNA molecules were 4 nucleotides 
larger than expected with the 3’ end, 4 nucleotides into the Leu(UUR) tRNA 
sequence, as previously described in Pearce et al. (2017). As rRNA lengths are not 
affected by the absence of YbeY, this suggests that even though the residues required 
for endonucleolytic activity are conserved, the bacterial function of YbeY in cleavage-
based processing of ribosomal RNA are not conserved. 
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Figure 4.2.17 Circularisation RT-PCR to assess changes in RNA processing upon YbeY knockout. 
RNA from isolated mitochondria from Hap1 parental and YbeY knockout cells were circularised and 
the 5’ and 3’ ends were analysed using RT-PCR and Sanger sequencing. (A) The analysis was 
performed for mt-tRNAsLeu(UUR), mt-tRNAIle, mt-tRNAGln, mt-tRNASer(AGY), and the 12S and 16S 
mt-rRNAs. Analysis of significance was calculated using Fisher’s exact test. N=above bar graphs, 
****p<0.0001 (B) The lengths of the 16S and 12S were measured and plotted in a box and 
whisker plot using Prism 7. The lines indicate the minimum and maximum values. The edges of the 
box indicate the upper and lower quartile. The middle line indicates the median. Number of data 
points are written above the box and whiskers plot. Significance was calculated using an unpaired 
Student’s T-test (n.s., not significant). 
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Figure 4.2.18 Analysis of the processing of 5’ and 3’ ends of tRNASer(AGY) (A) Mapping the 5’ and 
3’ ends to the wild-type sequence of tRNASer(AGY) in Hap1 parental and YbeY (-/-) cells. The 
sequencing results obtained from the circularisation RT-PCR were analysed manually. The 5’ and 3’ 
ends were deduced from the sequenced PCR products and mapped against the wild-type sequence. The 
5’ and 3’ ends were plotted independently as a percentage of the total 5’ reads and 3’ reads 
respectively. (B) Proportion of tRNASer(AGY) that are correctly cut at the primary transcript and with 
the correct addition of CCA at the 3’ end. The graphs were plotted using Prism 7.  
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4.2.5.4 Analysis of the mitochondrial transcriptome using RNA-Seq in YbeY deficient 
HEK293T cells 
 
Since, in mitochondrial YbeY, the residues required for endonucleolytic activity are 
conserved, the effect of YbeY knockout on the transcriptome was investigated. 
Compared to northern blot analysis done previously, deep sequencing provided a 
high-throughput comprehensive analysis of the mitochondrial transcriptome, 
including non-coding regions. To do this, mitochondria were isolated from parental 
HEK293T, YbeY (+/-) and YbeY (-/m) cells and RNA was extracted. The mt-RNA 
was treated with RiboZero Gold to remove the highly abundant mitoribosomal rRNA 
which drowns out the signal from other less abundant RNAs. Illumina TruSeq 
Stranded RNA libraries were prepared and deep sequencing was performed.  Since 
YbeY may be associated with RNA endonucleolytic processing, conventional 
alignment would discard any reads that do not align at the 5’ and 3’ ends. Therefore,  
the mapped reads were aligned against the mitochondrial genome giving higher 
priorities to alignment of the sequence to the interior of the genes. This was to avoid 
discarding reads produced from misprocessed ends. Finally, the sequencing reads 
corresponding to RNA molecules produced from the heavy and light strand were 
separated. 
Firstly, we compared the four non-canonical junctions (marked with a dotted red line) 
at the 5’ end of CO1 (Figure 4.2.19A), between ND5 and CytB (Figure 4.2.19B), 
between ATP8/6 and CO3 (Figure 4.2.19C), and the 3’ end of ND6 (within ND5 
antisense) as presented schematically in Figure 4.2.5. The dips in the graphs marking 
the sites of cleavage (marked with a dotted line). Due to mitochondrial isolation before 
RNA extraction and ribozero Gold treatment to remove rRNA, comparison of reads 
can only be made between the mt-mRNAs and mt-tRNAs. This only gives a 
comparison of abundance of one RNA relative to the another. No significant 
differences were observed in the cleavage of these molecules at the non-canonical 
cleavage sites (Figure 4.2.19). 
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Figure 4.2.19 RNA-Seq of RNA spanning the non-canonical cleavage junction encoded in the heavy 
and the light strand. Mitochondrial RNA from extracted from parental HEK293, YbeY (+/-) and 
YbeY (-/m) cells, rRNA was depleted using RiboZero Gold, a library was prepared and deep 
sequenced using the Illumina MiSeq platform. The sequencing reads were aligned against the 
mitochondrial genome. The cleavage sites are delineated with dotted lines. Non-canonical cleavage sites 
are marked with a red dotted line.Three biological repeats were performed for each cell line. 
Bioinformatic analysis was performed by Dr Lindsey Van Haute. (A) 5’ end of CO1, (B) 5’ of CytB 
(C) ATP8/6-CO3 junction (D) 3’ end of ND6  
 
Comparison of relative abundance of the various mature transcripts showed that the 
lack of YbeY had the strongest effect on certain mt-tRNAs. All the effects described 
below were most noticeable in the YbeY (-/m) cells but not in the YbeY (+/-) cells. 
This was similar to the phenotype observed in YbeY (-/m) cells in the [35S]-
methionine incorporation assay and western blotting. Hence, the YbeY (+/-) cells 
could be assessed as another control for comparison as the amount of wildtype YbeY 
protein present in this cell line in sufficient to maintain a healthy cell. Since the 
strongest effect was observed with tRNASer(AGY), which is found between two tRNAs 
tRNAHis and tRNALeu(UUR), tRNAs not immediately flanked by two mRNAs were 
studied to see if YbeY is required for their maturation.  Assessment of RNAs produced 
from the heavy strand showed a strong reduction in RNA-Seq read coverage for mt-
tRNAIle and tRNAMet (Figure 4.2.20A), and mt-tRNAPhe (Figure 4.2.20D) and a 
smaller decrease in mt-tRNAHis, mt-tRNASer(AGY) and mt-tRNALeu(CUN) (Figure 
4.2.20C). The number of reads spanning the region covering tRNATrp was very low. 
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Therefore, any conclusion made about tRNATrp cannot be made with a much 
certainty (Figure 4.2.20B).  
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Figure 4.2.20 RNA-Seq of mtRNAs encoded in the heavy strand. Mitochondrial RNA was extracted 
from parental HEK293T, YbeY (+/-) and YbeY (-/m) cells, rRNA was depleted using RiboZero 
Gold, a library was prepared and deep sequenced using the Illumina MiSeq platform. The sequencing 
reads were aligned against the mitochondrial genome. Three biological repeats were performed for each 
cell line. Bioinformatic analysis was performed by Dr Lindsey Van Haute. The separate genes are 
delineated with dotted lines. (A) mt-tRNAs between ND1 and ND2 (B) tRNATrp (C) mt-tRNAs 
between ND4 and ND5 (D) tRNAPhe 
 
Mitochondrial tRNAs encoded by the light strand were also assessed. This showed 
lower read coverage for mature tRNAGlu and CytB mRNA relative to ND6 (Figure 
4.2.21A). However, since this method of evaluating abundance is qualitative and 
requires comparison with adjacent regions, this could also be caused by a relative 
increase in ND6 levels. Moreover, tRNAAsn and tRNAAla also show a relative decrease 
(Figure 4.2.21B). The tRNAs for Tyr, Cys (Figure 4.20B) and Gln (Figure 4.2.21C) 
showed no marked difference between the control HEK293T cells and the cells with 
depleted YbeY levels.  
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Figure 4.2.21 RNA-Seq of mtRNAs encoded in the light strand. Mitochondrial RNA from extracted 
from parental HEK293T, YbeY (+/-) and YbeY (-/m) cells, rRNA was depleted using RiboZero 
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Gold, a library was prepared and deep sequenced using the Illumina MiSeq platform. The sequencing 
reads were aligned against the mitochondrial genome. Three biological repeats were performed for each 
cell line. The separate genes are delineated with dotted lines. Bioinformatic analysis was performed by 
Dr Lindsey Van Haute. (A) tRNAGlu (B) tRNATrp to tRNACys (C) tRNAsIle to tRNAMet 
 
Finally, analysis of other non-coding regions in the mitochondrial transcriptome 
showed a large decrease in the abundance of ncRNA located in the D-loop (pre-
tRNAPhe) in the YbeY-depleted cells. These reads map to the region corresponding to 
the 7S RNA species transcribed from the L-strand, required for mitochondrial DNA 
replication (Crews et al., 1979).  (Figure 4.2.22). This implies that YbeY may play a 
role in stability of the 7S RNA and thus may have knock-on effects on DNA 
replication. 
 
 
 
Figure 4.2.22 RNA-Seq of the D-loop region or RNA transcribed from the L-strand. Mitochondrial 
RNA from extracted from parental HEK293, YbeY (+/-) and YbeY (-/m) cells, rRNA was 
depleted using RiboZero Gold, a library was prepared and deep sequenced using the Illumina MiSeq 
platform. The sequencing reads were aligned against the mitochondrial genome. The 5’ end of 
antisense tRNAPhe is marked with a dotted line. Three biological repeats were performed for each cell 
line. Bioinformatic analysis was performed by Dr Lindsey Van Haute.  
 
Transcriptomic analysis of HEK293T cells with depleted YbeY showed a depletion of 
specific RNA molecules, especially tRNASer(AGY). The decrease in steady state levels of 
tRNASer(AGY) was also observed in northern blotting. This loss of tRNASer(AGY) may be 
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the cause of the effect on global mitochondrial translation. The small amounts of the 
tRNA observed in northern blots and the RNA-seq data would lead stalling of 
translation. However, previous work has shown that stalling of translation affects 
larger translation products more than the smaller translation products (Pearce et al., 
2017). This is observed in the [35S] in vivo translation assay performed on the YbeY 
deficient HEK293T cell lines, however, other causes of translational failure were 
investigated in YbeY-deficient cells.   
 
4.2.5.5 Analysis of mtDNA copy in YbeY (-/-) cells 
As there is a strong depletion of RNA transcribed from the light strand corresponding 
to the 7S RNA in YbeY (-/m) HEK293T cells, the mtDNA copy number in the 
knockout Hap1 cells was compared to the control cells. We assumed that the effect on 
7S RNA abundance is a result of YbeY depletion. This could identify any 
repercussions of 7S RNA depletion on mitochondrial DNA replication (figure 4.2.23). 
We showed that in YbeY (-/-) Hap1 cells, there is no difference in mtDNA copy 
number as compared to Hap1 parental control cells.  
 
 
Figure 4.2.23 Quantitative real-time PCR of control Hap1 parental and YbeY (-/-) Hap1 cells was 
performed to determine mtDNA copy number. N =3. The qPCR experiment was performed by Dr 
Lindsey Van Haute. 
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4.2.5.6 Analysis of the mitochondrial ribosome in the absence of YbeY 
As described earlier, the translation defect that affects all mtDNA-encoded OxPhos 
subunits could not be completely attributed to a deficiency in RNA processing and a 
decrease in tRNA steady state levels. Therefore, in order to identify if the loss of 
translation is caused by the deterioration of the translation apparatus, the integrity of 
the mitochondrial ribosome was investigated using a 10-30% isokinetic sucrose 
gradient. This involved resolving a cell lysate using the sucrose gradient, and 
separating the protein components in 100 µl fractions in a SDS-PAGE gel and 
analysing the profile of mt-LSU (MRPL3) and mt-SSU (MRPS17) proteins using 
western blotting. An increase in levels of assembled mt-LSU was observed for the mt-
LSU subunit (fractions 7- 11) and potentially a small decrease was observed in the mt-
LSU present in the monosome (fractions 11-13) in YbeY (-/-) cells. This accumulation 
of assembled mt-LSU was potentially caused by a stalling of monosome assembly in 
YbeY-deficient cells. However, a much stronger effect was seen in the small subunit in 
the knockout cells. In the absence of YbeY, the amount of free mt-SSU protein is 
increased, and a sharp reduction in assembled small subunit and mt-SSU in the 
monosome was observed (Figure 4.2.24).    
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Figure 4.2.24 Analysis of mitochondrial ribosome upon YbeY knockout. Mitoribosomal subassemblies 
in 750 µg of cell lysate were resolved using 10-30% (v/v) isokinetic sucrose gradient fractionation. 
Fractions were then analysed using western blotting. (A) Antibodies against MRPL3 were used to 
identify the mt-LSU. (B) Antibodies against MRPS17 were used to identify the mt-SSU. Bands were 
quantified using Image J and plotted as a proportion of total protein using Prism 7. 
 
The decrease in mt-SSU integrity indicated that YbeY is involved in mitoribosomal 
biogenesis. Various mitoribosomal biogenesis factors show interaction with rRNA, 
assembled subunits or monosomes depending on stage at which they assist 
mitoribosomal biogenesis. Therefore, sucrose gradient-fractionated mitoribosomes 
were probed for endogenous YbeY using western blotting (figure 4.2.25). This showed 
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that YbeY does not interact with the large or small subunit. This may be because 
YbeY only interacts transiently, weakly or indirectly with the assembling ribosome.  
 
 
 
Figure 4.2.25 Analysis of YbeY interaction with the mitochondrial ribosome. 750 ug of isolated 
mitochondria from Hap1 cells were separated using 10-30% (v/v) isokinetic sucrose gradient 
fractionation. 100 µl fractions were then analysed using western blotting. Antibodies against 
MRPL12 were used to identify the mt-LSU. Antibodies against MRPS18b were used to identify the 
mt-SSU. Antibodies against endogenous YbeY were used to identify YbeY. 
 
To quantitively assess changes in composition and the stability of the mitoribosome in 
YbeY (-/-) cells, we used quantitative - gradient fractionation – mass spectrometry 
(qGFMS). This involves growing the control and knockout cells in SILAC media, 
mixing them in equal proportion and isolating mitochondria. The mitochondria are 
then lysed and the ribosomal subassemblies are resolved using 10-30 % isokinetic 
sucrose gradient density fractionation. 100 µl fractions are extracted and run into a 4-
12 % bis-tris gel. These are stained with Coomassie Brilliant Blue and the stained 
protein bands are extracted and analysed using mass spectrometry. The proteins from 
the two cell lines are resolved by identifying heavy or light stable isotope labelling. 
Peptides common to both samples are identified and intensity of detection is measured 
for each fraction. The maximum intensity for each protein in the two samples is 
marked as the maximum value and the remaining intensity profile is scaled 
proportional to this value. The profile is then coloured from black to red 
corresponding to the increasing intensity. Each row signifies a different mitoribosomal 
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component. However, the intensity profiles can only be qualitatively compared 
between different proteins. This is because different proteins have different ionisation 
properties and thus their detection is not a function of their abundance. Therefore, 
the intensity profiles cannot be used to infer stoichiometry. 
 
Analysis of mitoribosomal integrity using qGFMS showed that, similar to the western 
blots and northern blot analysis of 12S rRNA, the large subunit was more abundant 
and the small subunit was less abundant in the YbeY knockout cells (Figure 4.2.26 
and Figure 4.2.27). However, the monosomal peak was lower for both the mt-LSU 
and mt-SSU in the YbeY (-/-) sample. A comparison of the ratio of free assembled 
subunit to the monosome showed that for both mt-LSU and mt-SSU, there is a larger 
proportion of subunit that is not assembled into the monosome (Figure 4.2.27).  
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Figure 4.2.26 Mitochondria from parental Hap1 and YbeY (-/-) cells, grown in heavy and light 
SILAC media respectively, were isolated and the lysates were separated using a 10-30% isokinetic 
sucrose gradient. Fractions were analysed using mass spectrometry. A heatmap was generated from the 
intensity of detection of peptides common to both samples with the red value containing maximum 
proportion of the peptide between the two samples. Each row depicts the abundance profile of a 
different mitoribosomal protein. This experiment was performed in collaboration with Pedro Giuomar 
and Mike Harbour.  
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Figure 4.27 Proportion of protein components in subunits relative those found assembled in 
monosomes. (A) The total abundance of the MRPs was calculated from the quantitative sucrose 
gradient fractionation-mass spectrometry results shown in Figure 4.26, for the unbound mt-LSU 
(fractions 8-10), unbound mt-SSU (fractions 6-8) and monosome (fraction 12). (B) The proportion 
of free subunit to assembled monosome was calculated for the Hap1 parental and YbeY (-/-) cells, 
and plotted using Prism 7. N=2 
 
The decrease in mitoribosomal SSU integrity might explain the strong reduction in 
mitochondrial translation that affects all mtDNA-encoded OxPhos subunits. 
However, how YbeY affects ribosomal biogenesis was unclear. Since, translation in 
YbeY (-/-) cells are completely restored upon complementation with the mutant 
protein predicted to lack endonucleolytic activity, it stands to reason that 
endonucleolytic activity may not be required for its ribosome-associated function. In 
addition, the loss of tRNASer(AGY) steady state levels may be a contributing factor to 
the loss of mitochondrial translation. Therefore, to elucidate the mode of action of 
YbeY, immunoprecipitation was used to identify interactors of YbeY. This could 
potentially indicate the interacting protein partners and, possibly shed some light on 
the mechanism by which YbeY influences ribosomal biogenesis and translation. 
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4.2.6 Immunoaffinity purification of YbeY to identify potential interactors 
Even though the effect of YbeY depletion had been extensively characterised, and 
various effects on RNA metabolism and mitoribosomal biogenesis were identified, the 
exact mechanism, site of action and substrate of YbeY was still unclear. Therefore, 
immunoaffinity purification was used to identify potential interactors of YbeY. 
To perform this, overexpression of flag/strep-2 tagged YbeY was induced in 
HEK293T Flp-In cells, the cell lysate was incubated with beads coated with anti-Flag 
antibody and the interacting proteins were eluted using flag peptide. The proteins 
were resolved on a 4-12% bis-tris polyacrylamide gel, prominent bands were cut and 
identified using mass spectrometry. Flag-tagged Luceriferase pulldown was used as a 
control to identify interactors non-specific to YbeY. A strong candidate was identified 
by mass spectrometric analysis as P32 (C1qBP) (Figure 4.2.28A). The other weaker 
band could not be identified. P32 is a multifunction mitochondrial chaperone protein 
that has been shown to bind to C1q complement component, Hyaluronic acid, and a 
large number of intracellular and extracellular proteins  (Storz et al., 2000; Fogal et 
al., 2010). To identify if this observed interaction with P32 was YbeY-specific and not 
a side-effect of YbeY overexpression, reciprocal immunopurification of Flag-tagged 
P32 was used. However, this did not pull down YbeY. Only a smaller band was 
identified as the post pre-sequence cleavage product of P32 (Figure 4.2.28B). This 
suggested that P32 might be upregulated in the cell as a response to overexpression of 
YbeY and therefore, is not a specific interactor of YbeY.  
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Figure 4.2.28 Immunopurification of YbeY and P32. Proteins containing a C-terminal flag tag were 
overexpressed in HEK293T Flp-In cell lines using 100 ng/ml doxycycline, mitochondria were 
isolated from the cells, the mitochondrial lysate was incubated with the beads coated with antibodies 
against the Flag epitope and the bound proteins were eluted using flag peptide. The eluent was resolved 
on a 4-12% Bis-Tris SDS-PAGE gel and prominent bands were cut for analysis using LC-
MS/MS (A) Flag/Strep2-tagged YbeY (n=2). Flag-tagged Luciferase was used as a control. (B) 
Flag-tagged P32  
 
Next, we performed a more sensitive and quantitative SILAC-based immunoaffinity 
purification using anti-flag antibodies. Instead of using the Flag/Strep2-tagged 
protein, a flag-tagged YbeY was used. Flag-tagged YbeY HEK293T Flp-In cells were 
grown in heavy and light stable isotope labelled amino acids. One of the two were 
induced with doxycycline to overexpress YbeY-flag. The cells were mixed in equal 
proportion, the mitochondria were extracted and the mitochondrial lysates were 
incubated with anti-flag antibody-covered beads. After multiple washes, the proteins 
were eluted using flag peptide. These proteins were then analysed using mass 
spectrometry. The proteins from the uninduced and induced cell lines were separated 
based on their stable isotope labelling. Peptides common to both samples were used to 
calculate the ratio of the amount pulled down with the overexpressed YbeY to the 
proteins pulled down due to non-specific interaction. The SILAC labelling allows for 
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the level of interaction to be quantified and allows weak and specific interactions to be 
identified. The experiment was performed with reciprocal labelling which also acts as 
an independent repeat. The log2(ratio of induced/uninduced) was plotted for both 
experiments.  
The top right quadrant of the graph signifies proteins that have been enriched in the 
overexpression cell line in reciprocal experiments. The proteins depicted in the lower 
left quandrant indicate those proteins that are more abundant in the control cell line. 
Proteins in the top left and bottom right quandrant are considered noise in the data 
that showed an increase in one sample but a decrease in the other (Figure 4.2.29A).  
A limitation of the SILAC method could be that when the mitochondria are lysed, the 
overexpressed YbeY may interact with proteins from the control cell line. This would 
dilute the signal of the interaction. This would lead to a lack of strong interactors of 
YbeY (Figure 4.2.29A). P32 was not identified as one of the major interactors of 
YbeY, possibly due to the different C-terminal tag used for pulldown. YbeY was 
highly abundant in the ‘induced sample’ (Figure 4.2.29A). YbeY was removed from 
the graph and the scales were adjusted to identify the strongest interactors of YbeY. 
This identified various mt-LSU (red diamonds in Figure 4.2.29B) and mt-SSU (blue 
diamonds in Figure 4.2.29B) component proteins, and other proteins related to 
mitoribosome biogenesis. The strongest interactor of YbeY was identified to be 
MRPS11. The next highest interactors were mt-LSU components MRPL2, MRPL4, 
MRPL20, MRPL21, MRPL42, MRPL43, MRPL50 and GADD5GIP1 (GADD45), 
and mt-SSU component MRPS26. The other strongest interactors included, heat 
shock protein, HSPA9, Aminoadipate-Semialdehyde Synthase, AASS1 (Sacksteder 
K.A. et al., 2010), ERAL1, a 12S ribosomal rRNA chaperone (Dennerlein S. et al., 
2010) and Large 60S Subunit Nuclear Export GTPase 1 and LSG1 (Kallstrom,G et 
al., 2003) (Figure 4.2.29B). This strongly suggests a role of YbeY in mitoribosomal 
biogenesis. 
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Figure 4.2.29 Immunoaffinity purification of flag-tagged YbeY. Overexpression of flag-tagged YbeY 
was induced in HEK293T flp-In cells grown in SILAC media (heavy or light) while cells grown in 
the opposite SILAC media were not induced. Cells were mixed in equal proportion and mitochondria 
were isolated. YbeY was pulled down from the mitochondrial lysate using beads coated with antibodies 
against the flag epitope and eluted using flag peptide. The immunopurified proteins were identified 
using mass spectrometry. The log2(ratio of peptide abundance in induced cells to peptide abundance in 
uninduced cells) were plotted on the X and Y axes from reciprocally- labelled experiments. Proteins in 
top right quadrant are those that were more abundant in the sample with YbeY overexpression and 
immunopurification while proteins in the lower left quandrant are more abundant in the control 
uninduced sample. (A) The graph was plotted with YbeY to show overexpression (B) and without 
YbeY for better resolution of pulldown products. Blue diamond, mt-SSU components, Red diamonds, 
mt-LSU components, grey diamonds, other. 
 
4.3 YbeY – Discussion 
The maturation of the mitoribosome involves RNA folding and the assembly of the 
nuclearly-encoded protein components. The biogenesis factors that direct this process 
remain largely unidentified. Here, we identify a novel mitochondrially-targeted 
putative RNA endonuclease called YbeY. In bacteria, this protein is vital for the 
removal of internal transcribed spacers from precursors of the ribosomal RNA and 
the degradation of improperly assembled ribosomes. However, in human 
mitochondria, this processing function is not required as the 16S and 12S rRNA do 
not have internal transcribed spacers that need to be removed. To identify the role of 
Ybey in the human mitochondria, we generate YbeY-deficient cell lines using zinc 
finger nuclease technology and show that the absence of YbeY leads to a loss of cell 
viability and OxPhos function, resulting from severely compromised translation. An 
initial hypothesis of the role of YbeY in processing of precursor mtRNA at non-
canonical cleavage sites between ATP6/8 and CO3 mRNAs was refuted via northern 
blotting and RNA-Seq analysis. However, we identified tRNASer(AGY) as a potential 
target of the endonucleolytic function of YbeY. Moreover, quantitative sucrose 
gradient fractionation and mass spectrometry of mitoribosomal assembly stages 
showed that in particular, biogenesis of the mt-SSU is impaired in YbeY knockout 
cells. Immunoaffinity purification of YbeY also identified mt-SSU component, 
MRPS11 as a key interactor. We propose that YbeY is a mitoribosomal biogenesis 
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factor that coordinates the assembly if the small subunit through hits interaction with 
MRPS11.  
 
4.3.1 YbeY is a vital for mitochondrial function 
YbeY is not a highly conserved protein. YbeY is absent in large sections of the 
evolutionary tree and the lack of a bacteria-like rRNA operon in mammalian 
mitochondria suggests a reassignment of YbeY’s function. In silico analysis of the 
amino acid sequence and the predicted structure showed that the residues involved in 
catalysis are conserved. The 3D structure modelling of the human YbeY using the E. 
coli homolog as a template showed that the structure of the catalytic site is conserved 
along with the Arg55 residue (equivalent to bacterial Arg59, PDB 1XM5) and the 
H3XH5XH zinc ion-binding motif, which are required for RNA binding and 
nuclease activity, respectively (Davies et al., 2010; Zhan et al., 2005). They also lie 
within an electropositive pocket which is the site predicted for nucleic acid docking. 
The zinc ion coordinated by the histidine triad is vital for catalysis as addition of a 
chelating agent, EDTA, inhibits RNase activity of the enzyme (Jacob et al., 2013). 
Previous analysis of the human YbeY also showed that certain residues required for 
protein-protein interactions in bacterial YbeY, namely Asp85 are conserved. There is 
an addition of nine amino acids (Gly75-Pro83) between two conserved beta sheets, 
which may confer additional protein interaction capabilities compared to its bacterial 
homolog (Ghosal et al., 2017). Taken together, this suggests that the endonucleolytic 
function of YbeY is conserved in humans.  
Using immunofluorescence analysis of YbeY localisation we show that YbeY is solely 
localised in the mitochondria implying that it does not play a role in nuclear gene 
expression. Western blot analysis of the fractionated human cells showed that YbeY is 
found in the mitochondrial matrix. This confirmed prediction made by mitochondrial 
localisation databases, Mitocarta 2.0 and Mitominer 4.0, based on information 
gathered from analysis of the mitochondrial proteome and bioinformatic analysis of 
the mitochondrial targeting sequence and comparison to the homolog in Rickettsia 
(Calvo et al., 2016; Hung et al., 2014, Smith and Robinson, 2016). Furthermore, the 
absence of YbeY in mitochondrial RNA granules does not necessarily suggest that it 
does not play a role in processing the nascent transcript because some RNA-
processing enzymes such as PUS1 are not found in RNA granules (Antonicka et al., 
2015).  
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In further work on YbeY, we confirmed that the protein is vital for mitochondrial 
function and cell viability. This result is consistent with studies in bacteria which show 
that YbeY is crucial for cell viability (Davies et al., 2010). Recently, Arroyo et al. 
(2016) created a ‘death screen’, which used CRISPR technology to delete genes in 
immortalised human cell lines. Then, the cells were replica plated in glucose medium 
or galactose medium, which forced the cells to rely on their mitochondria for ATP 
production. This identified YbeY as a protein vital for mitochondrial function and cell 
viability. 
 
4.3.2 Absence of YbeY leads to aberrant mt-RNA processing 
In E. coli, YbeY facilitates the processing of the 3’ end of 16S rRNA (SSU), the 
maturation of the 23S (LSU) and 5S rRNA molecules, and the degradation of 
defective late stage 70S ribosomes (Jacob et al., 2013). However, these cleavage steps 
are not required in mammalian mitochondria as there are no transcribed spacers 
encoded in the mitochondrial genome that need to be removed. The 12S and 16S 
mammalian mitochondrial rRNA-coding sequences are immediately preceded and 
succeeded by tRNA molecules (Figure 4.4). Furthermore, the 5S rRNA molecule in 
not encoded in mammalian mtDNA and in human mt-LSU has been replaced by a 
mt-tRNAVal (Amunts et al., 2015). All the mt-rRNA coding regions do not need to be 
processed similar to their bacterial equivalents. Instead, they are excised by RNase P 
and RNase Z as described by the Punctuation Model (see Introduction section 1.4). 
Therefore, the mammalian orthologue of YbeY is likely to have an alternate function 
in the mitochondria. YbeY may still be involved in the quality control and 
degradation of defective small subunit. 
This led us to propose that YbeY is involved in the processing of the non-canonical 
cleavage sites. Four major non-canonical cleavage sites have been identified that are 
not catered for by the Punctuation Model. These include the ATP8/6-CO3 junction, 
the ND5-Cytb junction, the 3’ end of ND6 and the 5’ end of CO1. The deletion of 
PTCD2 (Penticopeptide repeat domain protein 2) in mice led to a reduction in the 
processing of the ND5-CytB cleavage site. Similarly, FASTKD2 (FAST domain-
containing protein 2) is a kinase that binds to multiple sites along the ND6 mRNA 
and cooperates with the degradosome to facilitate the maturation of the ND6 
precursor transcript (Jourdain et al., 2015; Popow et al., 2015; Xu et al., 2008). No 
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proteins have been identified that enable the maturation of the ATP8/6-CO3 and 
CO1 precursor transcripts.   
The mitochondrially-targeted endoribonuclease we had identified appeared as a 
candidate for this purpose. However, our results show conclusively that YbeY is not 
responsible for these two cleavage events. Northern blotting of mtRNA form YbeY 
knockdown and YbeY knockout cells showed that ATP8/6-CO3 precursor levels 
were not affected by depletion of YbeY. In addition, transcriptomic analysis of YbeY 
YbeY-deficient HEK293T cells shows that the levels of all four non-canonical 
cleavage sites remain unperturbed. We also identified that the CO3 cleavage product 
of ATP8/6-CO3 processing contains an unusual di- or tri-phosphorylated or a 
hydroxyl group at its 5’ terminus. This is confirmed by a recent mitotranscriptomic 
analysis which showed a distinct lack of a 5’ monophosphate on CO3 (Rackham et al., 
2016).  Recent characterisation of bacterial YbeY showed that YbeY cleavage activity 
produces a 5’ hydroxyl and 3’ phosphate terminus (Jacob et al., 2013). Since the 
residues involved in endonucleolytic cleavage activity in bacteria are conserved in 
humans, it stands to reason that the mechanism of cleavage is also conserved. 
Therefore, any cleavage product of human YbeY must also have a 5’ hydroxyl group. 
Our results show that CO3 does not have a 5’ monophosphate, and thus may have a 
5’ hydroxyl group. This indicates that YbeY may indeed be responsible for the 
processing of the ATP8/6-CO3 precursor. However, northern blot analysis and 
RNA-Seq showed that the ATP8/6-CO3 precursor is not affected by the depletion of 
YbeY. 
Interesting, we observed a plethora of other changes to steady state levels potentially 
caused by aberrant processing events in YbeY-deficient cells. Northern blotting 
identified an increase in Complex I transcripts and decrease in Complex IV 
transcripts. However, this has been observed previously in mitochondria with deficient 
RNA metabolism. In PDE12 knockout cells where the lack of the poly-(A) 
exoribonuclease leads to spurious polyadenylation of mt-rRNAs and mt-tRNAs, and 
conditional TFB1M knockout mice lacking the methylation of two adenines on 12S 
rRNA, leads to a similar signature of increased complex I transcript and decreased 
complex IV transcripts (Metodiev et al., 2009; Pearce et al., 2017; Sharoyko et al., 
2014). This implies that these observed effects on mRNA stability are not specific to 
YbeY deficiency and are likely compensatory effects of mitochondrial translation 
deficiency. A noticeable reduction was observed in the RNA-seq analysis of the steady 
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state level of various tRNAs in YbeY (-/m) cells, namely tRNAs for Ser(AGY), Ile, 
Ala, Trp, Met, Leu(CUN) and Glu. A closer inspection of mt-tRNASer(AGY) showed 
that its steady-state level was reduced in northern blots in YbeY (-/-) cells. 
Circularisation RT-PCR showed that in YbeY (-/-) cells there was a severe reduction 
in mt-tRNASer(AGY) with correctly processed 5’ and 3’ ends, with the strongest change 
observed at the 5’ end.  
Human mt-tRNASer(AGY) is found between two other mt-tRNAs, tRNAHis and 
tRNALeu(UUR). Previous work had demonstrated that the 5’ end processing of mt-
tRNASer(AGY) is not performed by RNase P. Instead, using mitochondrial extracts on in 
vitro transcribed radiolabelled RNA substrates, Rossmanith (1997) showed that the 5’ 
of mt-tRNASer(AGY) is probably released through the action of 3’ endonucleolytic 
processing of mt-tRNAHis. This cleavage event does not take place in the absence of 
mt-tRNAHis. On the other hand, the presence of mt-tRNALeu(UUR) is dispensable for 
mt-tRNASer(AGY) 3’ end processing. The 5’ end mt-tRNAHis- mt-tRNASer(AGY) end-to-
end junction is conserved in all vertebrates, while the 3’ end of mt-tRNASer(AGY) is 
variable. For example, in the platypus, there is a 4 nucleotide overlap between the 3’ 
end of Ser(AGY) and the 5’ end of Leu(UUR). This implies that the sequence or 
structure of mt-tRNAHis is necessary of the recognition of the cleavage site at the 5’ 
end of mt-tRNASer(AGY) (Rosmanith, 1997). 
Normally, 5’ processed products of RNase P are preferred substrates of 3’ end 
processing of tRNA by RNase Z activity (Brzezniak et al.,2011, Rossmanith, 1997, 
Rackham et al., 2016). However, this is not the case for mt-tRNASer(AGY) which shows 
cleavage activity in a non-hierarchical cleavage of the 5’ and 3’ end independent of 3’ 
and 5’ cleavage respectively (Rossmanith. 1997). A recent mitotranscriptomic analysis 
of MRPP3-deficient mice showed that indeed, the steady state levels of mt-
tRNASer(AGY) are not affected by lack of RNase P activity. However, the effect on the 
other tRNAs mentioned above is not as pronounced, suggesting a possible 
redundancy in the system for these tRNAs (Rackham et al., 2016). Therefore, this 
analysis shows that YbeY is required for the accurate processing of tRNASer(AGY) from 
the primary transcript. In the absence of YbeY, the 5’ and 3’ ends of the tRNA are 
erroneously identified.  It is unclear if YbeY directly cleaves the transcript itself or if it 
is responsible for the recognition of the tRNA termini and targeting of the nuclease to 
these sites for accurate cleavage. 
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The depletion of YbeY also led to a distinct decrease in 7S RNA produced from the 
L-strand. This RNA species is required for the synthesis of 7S DNA and the initiation 
of DNA replication. However, no change was observed in mt-DNA copy number, 
suggesting that 7S levels are not the rate-limiting step in DNA replication. A similar 
effect on 7S RNA is seen in MRPP3-deficient cells and may be a consequence of a 
disruption of RNaseP activity (Rackham et al., 2016). This suggests that disruption of 
primary transcript processing (due to a lack of MRPP3 or YbeY) may lead to a 
compensatory switch from DNA replication to transcription, preventing the 
termination of LSP transcription elongation at CSB2. This would lead to the observed 
7S RNA depletion in the YbeY (-/-) cells. 
 
4.3.3 YbeY is necessary for mitoribosome biogenesis 
YbeY in bacteria plays a key role in the biogenesis and quality control of the 
ribosome. It is responsible for the maturation of SSU rRNA, LSU rRNA and 5S 
rRNA. In addition, YbeY identifies and degrades 70S ribosomes containing defective 
SSUs, thus facilitating ribosomal quality control. We sought to elaborate on the 
source of the mitochondrial dysfunction further. Cells lacking YbeY showed a high 
reliance on glycolysis. They were incapable of growing in galactose medium and 
OxPhos function was severely affected by the lack of YbeY. Western blot analysis of 
components of the respiratory complexes showed a reduction in complexes which 
have mitochondrially-encoded components suggesting a deterioration of 
mitochondrial translation in YbeY deficient cells. Furthermore, labelling of newly 
synthesised translation products with [35S]-methionine showed that mitochondrial 
translation was reduced in a YbeY dose dependent manner. A reduced amount of 
YbeY in the hemizygous HEK293T cells led to a reduced effect on translation. 
However, a lack of YbeY led to a lack of measurable translation products after 30 
minutes of labelling. Moreover, translation was uniformly decreased irrespective of the 
size of the translation product. In a recent paper by Pearce et al. (2017), larger 
translation products were affected more than the smaller translation products caused 
by translational stalling due to lack of a specific tRNAs. This suggests that the 
translation problem we observe is due to defective ribosomes rather than translational 
stalling. Moreover, surprisingly, reintroduction of YbeY lacking the H117 residue, 
required for zinc sequestration and catalysis, led to a rescue of mitochondrial 
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translation. This indicates that the function of YbeY in mitochondrial translation is 
independent of its endonucleolytic activity.  
To identify the effect of YbeY on mitoribosomal integrity, we used in vivo SILAC 
labelling of parental and knockout cells, sucrose gradient fractionation of the cell 
lysate and mass spectrometric analysis (qGFMS). This allowed us to successfully 
resolve the assembled ribosome, the individual subunits and their subunits, and 
quantify changes in their composition. This method has been successfully used in the 
past to identify subassemblies in bacterial small subunit assembly (Sashital et al., 
2014). Using this method, we identified a decrease in mt-SSU levels and higher levels 
of mt-LSU. Moreover, a decrease was observed in the levels of mt-LSU assembled 
into monosomes. However, this effect on the mt-LSU was not as severe as in the mt-
SSU. This increase in mt-LSU may be a compensatory effect as a response to a lack of 
mt-SSU assembled into monosomes. Alternatively, these differences in levels may be 
caused by a decrease in stability of improperly assembled ribosomes.  
The compensatory increase in mt-LSU has been previously observed in mice 
containing a mutation in MRPS34, which show a loss of mt-SSU assembly. In these 
mice, there is an increase in mt-LSU protein levels and a decrease in monosome 
assembly (Richman et al., 2015). Northern blotting also showed that 12S rRNA steady 
state levels are reduced in the absence of YbeY. Overall, this indicates that YbeY 
plays a role in mt-SSU assembly and a loss of YbeY leads to a defect in mitoribosomal 
biogenesis. However, the interaction between YbeY is transient or weak as YbeY did 
not co-migrate with the mitochondrial small or large subunit in sucrose gradients.  
 
4.3.3.1 YbeY assists mt-SSU assembly via interactions with MRPS11 
In bacteria, YbeY is responsible for 3’ end processing of the SSU rRNA, the 
maturation of the 23S LSU rRNA and 5S RNA molecule, and the degradation of 
assembled ribosomes containing defective SSUs (Jacob et al., 2013). In our 
experiment, YbeY showed a clear role in mt-SSU biogenesis. A rescue of knockout 
translation by a catalytic mutant suggests that this role in mitoribosomal biogenesis 
may not be related to its endonucleolytic activity. However, bacteria lacking YbeY 
complimented with human YbeY do not show a rescue of SSU rRNA processing. 
These cells did show a partial rescue of stress sensitivity when human YbeY was 
introduced. This partial rescue was not observed with catalytically inactive human 
YbeY (Ghosal et al., 2017). This suggests a divergence of human YbeY function from 
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its bacterial homolog and that the endonucleolytic function may be independent of its 
function in assisting mitochondrial translation. 
We next looked into identifying the mechanism by which YbeY influences 
mitoribosome biogenesis. To do this, we performed SILAC-based immunoaffinity 
purification of flag-tagged YbeY. Interestingly, we identified various mt-LSU 
components, including, MRPL2, MRPL4, MRPL20, MRPL21, MRPL28, MRPL42, 
MRPL43, MRPL44, MRPL50 and GADD45GIP1 (Figure 4.3.1). Investigation of 
these proteins in the qGFMS data showed that these proteins were not depleted in 
response to the loss of YbeY, which suggests that the interaction may be indirect 
through RNA. Three non-mitoribosomal proteins were also identified - HSPA9, 
LSG1 and AASS (Table 4.3.1). 
 
Figure 4.3.1 YbeY interactors on the mitoribosomes. Light grey, mitoribosomal proteins; Dark grey, 
rRNA (A) mt-LSU. Interactors form a belt around the middle of the protein. (B) mt-SSU. Interactors 
are also found around the exterior of the protein. The structure was visualised using PyMol molecular 
graphics system (PDB: 3J9M) 
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Figure 4.3.2 Effect of YbeY knockout on sucrose gradient fractionation of interactors of YbeY. 
Heatmap from figure 4.23 filtered for interactors of YbeY. Red indicates maximum intensity of 
detection while black indicated lack of detection of the protein in that fraction. In the case of 
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MRPS11, the heatmap was generated from the unmixed SILAC sampels as MRPS11 was not 
detected in the knockout cells and thus a comparison could not be generated. It must be noted that the 
lack of detection of MRPS11 does not necessarily indicate absence of protein. 
 
Protein Localisation Function Reference 
HSPA9  See Table 3.3.1  
LSG1 Nucleus, 
Endoplasmic 
reticulum, 
cytoplasm 
GTPase involved 
with cytoplasmic 
ribosomal 
biogenesis 
Reynaud et al. 
(2005) 
AASS Mitochondria Lysine degradation 
pathway 
Markovitz et al. 
(1984) 
 Table 4.3.1 Non-mitoribosomal protein interactors of YbeY 
 
However, the strongest interactor of human YbeY was identified to be MRPS11. In 
bacteria, YbeY interacts with the small subunit component, S11 and small subunit 
biogenesis factor, Era. A recent pulse quantitative proteomic analysis of bacterial SSU 
assembly identified that S11 is one of the last proteins to assemble, as there are 
essentially no precursor pools with S11 in them (Chen et al., 2012). Era is a GTPase 
that binds to the precursor of 30S bacterial ribosomal small subunit close to the 3’ 
terminus of the 16S rRNA, while interacting with S2, S7, S11 and S18. In bacteria, it 
facilitates maturation of the RNA by acting as a chaperone. Era is displaced by 
ribosomal protein S1 on the final assembly step, completing the maturation of the 
bacterial small subunit. In vitro and in silico analysis showed that bacterial YbeY 
interacts with Era and S11 suggesting that YbeY may interact with the assembling 
small subunit at the 3’ terminus of the rRNA. Furthermore, investigation of bacterial 
YbeY interaction through targeted mutations indicated that the interaction between 
YbeY and Era is indirect, through its interaction with S11. The efficacy of YbeY in 
the maturation of 16S rRNA in bacteria is highly dependent on its interaction with 
S11. Given that no RNA-targeting domain has been identified in YbeY that could 
confer sequence specificity, this interaction may target the nuclease to its substrate 
(Vercruysse et al., 2016).  
Human YbeY not only showed an interaction with MRPS11, it also showed a weaker 
(and possibly indirect) interaction with ERAL1 (homolog of bacterial Era). In the 
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qGFMS data, MRPS11 was not detectable in the YbeY KO samples while ERAL1 
levels increased in response to the absence of YbeY. This suggests that like in the 
bacteria, the interaction with ERAL1 is indirect mediated through its interaction with 
MRPS11. This also implies that the site of interaction of YbeY is conserved and lies at 
the 3’ end of the SSU rRNA. In the mammalian mitoribosome, the region adjacent to 
S11 are protruding out of the structure and could be the potential site for YbeY 
binding (see figure 4.3.3) (Greber and Ban, 2015). Here, similar to its bacterial 
ortholog, YbeY may degrade improperly assembled SSU rRNA. The bacterial YbeY 
only cleaves single stranded RNA. It is incapable of cleaving dsRNA, RNA that 
contain 2’-O-ribose methylations, hairpin loops, and 3’ ssRNA extensions after 
hairpin loops that are 10 nucleotides or fewer (Jacob et al., 2013). MRPS11 binds to 
two distal regions of the 12S rRNA (see figure 4.3.3). The secondary structure of these 
regions is predominantly base paired. Moreover, the hairpin loop at the 3’ end of the 
rRNA is not only bound by ERAL1 (Uchiumi et al., 2010), but is also dimethylated by 
TFB1M. YbeY may act as a part of quality control mechanism as it would only be 
able to degrades rRNA that is not base paired or methylated. In the mitochondrial 
SSU, YbeY may facilitate late stage assembly and quality control of final maturation 
of the small subunit.  
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Figure 4.3.3 In silico footprinting of MRPS11. (Right and below) The distance of each amino acid 
of MRPS11 to each nucleotide of 12S rRNA was calculated. From this, all the nucleotides within 
hydrogen bonding distance were filtered out and mapped onto the schematic diagram of 12S rRNA. 
Red lines around the 12S rRNA indicate sites at which MRPS11 comes within 3Å of the rRNA. 
Orange hexagons indicate sites of modification on the rRNA. (Left) The 3D structure of the small 
subunit where the rRNA is in gray and the MRPSs are in wheat. MRPS11 is depicted in green. The 
sites of MRPS11 interaction on the rRNA are shown in red. This structure also illustrates the exposed 
rRNA to which both ERAL1 and YbeY can bind (Uchiumi et al., 2010). The structure was 
visualised using PyMol molecular graphics system (PDB: 3J9M) 
	192	
Interactomic analysis of bacterial YbeY showed that it does not associate with various 
translation apparatus-associated factors such as translation initiation factors (IF2 and 
IF3) and ribosome biogenesis factors (KsgA, GsgA, RbfA and RimM). YbeY also does 
not interact with exoribonuclease, RNase R with which it degrades improperly 
assembly 70S ribosomes. One interesting protein bound to bacterial YbeY was YbeZ, 
which is a protein of unknown function with a NTP hydrolase domain (Kazakov et 
al., 2003). It’s function in YbeY’s role in ribosome biogenesis and quality control is 
unknown. However, as a NTPase, it may be required for dissociation of YbeY from 
the ribosome fuelled by the hydrolysis of ATP or GTP. In human, no homolog of 
YbeZ has been identified. Our results also fail to identify a mitochondrially-targeted 
NTPase interactor. Hence, this role may not be conserved in humans.  
 
 
Figure 4.3.4 Schematic model of YbeY in mitoribosomal biogenesis. YbeY (purple) assists mt-SSU 
assembly through its interaction with MRPS11 (green). After its transient interaction with the mt-
SSU, it dissociates and allows monosome formation.  
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5 Concluding remarks and future directions 
 
The work presented here describes two distinct responses to knockouts of factors 
involved in mitoribosomal biogenesis. Studies performed on knockout and 
overexpression cell lines, provide evidence for the dispensability of MRM1 and the 
G1145 rRNA methylation on various aspects of mitoribosomes maturation, 
mitochondrial translation and function. We have also not identified any 
mitoribosomal component interactors of MRM1. For further research, we aim to 
directly confirm complete loss of methylation using mass spectrometry in order to 
exclude the possibility that the lack of observed phenotype is caused by the presence of 
a few molecules with the Gm1145 modification. It is also possible that redundancies in 
the system may cause a few RNA molecules to be modified by alternative proteins 
that are not detectable by the primer extension assay. Further research needs to focus 
on finding conditions where mitoribosomes will show a measurable impact of loss of 
the modification. This may be in the form of intraribosomal stresses, such as 
antibiotics and inhibitors, or through the generation of double mutants or cell lines 
expressing dominant negative protein.  
In this work, we have also identified YbeY as a novel factor, vital for mitoribosomal 
assembly and integrity. We have shown that YbeY is mitochondrially-localised and 
depletion of YbeY leads to a loss of mitochondrial translation resulting in a reduction 
of OxPhos function and consequently, a loss of cell viability. Northern blotting and 
RNA-Seq analysis identified mitochondrial tRNASer(AGY) as a potential target for 
YbeY endoribonucleolytic activity. Loss of YbeY had a detrimental effect on the levels 
of assembled mt-SSU. Immunoaffinity purification identified MRPS11 as a key 
interactor of YbeY and a potential mechanism through which mt-SSU biogenesis 
could be affected by YbeY. Further evidence needs to be gathered to confirm the 
interaction of YbeY and the mt-SSU through the MRPS11 and the role this 
interaction plays in mt-SSU assembly. We aim to perform further crosslinking studies 
to confirm the YbeY-MRPS11 interaction and CLIP assays to identify RNA targets of 
YbeY.  
YbeY also seems to have independent endonucleolytic functions in the mitochondria 
as loss of mitochondrial translation can be rescued through the reintroduction of 
predicted catalytically inactive protein. However, the loss of endonucleolytic activity 
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needs to be confirmed through RNA-Seq and northern blotting against tRNASer(AGY). 
If the tRNAs are still improperly processed in these cells rescued with predicted 
catalytically inactive protein, this would imply that YbeY performs endonucleotytic 
functions independent of its role in assisting mitoribosomal biogenesis. Northern blot 
analysis needs to be extended to all the tRNAs shown to be affected in the RNA-Seq 
data.  Furthermore, RNA-Seq analysis of Hap1 knockout cells needs to be performed 
to confirm the observed effects on RNA steady state levels observed in YbeY-deficient 
HEK293T cells.  
This work has contributed to the building body of knowledge on the role of chemical 
modifications of rRNA on mitoribosomal biogenesis, and has identified a novel 
mitoribosomal biogenesis factor that may also have a role in RNA processing in the 
mitochondria. The latter discovery points towards a possible mechanism that connects 
mitochondrial RNA processing to mitoribosomal biogenesis and translation. 
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